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voor Pap en Mam
Charles R. Darwin (1809 - 1882)
“When we no longer look at an organic being as a savage looks at a ship, as at 
something wholly beyond his comprehension; when we regard every production of 
nature as one which has had a history; when we contemplate every complex structure 
and instinct as the summing up of many contrivances, each useful to the possessor, 
nearly in the same way as when we look at any great mechanical invention as the 
summing up of the labour, the experience, the reason, and even the blunders of 
numerous workmen; when we thus view each organic being, how far more interesting, 
I speak from experience, will the study of natural history become!” 
(Charles R. Darwin (1859): On the origin of species by means of natural selection -or 
the preservation of favoured races in the struggle for life- p485)
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The synthesis of ribosomes is one of the most energy demanding processes in the cell. In eukaryotes, the production of ribosomes is restricted to a specialized non-membrane bound nuclear compartment 
called the nucleolus. The architecture of the nucleolus heavily depends on the 
active synthesis of ribosomal RNA molecules. De novo transcribed ribosomal 
RNA is extensively modifi ed by numerous trans-acting factors. The majority of 
these factors are protein-RNA complexes which are generally referred to as 
small nucleolar ribonucleoprotein particles (snoRNPs). Specifi c nucleotides of 
the ribosomal RNA are methylated or pseudouridinylated by specifi c snoRNPs 
in a site-directed manner. Another subset of snoRNPs processes the ribosomal 
RNA by endonucleolytic cleavages. RNase MRP belongs to the third and rather 
small class of RNase MRP / RNase P snoRNPs, and mainly functions in the 
cleavage of ribosomal RNA precursors. The other family member, RNase P, is 
involved in the endonucleolytic processing of transfer RNA precursors. In this 
chapter an overview is given of the current knowledge of the RNase MRP and 
the related RNase P complex.
Biosynthesis of ribosomal RNA in 
the nucleolus
The mature eukaryotic ribosome consists 
of two major subunits, which sediment at 
40S and 60S and are generally referred 
to as small and large ribosomal subunit, 
respectively. Together they form the mature 
rib are generally referred to as small and large 
ribosomal subunit, respectively. Together they 
form the mature ribosome which sediments 
at 80S. Besides many proteins, the fully 
assembled human ribosome contains four 
different ribosomal RNAs (rRNA). The 18S 
rRNA is the only rRNA associated with the 40S 
ribosomal subunit and the 5S, 5.8S and 28S 
rRNAs are found in the 60S ribosomal subunit. 
In the nucleolus, the 18S, 5.8S and 28S 
rRNAs are transcribed by RNA polymerase 
I as a long polycistronic precursor RNA. To 
obtain mature rRNAs from this precursor, 
the latter is extensively processed by a large 
variety of trans-acting factors which catalyse 
both nucleotide modifi cations and endo- and 
exoribonucleolytic cleavages (1). The 5S 
rRNA is transcribed by RNA polymerase III 
in the nucleoplasm from a distinct gene and 
transferred to the nucleolus where it is needed 
for ribosome assembly (2).
In order to facilitate the almost continuous 
   12                Chapter 1
demand of de novo protein synthesis during 
interphase, large amounts of ribosomes are 
being produced in a cell. In an actively growing 
HeLa cell, approximately 400,000 ribosomal 
proteins enter the nucleolus each minute, 
which means that on average 10,000 ribosomal 
subunits are synthesized each minute and a 
similar number of newly assembled ribosomal 
subunits have to be transported over the 
nuclear envelope to the cytoplasm in the same 
period of time. This impressive production 
of ribosomes obviously needs an equally 
effi cient, simultaneous production of ribosomal 
RNAs. For that purpose, the gene encoding 
the 18S, 5.8S and 28S rRNAs is present in 
multiple copies. In total, there are about 200 
copies of this polycistronic rDNA gene present 
on fi ve different chromosomes in the human 
system. The gene which encodes the human 
5S rRNA is present in approximately 2,000 
copies, all present on chromosome 1 (2). 
As indicated above, most of the transcription 
and processing of rRNA is restricted to the 
nucleolus. This large non-membrane-bound 
nuclear compartment was fi rst described in 
1836 by Valentin (3) and typically represents 
the highest concentration of mass in an 
eukaryotic cell. Therefore, one might think 
that nucleoli are quite rigid structures, but 
the opposite is true. Recent data show that 
nucleoli and their associated constituents are 
highly dynamic (4) and that their formation 
and conformational integrity requires ongoing 
transcription of the ribosomal DNA (5). As a 
consequence, nucleoli are only present in 
interphase cells and disassembled during 
mitosis. A closer inspection of the nucleolus 
learns that several subnucleolar structures 
can be discerned. In human nucleoli typically 
three sub-nucleolar compartments are 
Figure 1. Nucleolar morphology.
The left panel shows a light microscopic 
image of a typical human HEp-2 cell with 
multiple nucleoli in the nucleus. In the upper 
right panel, an electron microscopic image 
of a human nucleolus is depicted. The lower 
right panel shows a schematic representation 
of the subnucleolar compartments, present 
in an interphase nucleolus (4-6). FC: fi brillar 
center, DFC: dense fi brillar component, GC: 
granular component.
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found (Figure 1). The fi brillar center (FC) 
contains decondensed rDNA and important 
transcription factors such as the upstream 
binding factor, DNA topoisomerase I and RNA 
polymerase I. The dense fi brillar component 
(DFC) surrounds the multiple FCs and 
contains most of the early rRNA processing 
factors. The transcription of rRNA most 
probably takes place at the transition zone 
between the FC and the DFC. The FC and 
DFC are embedded in a granular component 
(GC) which accounts for the majority of the 
nucleolar mass and is thought to be involved 
in most of the late rRNA processing steps. The 
nucleolar architecture refl ects the vectorial 
processing of pre-rRNA into pre-ribosomes 
(6). In the nucleolus, the pre-rRNA undergoes 
extensive posttranscriptional modifi cation 
which include the conversion of specifi c 
uridine nucleotides to pseudouridines, the 
methylation of certain riboses and bases and 
exo- and endoribonucleolytic processing of 
precursor rRNA which eventually leads to the 
mature 18S, 5.8S and 28S rRNAs (7). 
The majority of these maturation reactions 
are mediated by so-called small nucleolar 
ribonucleoprotein particles (snoRNPs). These 
macromolecular complexes typically consist 
of an essential snoRNA subunit and multiple 
protein subunits. The RNA moiety of snoRNPs 
has been shown to be essential for the 
catalytic action of these complexes as they not 
only serve as a binding scaffold for the actual 
converting enzymes but also as a sequential 
guide for rRNA substrate recognition or 
even participate in the catalysis themselves 
(11;12). Based on the association of shared 
protein subunits and common features of 
their RNA moieties, snoRNPs are divided 
into the following three major groups: box C/D 
snoRNPs, box H/ACA snoRNPs and RNase P 
/ RNase MRP (9) (Figure 2).
Small nucleolar ribonucleoprotein 
particles
Box C/D snoRNPs
This class of snoRNPs is characterized by the 
presence of two short conserved sequence 
elements in their RNA components, referred 
to as box C and box D. The box C/D snoRNPs 
function in posttranscriptional methylation 
on the 2’ hydroxyl group of riboses (2’-O-
methylation) of pre-rRNA (13). All box C/D 
snoRNPs share protein subunits that are 
typical for this class of snoRNPs and for some 
box C/D snoRNPs additional and specifi c 
proteins have been identifi ed. The major box 
C/D specifi c core protein is fi brillarin, which is 
likely to be the methyltransferase responsible 
for the 2’-O-methylation of pre-rRNAs. Other 
conserved core proteins of the box C/D 
snoRNP complexes are Nop58, Nop56 and 
15.5K (9). Besides their function in 2’-O-
methylation, some box C/D snoRNPs have 
   14                Chapter 1
been demonstrated or suggested to function 
in the cleavage of pre-rRNA, e.g. the U3, U8 
and U22 snoRNPs (7). A large RNP complex, 
containing the U3 snoRNA and 28 associated 
proteins was purifi ed from Saccharomyces 
cerevisiae. This macromolecular complex, also 
known as the small subunit (SSU) processome 
is required for pre-18S rRNA processing in the 
nucleolus. It has been demonstrated that the 
SSU processome corresponds to the “terminal 
knobs” which are typically present at the end 
of nascent pre-rRNA transcripts as visualized 
by electron microscopic analysis of chromatin 
spreads (14).
Box H/ACA snoRNPs
The box H/ACA snoRNPs harbor snoRNAs 
which typically hold a common ‘hairpin-
hinge-hairpin-tail’ structure and contain the 
conserved boxes H and ACA. The box H/ACA 
snoRNAs direct the pseudouridinylation of 
certain uridine nucleotides in pre-rRNA by 
means of complementary sequences present 
in the hairpin structures (11). Until now, four 
box H/ACA snoRNP associated proteins have 
been described, GAR1, dyskerin, NOP10 
and NHP2 (15;16). These proteins, as well 
as a box H/ACA motif, are also found in the 
telomerase complex, a ribonucleoprotein 
reverse transcriptase responsible for adding 
one strand of simple sequence DNA repeats to 
the ends of linear chromosomes. Besides the 
common box H/ACA proteins, two telomerase 
Figure 2. Interaction of box C/D and box H/ACA snoRNAs 
with substrate RNAs.
A: Box C/D snoRNAs contain the conserved boxes C and D. 
The C and D boxes are often close to each other due to folding 
of the RNA. The boxes C’ and D’, imperfect copies of the boxes 
C and D, frequently co-exist in box C/D snoRNAs. Boxes 
C/D and C’/D’ function in the guided 2’-O-methylation (Me) 
of ribosomal RNA (13), which basepairs with complementary 
regions present on these snoRNAs (reviewed by (8-10)). R: 
purine. B: The box H/ACA snoRNAs are characterized by the 
presence of two short hairpins and two short single stranded 
regions containing the conserved boxes H (ANANNA) and 
ACA (ACANNN) (11). The internal loops position the substrate 
ribosomal RNA for site specifi c conversion of uridine to 
pseudouridine (Ψ). N: any nucleotide.
A
B
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specifi c proteins have been identifi ed, TEP1 
and the reverse transcriptase hTERT (17). 
Other box H/ACA snoRNP specifi c protein 
components have not been identifi ed yet.
RNase P / RNase MRP
RNase P and RNase MRP represent the third 
class of small nucleolar RNPs. RNase P is 
a precursor tRNA processing enzyme which 
is ubiquitously present in every organism 
investigated. RNase MRP is described to 
process several RNAs, but in contrast to 
RNase P it is not found in eubacteria and 
Archaea (18). Because the RNA subunits of 
RNase P and RNase MRP can adopt very 
similar conformations (Figure 3), RNase P 
and RNase MRP are most likely evolutionarily 
related (19). Below, these complexes will be 
discussed in more detail.
RNase P and RNase MRP
RNase P function
The maturation of tRNAs requires several 
processing steps which include the removal 
of 5’ leader and 3’ trailer sequences, 
removal of pre-tRNA introns, the addition 
of the 3’ CCA sequence and the chemical 
modifi cation (e.g. pseudouridinylation and 
methylation) of a number of nucleotides. 
The removal of the 5’ leader sequence is 
catalyzed by the endoribonucleolytic action 
Figure 3. Secondary structures of human RNase MRP and 
RNase P RNAs.
The human RNase MRP and RNase P RNAs are 267 and 341 
nucleotides long, respectively. Evidence for the secondary 
structures of these RNAs was obtained by several studies on 
prokaryotic RNase P RNA and the RNase MRP RNA of the 
yeast and human system. The helices are named after the 
model presented by Frank and co-workers (20). The black line 
represents a long distance interaction, known as the P4 helix.
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of a ribonucleoprotein particle called RNase P 
(Figure 4). The RNase activity of RNase P was 
fi rst detected in the eubacterium Escherichia 
coli by virtue of cleaving the 5’ leader sequence 
of a tyrosine pre-tRNA in vitro (21). E. coli
RNase P is composed of only two subunits: 
an RNA subunit (M1 RNA) and a protein 
subunit (called C5) (18). Bacterial RNase P 
and the self-splicing pre-rRNA of Tetrahymena 
thermophila were the fi rst two catalytic RNAs 
(ribozymes) ever described (12;22). This 
fi nding made an important contribution to the 
concept of the ancient “RNA world”, in which 
RNAs, rather than polypeptides were the 
major biological catalysts. Under high salt 
conditions, the M1 RNA of E. coli RNase P is 
able to cleave a pre-tRNA substrate without the 
help of the C5 protein. In the human system, 
the RNase P ribonucleoprotein particle is also 
responsible for the 5’ maturation of pre-tRNAs 
(18;23). In agreement with the E. coli RNase 
P particle, human RNase P also contains 
an RNA subunit (H1 RNA). Although the H1 
RNA is required for RNase P activity, it is not 
able to act as an RNase without the help of 
proteins. The human RNase P contains 10 
proteins (23), and recently it was reported that 
only 2 of these proteins are required for pre-
tRNA cleavage (24). An in vitro reconstituted 
RNase P complex consisting of the H1 RNA 
and the Rpp21 and Rpp29 (hPop4) proteins 
was capable to cleave the 5’ leader from a 
pre-tRNA substrate. 
Figure 4.  RNase P function.
RNase P is a ubiquitous endoribonuclease present in every 
organism. To obtain mature tRNA, RNase P processes the 5’ 
end of the pre-tRNA by endonucleolytic removal of the 5’ leader 
sequence (18;23). The secondary structure represents any pre-
tRNA. RNase P is depicted as scissors. 
Figure 5. Mitochondrial RNase MRP function.
The RNase MRP complex functions in the generation of 
RNA primers, necessary for the initiation of heavy strand 
mitochondrial DNA replication. From the light strand promoter 
(LSP) region, a transcript is generated by mitochondrial RNA 
polymerase. This RNA is subsequently processed at multiple 
sites and the oligonucleotides are used for the priming of 
heavy strand mitochondrial DNA replication (29-33). The 
scissors represent the RNase MRP complex.
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Besides its involvement in pre-tRNA 
processing, the RNase P complex of S. 
cerevisiae has been described to be involved 
in pre-rRNA processing (25-27). Recently, a 
physical interaction between human RNase 
P and the RNA polymerase III transcription 
complex was reported by the group of Nayef 
Jarrous (28).
RNase MRP function
The RNase for mitochondrial RNA processing 
(RNase MRP) was fi rst described by Chang 
and Clayton in 1987 (29). In the murine, 
human, rat, bovine and yeast systems it has 
been shown that the endoribonuclease cleaves 
a mitochondrial transcript, which is derived 
from the light strand promoter (LSP) region 
and involved in the heavy strand mitochondrial 
DNA replication (29-32). RNase MRP cleaves 
this RNA molecule at defi ned sites (33) and the 
resulting products are subsequently used as a 
primer to initiate mitochondrial DNA replication 
from the LSP region by mitochondrial DNA 
polymerase (Figure 5). Paradoxically, the 
majority of RNase MRP in the cell was 
detected in the nucleolus (reviewed by (34)), 
the major cellular site for ribosome synthesis. 
This suggested also a role for RNase MRP 
in ribosome synthesis and in 1993 it was 
reported that depletion of RNase MRP RNA in 
S. cerevisiae affected the posttranscriptional 
processing of the 5’ end of 5.8S rRNA (35). In 
addition, the analysis of temperature sensitive 
RNase MRP RNA mutants revealed an 
altered rRNA processing pattern (36). Direct 
evidence for a role of RNase MRP in pre-rRNA 
processing was obtained by purifi cation of 
RNase MRP from S. cerevisiae. The purifi ed 
snoRNP was able to cleave in vitro an RNA 
substrate derived from the internal transcribed 
spacer 1 (ITS1) (37). The exact position of 
RNase MRP cleavage in ITS1 was mapped 
at site A3 (Figure 6). Cleavage of ITS1 at 
site A3 leads to the generation of the short 
     
Figure 6. Nucleolar RNase MRP function.
The majority of the RNase MRP complex is 
located in the nucleolus, where it functions in the 
processing of pre-ribosomal RNA (pre-rRNA). 
Here, the pre-rRNA of Saccharomyces cerevisiae
is depicted. The newly transcribed pre-rRNA 
contains the redundant external transcribed 
spacers (ETS) and internal transcribed spacers 
(ITS). These spacer sequences are removed by 
several trans-acting factors. The RNase MRP 
complex cleaves the pre-rRNA near the 5’ end of 
5.8S rRNA at site A3, thereby contributing to the 
maturation of the 5.8S rRNA (37). The scissors 
represent the RNase MRP complex.
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version of 5.8S rRNA (5.8S(S)), whereas the 
biosynthesis of the long version of 5.8S rRNA 
(5.8S(L)) is independent of this processing step. 
Interestingly, cleavage of ITS1 at site A3 is not 
essential for S. cerevisiae viability (35). Only 
recently, experimental evidence has been 
obtained that also in the human system RNase 
MRP plays a role in the processing of pre-rRNA 
(38;39). Evidence for a third function of the S. 
cerevisiae RNase MRP particle was obtained 
by Schmitt and co-workers, who found that 
specifi c RNase MRP RNA mutants which 
show an “exit from mitosis” delay phenotype 
exhibit an increase in CLB2 mRNA levels (40). 
RNase MRP was reported to cleave the 5’ UTR 
of the CLB2 mRNA (Figure 7), which explains 
the increased mRNA levels in RNase MRP 
RNA “exit from mitosis” mutants (41). Possibly 
related to this novel function, RNase MRP was 
recently described to localize also in specifi c 
cytoplasmic bodies, named TAM-bodies 
(temporal asymmetric MRP bodies) (42).
RNase P and RNase MRP 
composition and architecture
Human RNase P and RNase MRP are 
composed of several protein subunits and 
an RNA subunit of 341 and 267 nucleotides, 
respectively. The RNAs participate in the 
endonucleolytic reaction performed by these 
complexes and in addition serve as a scaffold 
for protein binding. Autoantibodies from serum 
of patients suffering from systemic lupus 
erythematosus, scleroderma, Raynaud’s 
phenomenon or polymyositis (also known as 
anti-Th/To antibodies) (43), which recognize 
epitopes specifi cally present on both the RNase 
P and RNase MRP complexes, facilitated the 
identifi cation of the RNA subunits of the human 
RNase P and RNase MRP particles (44;45). 
Although the RNA subunits of the RNase P 
and RNase MRP complexes have only little 
sequence homology, they can adopt very 
similar secondary structures (18;19) (Figure 
Figure 7. Nuclear RNase MRP function.
In Saccharomyces cerevisiae, RNase MRP 
contributes to the regulation of the cell cycle by 
cleavage of the 5’ untranslated region (5’UTR) 
of the cyclin B2 (CLB2) mRNA (41). RNase 
MRP cleaves the 5’UTR of the CLB2 mRNA 
endonucleolytically at 5 distinct positions. 
Cleavage of the CLB2 mRNA by RNase MRP 
promotes the subsequent degradation of the 
mRNA by the Xrn1 exoribonuclease, resulting in 
a downregulation of the cyclin B2 expression.
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3). Because of the high degree of structural 
similarity, it is generally believed that RNase P 
and RNase MRP are evolutionarily related and 
that RNase MRP originates from an ancient 
RNase P complex (Figure 8).
RNase P and RNase MRP RNA sequences 
and predicted secondary structures for many 
eubacteria, Archaea and eukarya are available 
(48;49). For the E. coli and Bacillus subtilis
RNase P RNAs and S. cerevisiae and Homo 
sapiens RNase MRP RNAs also structural 
information has been obtained by nuclear 
magnetic resonance, X-ray crystallography 
and chemical/enzymatic structure probing 
experiments (50-55). In Figure 3, secondary 
structures for the human RNase P and RNase 
MRP RNAs are shown. The structure of the 
“lower” part of the RNase P and RNase MRP 
sRNAs is very similar, whereas the structure 
of the “upper” part of these RNAs displays 
more differences. As a consequence the 
latter part has previously been termed the 
specifi city domain. The “lower” part of the 
human RNase P and RNase MRP RNAs 
share several structural elements, and one of 
the most pronounced and important domains 
in this region is the P4 domain. The P4 helix 
is formed by a “long range interaction” of two 
single stranded regions, thereby making the 
RNA to fold into the so-called cage-shaped-
structure (56). In E. coli this element has 
been demonstrated to be essential for the 
Figure 8. Evolution of the RNase P and RNase MRP complex.
A schematic representation of the most likely evolutionary relationship between RNase P and RNase MRP is presented. From left 
to right: from the “RNA world” concept (an hypothetical stage in the origin of life on Earth in which mainly RNA molecules were 
responsible for biocatalysis (46)), an early RNase P-like RNA molecule arouse. With the development of the eubacteria, the RNase P 
RNA recruited a protein subunit (known as the C5 protein), to cope with the increased biochemical complexity. In vitro, the Escherichia 
coli RNase P RNA molecule is able to catalyze the pre-tRNA processing accurately without the C5 protein. With the evolution of the 
Archaebacteria, the number of RNase P associated protein subunits increased. A generally accepted hypothesis is that RNase MRP 
developed from RNase P in early eukaryotic evolution and that both complexes gained even more protein subunits. After the “birth” of 
RNase MRP from RNase P, in the eukaryotes both particles started to support distinct functions in cellular RNA metabolism (18;47). 
Note that the sizes of the subunits are not in proportion to their molecular mass.
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endonucleolytic activity of the RNAs and has 
been shown to bind divalent ions (e.g. Mg2+) 
which are essential for its activity (57;58). 
There are no protein subunits known which 
directly bind to the P4 domain. However, 
some proteins bind in close proximity to the 
P4 domain via another important domain 
designated the P3 domain. This domain is 
present in all RNase P and RNase MRP RNAs 
that have been characterized, but its structure 
shows some variation between species (20). In 
all vertebrates this domain has a typical stem-
loop structure in which the stem is interrupted 
by an internal loop. Although for E. coli RNase 
P RNA, the P3 domain is not essential for 
pre-tRNA cleavage, the presence of the P3 
domain enhances the effi ciency of RNase P 
activity (59). The P3 domain of S. cerevisiae
RNase P RNA has been shown to be essential 
for RNase P maturation and function (60). For 
human RNase P and RNase MRP RNA, the 
P3 domain has been shown to play a role in 
their accumulation in the nucleoli (61;62). A 
role in particle assembly has been suggested 
as well (63).
Although the protein compositions of RNase 
P and RNase MRP within the same organism 
are highly similar, the protein composition can 
differ to some extent between organisms. As 
mentioned before, the particle complexity of 
the bacterial RNase P is relatively simple as it 
consists of only two subunits (the M1 RNA and 
the C5 protein). In agreement with their higher 
need for regulatory molecular complexity, the 
RNase P and RNase MRP complexes of higher 
organisms exhibit a signifi cantly more complex 
composition (Table 1 and reviewed  by (18)). 
Interestingly, analysis of the composition 
of Archaeal RNase P complexes (e.g. 
Pyrococcus horikoshii and Methanococcus 
thermoautotrophicus) revealed that all of the 
protein subunits that are associated with 
Archaeal RNase P exhibit a high degree of 
homology with eukaryotic RNase P proteins. 
The P. horikoshii RNase P protein subunits 
PH1771, PH1481, PH1877, PH1601 and 
PH1496 are the Archaeal counterparts for 
the human Rpp29 (hPop4), hPop5, Rpp30, 
Rpp21 and Rpp38 proteins, respectively 
(64-66). The human RNase P / RNase MRP 
protein subunits hPop1, hPop4, hPop5 and 
Rpp21 (67-70) have been identifi ed by virtue 
of amino acid sequence homology with their 
S. cerevisiae counterparts Pop1p, Pop4p, 
Pop5p and Rpr2p, respectively (see Table 1) 
(71-73). The human Rpp14, Rpp20, Rpp25, 
Rpp30, Rpp38 and Rpp40 proteins were 
identifi ed by analyzing highly purifi ed RNase 
P from HeLa cells (74-77). The RNase MRP 
and RNase P complexes of S. cerevisiae also 
have protein subunits for which no orthologues 
in the human system have been found so far 
(Table 1).
To maintain the architectural integrity of 
a stable ribonucleoprotein particle, an 
extensive intermolecular interaction network 
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is a prerequisite. Many studies reported the 
existence of such an interaction network among 
the subunits of P. horikoshii RNase P (86), S. 
cerevisiae RNase MRP and RNase P (78) and 
human RNase MRP and RNase P complexes 
(79;81;82). From these data it appeared that 
not all protein subunits directly bind to the RNA 
moiety. In the human RNase MRP and RNase 
P complexes hPop1, hPop4, Rpp20, Rpp21, 
Rpp25 and Rpp38 directly bind to both RNAs. 
For some proteins more detailed information 
about their interactions has been obtained. 
Using UV-crosslinking techniques, Pluk and 
van Eenennaam and co-workers showed that 
Rpp20 and Rpp25 directly interact with the 
P3 domain of the human RNase MRP RNA, 
whereas the Rpp38 protein was found to bind 
to the specifi city domain (i.e. upper part) of the 
RNase MRP RNA (87;88). They also reported 
that hPop1 most likely interacts indirectly with 
both of these domains, most probably via 
interactions with Rpp38 and Rpp20 or Rpp25. 
Also Jiang and colleagues could not detect a 
direct interaction between hPop1 and RNase 
P RNA (82). 
Characteristics of individual 
RNase P / RNase MRP subunits
In contrast to many other snoRNAs, the RNAs 
of the RNase MRP and RNase P complexes 
are not intron-encoded and are transcribed 
by RNA polymerase III. The human RNase 
MRP RNA (also known as Th or 7-2 RNA) 
is encoded by the single copy RMRP gene 
on chromosome 9 (89). The human RNase 
P RNA (also known as H1 or 8-2 RNA) is 
encoded by the single copy RPPH1 gene on 
chromosome 14 (90). Although an oligo-U 
termination signal is present in both genes and 
3’ extended versions of these RNA transcripts 
may exist, no evidence for posttranscriptional 
processing of RNase P and MRP RNA in the 
human system has been obtained. However, 
in S. cerevisiae, the RNase D family of 
exoribonucleases is known to play a role in 
the 3’ end trimming of RNase P and MRP RNA 
precursors (91). Like other RNA polymerase 
III transcripts, the RNase P and RNase MRP 
RNA are most likely not posttranscriptionally 
modifi ed at the 5’ end. 
Only few RNase P / RNase MRP proteins 
have been characterized in detail so far. 
Therefore, the function of the individual 
protein subunits remains largely unclear. For 
hPop1, Rpp40, Rpp38 and hPop4 functional 
nuclear localization signals as well as 
sequence elements required for their nucleolar 
accumulation, which are mainly composed of 
stretches of basic amino acid residues, have 
been described (92;93). Rpp38 contains a 
domain which shows some homology with 
the Haloarcula marismortui L7Ae kink-turn 
binding protein (94). Although the RNase MRP 
RNA has been reported to contain a putative 
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kink-turn structure in its specifi city domain, 
the region containing also the Rpp38 binding 
site, it is unlikely that this structure mediates 
its interaction, because the putative kink-turn 
is not conserved in RNase P RNA. 
Due to the absence of a potential nuclear 
localization signal, the subcellular localization 
of hPop5 was proposed to be dependent on 
its association with other (RNase P / RNase 
MRP) proteins. A similar mechanism has 
been proposed for Rpp14 (93). Interestingly, 
hPop5 and Rpp14 exhibit signifi cant sequence 
homology (69). In addition, Rpp14 is known 
to play a role in tRNA substrate recognition 
as it has been shown to bind pre-tRNA (70). 
Rpp14 has also been shown to interact with 
the LIMD1 protein and the exosome subunit 
OIP2 (81). The relevance of these fi ndings is 
still unclear. 
Another structural relationship was reported 
for the Rpp20 and Rpp25 proteins, which 
both appear to be related to the Alba-family 
of ancient DNA-binding proteins (95). Rpp25 
contains a proline rich C-terminus which 
might play a role in protein-protein interaction. 
Rpp20 has been shown to be able to hydrolyze 
ATP and GTP (96). Purifi ed RNase P from 
HeLa cells also displays ATPase activity. 
However, the enzyme kinetics and sensitivity 
to ATPase inhibitory agents of purifi ed RNase 
P are different from the non-RNase P bound 
Rpp20. Therefore, it is unclear whether the two 
Figure 9. Properties of human RNase MRP / RNase 
P protein subunits.
Schematic structures of the protein subunits of human 
RNase MRP and RNase P are shown. The numbers 
on the right of each protein represent the C-terminal 
aminoacid of each protein and indicate the number of 
amino acids of each of these polypeptides. The small, 
light grey boxes in hPop1, Rpp40, Rpp38 and hPop4 are 
regions which are required for the localization of these 
proteins to the nucleus and nucleolus (92;93). The large, 
dark grey box in Rpp38 is the putative kink-turn binding 
domain of this protein which shares characteristics 
with the L7Ae kink-turn binding protein of Haloarcula 
marismortui (94). The large, light grey boxes in Rpp25 
and Rpp20 are amino acid stretches with homology 
to the Alba-family of Archaeal DNA binding proteins 
(95). The small, dark grey box in Rpp25 represents a 
proline-rich region near the C-terminus of the protein. 
The small, dark grey box in Rpp20 marks a region which 
shows weak homology with the ABC transporter ATPase 
signature motif and the DIxxN box of DEAD-box RNA 
helicases (96). For Rpp30, hPop5, Rpp21 and Rpp14 no 
specifi c amino acid elements have been identifi ed.
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ATPase activities are the same. In agreement 
with a putative regulatory function, Rpp20 
was previously described as an “add-on” 
component, since it is able to interact with the 
non-RNase P / RNase MRP proteins Hsp27, 
SMN and KIAA065 (81;97).
The RNase P and RNase MRP complexes of 
S. cerevisiae display a signifi cant overlap in 
protein composition. There are, however, clear 
differences between these two complexes 
in yeast. The Rpr2p protein specifi cally 
associates with RNase P (73) and the RNase 
MRP particle is characterized by the specifi c 
association of Snm1p and RMP1 (98;99). 
For both S. cerevisiae RNase MRP-specifi c 
proteins, no human homologues have been 
identifi ed. For the RNase P-specifi c protein 
Rpr2p however, the human homologue 
appeared to be Rpp21. For Rpp21, there 
is strong evidence that this protein is also 
specifi cally associated with RNase P in 
mammals (28;80). In addition, Rpp21 is able to 
bind both precursor and mature tRNA, which 
underscores its potential RNase P specifi c 
function (70;100). An overview of all protein 
subunit features is presented in Figure 9. 
RNase MRP and human disease
The human RNase MRP small nucleolar 
ribonucleoprotein particle has been implicated 
in different human diseases. As already 
mentioned above, the anti-Th/To antibodies, in 
some cases present in the serum from patients 
suffering from the autoimmune diseases 
systemic lupus erythematosus, scleroderma, 
primary Raynaud’s phenomenon or 
polymyositis (43;101), recognize both RNase 
P and RNase MRP particles. Several protein 
components have been reported to be targeted 
by these autoantibodies and the most prevalent 
reactivities are directed to Rpp20, Rpp25 and 
Rpp38 and hPop1 (101). RNase MRP is 
also implicated in the autosomal recessively 
inherited disorder cartilage-hair hypoplasia 
(CHH) or McKusick-type metaphyseal 
chondrodysplasia (OMIM: #250250). This 
developmental disorder was fi rst described by 
McKusick in 1965 (102). Prominent features 
of patients suffering from this disease are 
dwarfi sm (CHH-patients usually don’t get 
taller than 150 cm), hypoplastic hair and short 
limbs. Furthermore, CHH-patients often have 
congenital megacolon (Hirschprung’s disease) 
and develop an impaired immune system by 
T-cell defi ciency. CHH was the fi rst human 
disease known to be caused by mutations 
in a nuclear encoded structural RNA. The 
affected gene was identifi ed by Ridanpää 
and co-workers (103) as the gene for the RNA 
component of the RNase MRP complex. The 
major CHH-associated mutation in the RMRP 
gene is the single nucleotide substitution 
70A>G. This mutation is detected in more 
than 90% of all reported CHH-cases and was 
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calculated to originate from a single mutation 
event, which took place 3900-4800 years ago 
(104). Nucleotide 70A is located close to the 
important P4 long-range interaction in the RNA 
and is part of a short single stranded region 
referred to as the J3/4 domain. The J3/4 
domain is highly conserved among all known 
RNase MRP and RNase P RNAs and previous 
studies on the J3/4 domain in the E. coli RNase 
P RNA provided evidence for divalent metal 
ion binding sites crucial for enzymatic activity 
of the RNA (105;106). As a consequence, 
it is likely that the 70A>G mutation affects 
the catalytic activity of the enzyme, which is 
indeed supported by recent fi ndings (39). In 
addition to the 70A>G mutation, a high number 
of other mutations in the RMRP gene have 
been described, both in the promoter and in 
the transcribed region. In the transcribed part 
almost 60 different insertions and substitutions 
have been found (Figure 10). Most of these 
mutations are located at positions which are 
involved in intramolecular basepairing. As 
such they might destabilize secondary and 
tertiary structures and as a consequence 
affect the activity of the RNase MRP complex. 
Mutations in the RNA component of the human 
RNase MRP complex are also described to 
be involved in anauxetic dysplasia (39) and 
may be involved in Omenn syndrome as well 
(107). 
Figure 10. Cartilage-hair hypoplasia-
associated single nucleotide substitutions 
in the human RNase MRP RNA.
In the secondary structure of the human 
RNase MRP RNA the positions of single 
nucleotide mutations associated with CHH 
are highlighted with black circles. “Dup” 
indicates a duplication of a preceding 
nucleotide stretch. “Ins” indicates the insertion 
of a nucleotide. “Del” and the box mark the 
position of nucleotide deletions. Presently, 
58 nucleotide substitutions, insertions, 
duplications and deletions have been reported 
to be associated with CHH. (108;109), Bonafé 
pers. comm. and reviewed by (105).
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Outline of this thesis
Before the studies described in this thesis 
started, much knowledge was obtained about 
the protein composition of the human RNase 
MRP and RNase P ribonucleoprotein particles 
and the subcellular localization of individual 
subunits. Additionally, a role for RNase MRP 
in CHH had been discovered. However, only 
few data were available on the architecture of 
these complexes. To understand the molecular 
mechanism by which these enzymes catalyse 
the cleavage of their substrate RNAs, insight 
into the assembly of these ribonucleoprotein 
particles is required. The studies described 
in this thesis were performed to shed more 
light on these issues. Experiments to get more 
insight into the architecture of these complexes 
were initiated by analyzing protein-protein and 
protein-RNA interactions between subunits 
of the human RNase MRP and RNase P 
complexes using a GST pull-down approach. 
In Chapter 2, the results of these subunit-
subunit interaction studies are described. We 
found that the proteins and the respective 
snoRNA interact via an extensive network of 
protein-protein and protein-RNA interactions. 
The most effi cient protein-protein interaction 
found was the interaction between Rpp20 and 
Rpp25. These proteins seemed to interact in 
an extraordinarily effi cient way. To evaluate 
the association of protein subunits with intact 
RNase P and RNase MRP from human 
cells further, density gradient sedimentation 
analyses were conducted and the results are 
described in Chapter 3. We found that Rpp20 
and Rpp25 only interact with the RNase MRP 
subpopulation that is not associated with pre-
ribosomal complexes. In this chapter we also 
provide evidence for the existence of RNase 
P specifi c proteins in human cells. The strong 
interaction between Rpp20 and Rpp25 and 
their absence from pre-ribosome associated 
RNase MRP complexes prompted us to study 
these proteins into more detail. Chapter 4
describes our fi ndings on the Rpp20-Rpp25 
heterodimer and amongst others we show that 
the effi cient interaction of these subunits with 
the RNase MRP RNA is mutually dependent. 
The effect of their heterodimerization on their 
subcellular localization and expression levels 
was also addressed. The identifi cation of 
CHH-related mutations in the P3 domain of the 
RNase MRP RNA raised the question whether 
these mutations affected the association of 
Rpp20 and/or Rpp25 with the RNase MRP 
RNA. In Chapter 5 we show that certain P3 
mutations indeed diminish the effi ciency of 
Rpp20 and Rpp25 binding. The results of all of 
these studies are discussed in Chapter 6.
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Introduction
RNase MRP was originally identifi ed as an 
endoribonuclease able to cleave an RNA 
substrate derived from the mitochondrial origin 
of DNA replication in vitro (1). Consequently, 
a role for RNase MRP in the priming of 
mitochondrial DNA replication was proposed. 
Later, it was found that the majority of the 
cellular RNase MRP pool was localised in the 
nucleolus (2;3), where it was shown to cleave 
the precursor rRNA in vitro, thereby contributing 
to the maturation of the 5’ end of 5.8S rRNA 
(4). The characterisation of the murine RNase 
MRP particle showed that it contains an RNA 
species (also referred to as Th or 7-2 RNA) that 
is required for its enzymatic activity (5). RNase 
MRP RNA is nuclear encoded and classifi ed 
as a small nucleolar RNA (snoRNA). SnoRNAs 
exist in the nucleolus as small nucleolar 
ribonucleoprotein complexes (snoRNPs). 
These complexes are involved in various 
steps of ribosomal RNA biosynthesis (6;7). 
Based on structural and functional differences, 
three classes of snoRNPs can be discerned.
Box C/D snoRNPs are involved in 2’-O-
The eukaryotic ribonuclease for mitochondrial RNA processing (RNase MRP) is mainly located in the nucleoli and belongs to the small nucleolar ribonucleoprotein (snoRNP) particles. RNase MRP is involved in the 
processing of pre-rRNA and the generation of RNA primers for mitochondrial 
DNA replication. A closely related snoRNP, which shares protein subunits 
with RNase MRP and contains a structurally related RNA subunit, is the pre-
tRNA processing factor RNase P. Up to now ten protein subunits of these 
complexes have been described, designated hPop1, hPop4, hPop5, Rpp14, 
Rpp20, Rpp21, Rpp25, Rpp30, Rpp38 and Rpp40. To get more insight into the 
assembly of the human RNase MRP complex we studied protein-protein and 
protein-RNA interactions by means of GST pull-down experiments. A total of 19 
direct protein-protein and 6 direct protein-RNA interactions were observed. The 
analysis of mutant RNase MRP RNAs showed that distinct regions are involved 
in the direct interaction with protein subunits. The results provide insight into the 
way the protein and RNA subunits assemble into a ribonucleoprotein particle. 
Based upon these data a new model for the architecture of the human RNase 
MRP complex was generated.
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methylation and endonucleolytic cleavage 
(8), box H/ACA snoRNPs mediate 
pseudouridinylation (9) and RNase MRP 
and the related RNase P are involved in 
endonucleolytic processing events (10). 
RNase MRP shares both functional and 
structural features with RNase P (10;11). 
RNase P is involved in the processing of 
pre-tRNA. Like the RNase MRP particle, 
the RNase P particle contains an essential 
RNA subunit, also referred to as H1 or 8-2 
RNA. Although the sequences of both RNA 
subunits are not highly conserved, they can 
be folded into similar secondary structures 
(12;13). Furthermore, both complexes share 
protein subunits that co-purify with the 
respective endoribonuclease activities. RNase 
P is ubiquitously present in every investigated 
organism, whereas RNase MRP is restricted to 
eukaryotes. The conserved properties of both 
complexes strongly suggest that they have 
evolved from a common prokaryotic ancestor 
(14). RNase MRP was previously shown to be 
involved in the ancient recessive pleiotropic 
human disease cartilage-hair hypoplasia 
(CHH) (15;16). In patients with CHH, the 
gene encoding the RNA subunit of RNase 
MRP (RMRP) is mutated. In the coding region 
of a predominant CHH-associated allele, 
the adenine on position 70 is substituted by 
guanine. This 70 A→G mutation was shown 
to be the cause of CHH. In other patients 
the RMRP gene displays other nucleotide 
substitutions and small sequence duplications. 
The effect of these mutations on the function of 
the human RNase MRP complex is not known 
yet. 
Many studies have addressed the protein 
composition of the RNase MRP and RNase 
P complexes. Proteins that co-purify with 
human RNase MRP and RNase P are: hPop1, 
hPop4 (also designated Rpp29), hPop5, 
Rpp14, Rpp20, Rpp21, Rpp25, Rpp30, 
Rpp38 and Rpp40 (17-24). Some insight into 
the intermolecular interactions between the 
human RNase MRP RNA and a limited number 
of protein subunits (Rpp20, Rpp25, Rpp38 and 
hPop1) was previously provided (25). Recently, 
additional data on mutual subunit-subunit 
interactions generated by yeast two- and 
three-hybrid analyses for components of both 
the human and Saccharomyces cerevisiae
RNase P became available (26-28). In this 
study we have systematically investigated 
direct intermolecular interactions between the 
human RNase MRP subunits using a GST 
pull-down assay. These experiments identifi ed 
nineteen strong and six weak protein-protein 
interactions. In addition, six out of eight GST-
fusion proteins exhibited RNase MRP RNA 
binding properties. The analysis of RNase 
MRP RNA deletion mutants provided more 
detailed information on the regions of the MRP 
RNA that are involved in the interactions with 
these proteins. The data obtained in this study, 
in combination with previously published 
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data, were used to generate a structural 
model for the human RNase MRP complex.
Results
To shed more light on the architecture of the 
human RNase MRP complex, we investigated 
the mutual interactions between all currently 
known subunits. Protein-protein and protein-
RNA interactions were investigated in vitro by a 
GST pull-down assay. The ORFs of all human 
RNase MRP proteins were cloned into the 
pGEX-2T’G expression vector. Subsequently, 
the GST-hPop1, GST-hPop4, GST-hPop5, 
GST-Rpp14, GST-Rpp20, GST-Rpp21, GST-
Rpp25, GST-Rpp38 fusion proteins and, as 
controls, GST and GST-hRrp42p (a fusion 
protein of GST and the human exosome subunit 
hRrp42p (29) were expressed in Escherichia 
coli and purifi ed by means of glutathione-
Sepharose affi nity chromatography (Figure 1). 
Note that in addition to the full-length fusion 
proteins, the purifi ed fractions, in particular 
those of GST-hPop1, GST-hPop4, GST-
Rpp21 and GST-Rpp38, contained variable 
levels of faster migrating polypeptides, 
which presumably represent degradation 
products of the recombinant proteins. Several 
attempts to express the GST-Rpp30 and GST-
Rpp40 fusion proteins were not successful.
Protein-protein interactions
The human RNase MRP protein subunits were 
produced by in vitro transcription/translation 
using a rabbit reticulocyte lysate system and 
35S-labeled methionine. SDS-PAGE analysis 
demonstrated that all of these were effi ciently 
produced in the in vitro translation system (data 
not shown). The purifi ed GST-fusion proteins 
were immobilised by binding to glutathione-
Sepharose beads and incubated with each 
Figure 1. Recombinant GST-fusion proteins 
of RNase MRP subunits.
The composition of the recombinant GST-
fusion protein preparations was analysed by 
SDS-PAGE. The asterisks (*) indicate the 
full-length GST-(fusion) proteins. Lane 1, GST; 
lane 2, GST-hRrp42p; lane 3, GST-hPop1; 
lane 4, GST-hPop4; lane 5, GST-hPop5; lane 
6, GST-Rpp14; lane 7, GST-Rpp20; lane 8, 
GST-Rpp21; lane 9, GST-Rpp25; lane 10, 
GST-Rpp38. The faster migrating polypeptides 
most likely represent truncated versions of the 
full-length recombinant proteins. The positions 
of molecular mass markers are indicated on 
the left.
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of the radiolabeled in vitro translated proteins. 
Radiolabeled proteins interacting with the GST-
fusion proteins were analysed by SDS-PAGE
and autoradiography. As controls for the 
specifi city of these assays GST alone and 
GST-hRrp42p were used. Using this approach 
a total of eighteen effi cient and seven less 
effi cient protein-protein interactions were 
observed. The results of a few representative 
experiments are shown in Figure 2: effi cient 
interactions (at least 20% of input protein co-
precipitated) in Figure 2A-D and an example 
of a weak interaction (less than 20% of input) 
in Figure 2E. A summary of all interactions 
detected is shown in Figure 3. Six interactions 
were detected in “two directions”, i.e. with 
either one or the other interacting protein fused 
to GST. These interactions are hPop1-hPop4 
(Figure 2A,B), hPop4-hPop5, hPop4-Rpp38, 
hPop5-Rpp14, hPop4-Rpp25 and Rpp20-
Rpp25. All the other interactions were only 
detected in one direction, which may be at least 
in part due to the fact that GST-fusion proteins 
of Rpp30 and Rpp40 were not available.
In addition, this phenomenon may be explained 
by interference of the GST-part of the 
recombinant protein with the interaction with the 
in vitro translated protein. Interestingly, hPop1, 
hPop4 and Rpp14 each displayed interactions 
with fi ve other RNase MRP proteins (Figure 3). 
The interaction between Rpp20 and Rpp25 
appeared to be the most effi cient one 
observed in this assay (Figure 2D). The 
Figure 2. GST-pull down analysis of RNase MRP protein–
protein interactions.
GST-fusion proteins were incubated with 35S-labeled in vitro
translated proteins and after precipitation by glutathione-
Sepharose co-precipitated radiolabeled proteins were analysed 
by SDS-PAGE and autoradiography. In each panel, lane 1 
shows the radiolabeled input protein, lane 2 and 3 the negative 
control precipitations with GST and GST-hRrp42p, respectively, 
and lane 4 the material precipitated by the GST-tagged RNase 
MRP protein. A: Interaction between GST-hPop1 and hPop4. 
B: Interaction between GST-hPop4 and hPop1. C: Interaction 
between GST-hPop4 and hPop4. D: Interaction between 
GST-Rpp20 and Rpp25. E: Interaction between GST-hPop5 
and Rpp25. 
B
A
C
D
E
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strength of this interaction was substantiated 
by the fact that it was not affected by salt 
concentrations up to 3M KCl (results not 
shown). The Rpp21 protein appeared to be 
a rather sticky protein, because in the GST 
pull-down assay both GST-Rpp21 and in vitro
translated Rpp21 gave rise to relatively high 
signals with all proteins, including the negative 
controls (GST and GST-hRrp42p). Raising 
the KCl concentrations to 150 mM resulted 
in the disappearance of these non-specifi c 
co-precipitations. Interestingly, under these 
conditions the Rpp40 protein still interacted 
with GST-Rpp21. Several GST-tagged RNase 
MRP proteins, particularly hPop1 and hPop4 
were observed to homodimerise with the 
corresponding in vitro translated protein in the 
GST pull-down assay. In Figure 2C, the result 
for the GST-hPop4-hPop4 interaction is shown. 
Besides homodimerisation, also the formation 
of multimers may explain these results. 
Figure 3. Summary of protein-protein interactions between the RNase MRP protein subunits detected by GST pull-down 
analyses.
The dark-grey boxes indicate effi cient interactions (more than 20% of input radiolabeled protein precipitated) that were detected with 
either one or the other interacting partner fused to GST; the grey boxes mark effi cient interactions that were detected in only one of the 
reciprocal pull-downs; the light-grey boxes indicate relatively weak interactions (less than 20% of input protein precipitated). Because 
GST-Rpp30 and GST-Rpp40 were not available, these proteins were not analysed. 
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Protein-RNA interactions
Because the RNA component of RNase MRP 
is expected to play a major role in assembly 
of the ribonucleoprotein particle, we next 
investigated direct interactions of protein 
subunits with the RNA. For these analyses 
GST pull-down experiments were performed 
with 32P-labeled, in vitro transcribed RNA.
First the binding to full length RNase MRP and 
RNase P RNA was examined. As shown in 
Figure 4, six of the GST-tagged RNase MRP 
protein subunits bound to both RNase MRP 
and RNase P RNA, whereas the remaining 
two proteins, GST-hPop5 and GST-Rpp14 
did not show detectable binding. A control 
RNA, hY1 RNA, a small RNA associated with 
the cytoplasmic Ro RNPs was not detectably 
precipitated by any of the GST-fusion proteins, 
except for GST-Rpp21, which resulted in weak 
hY1 RNA signals. The latter observation is 
most likely due to the sticky nature of Rpp21 
(see above). To investigate the regions of the 
Figure 4. Direct interactions between GST-tagged RNase MRP proteins and the human RNase MRP and RNase P RNAs.
The eight bacterially expressed GST-fusion proteins were incubated with a mixture of 32P-labeled, in vitro transcribed, full-length 
human RNase MRP RNA, RNase P RNA and hY1 RNA, a small RNA associated with human Ro RNPs which was included as a 
negative control. Binding of these RNAs was determined by GST pull-down followed by denaturing gel electrophoresis of the co-
precipitated RNAs and autoradiography. Ten percent of the input RNA was loaded in lane 1. The GST fusion proteins are indicated 
above the lanes (lanes 3-10). GST alone was used as a control (lane 2). The positions of RNase P RNA (P), RNase MRP RNA (MRP) 
and hY1 RNA (hY1) are indicated on the left.
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RNase MRP RNA involved in the interactions 
with these proteins in more detail, a number 
of RNase MRP RNA deletion mutants (Figure 
5) were analysed for their protein-binding 
properties in the GST pull-down assay. 
In Figure 6 a representative subset of the 
experimental data is shown. The results of 
these analyses are summarised in Figure 7. 
In agreement with their lack of interaction 
with the full length RNase MRP RNA, GST-
fusion proteins of hPop5 and Rpp14 did not 
show any interaction with either of the RNase 
MRP mutants. All truncations of the RNase 
MRP RNA except for MRPΔ87-115 reduced 
the effi ciency of binding by hPop1. Deletions 
of nucleotides 1-66 and 132-176 only had 
a relatively small effect on hPop1 binding, 
whereas an additional deletion of nucleotides 
198-267 more drastically affected the binding 
of this protein. Taken together, these data 
suggest that hPop1 contacts the RNase MRP 
RNA at multiple sites and that the P4 region 
may be critically important for its interaction. 
Rpp20 displayed a strong interaction with the 
mutant lacking nucleotides 132-176, but only 
weakly interacted with all the other mutants 
analysed, except for the P3 domain, which was 
bound only slightly less effi ciently than the full 
length RNA. These data suggest that for Rpp20 
binding the P3 region and the P8/P9 region are 
important. Rpp25 showed effi cient binding not 
only to the full-length RNA, but also to several 
mutants. Only a deletion of nucleotides 1-66 
Figure 6. GST pull-down analysis of RNase MRP protein–
RNA interactions.
GST-fusion proteins were incubated with radiolabelled in vitro
transcribed mutants of RNase MRP RNA (see Figure 5) and after 
precipitation by glutathione–Sepharose, co-precipitated RNAs 
were analysed by gel electrophoresis and autoradiography. In 
all panels, lane 1 shows the mixture of radiolabelled input RNAs 
and lane 2 the negative control precipitation with GST. Lane 
3 contains the RNAs precipitated by GST–hPop1 (A), GST–
Rpp20 (B and C) and lane 4 contains the RNAs precipitated by 
GST–Rpp25 (B) or GST-Rpp38 (C), respectively.
A
B
C
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in combination with a deletion of nucleotides 
198-267 signifi cantly reduced Rpp25 binding. 
These data are consistent with the presence 
of two high-affi nity binding sites for Rpp25 in 
the RNase MRP RNA, one situated in the P3 
domain and another in the P4/P19 region. In 
addition to the full length RNA, hPop4 also 
effi ciently interacted with mutant RNAs lacking 
nucleotides 87-115 and 132-176. However, 
deletion of the nucleotides comprising the 
P3 domain reduced the binding effi ciency of 
hPop4 drastically. The additional deletion of 
nucleotides 198-267 completely abrogated the 
interaction between hPop4 and the RNA. In 
agreement with the reduced binding of hPop4 
with the mutant RNA lacking the P3 domain 
(MRP67-267), hPop4 showed an effi cient 
interaction with MRP1-82. These data strongly 
suggest that hPop4 interacts with the MRP 
RNA by binding to more than one region of the 
RNA. As observed for Rpp25, both the P3 and 
the P4/P19 regions are important for hPop4 
binding. Rpp38 effi ciently interacted with the 
mutants lacking nucleotides 1-66 or 87-115 
and somewhat less effi ciently with mutants 
MRPΔ132-176 and MRP67-197. No or hardly 
any binding was observed for Rpp38 when the 
3’ truncation was increased up to nucleotide 
167 or to the isolated P3 domain. This indicates 
that Rpp38 binding is dependent on elements 
in the P12 domain, although the deletion of 
nucleotides 132-176 only partially decreased 
its binding effi ciency. The interpretation of the 
data for Rpp21 is diffi cult, because this protein 
is known to display a sticky behaviour in 
interaction studies. Indeed, moderate binding 
to all RNase MRP mutants was observed. 
Therefore, no conclusions can be drawn for 
the binding of this protein to RNase MRP 
RNA.
Figure 7. Summary of protein-RNA 
interactions between the RNase 
MRP subunits detected by GST 
pull-down analyses.
The effi ciency of binding by the GST-
fusion proteins to the deletion mutants 
of RNase MRP RNA was determined 
by three independent experiments. 
The most effi cient interactions 
are indicated by dark-grey boxes, 
intermediate interactions by grey 
boxes and weak interactions by light-
grey boxes. In agreement with the 
lack of interaction with the full-length 
RNase MRP RNA (Figure 4), GST-
hPop5 and GST-Rpp14 did not shown 
detectable interactions with any of the 
RNase MRP RNA mutants. 
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Discussion
Reconstitution of the RNase MRP complex will 
be required to unravel the role of the individual 
subunits in the endonucleolytic cleavage of 
substrate RNAs. As a fi rst step towards in vitro
reconstitution of this ribonucleoprotein particle, 
we have determined mutual interactions 
between its protein and RNA subunits. Using 
GST pull-down assays, we have detected 25 
protein-protein and 6 protein-RNA interactions. 
At least one interaction with another subunit 
was found for each of the known subunits. 
These data can be used to build a model for 
the human RNase MRP complex (see below), 
which will provide a basis for its reconstitution 
using individual (recombinant) subunits. 
Protein-protein interactions
A total of 19 distinct protein-protein interactions 
were detected, 6 of which were found when 
either one or the other interacting partner was 
fused to GST. Four of these (the interactions 
between hPop1 and hPop4, hPop4 and 
hPop5, hPop4 and Rpp38, and between 
Rpp20 and Rpp25), were not only detected 
when the two members of a particular pair 
of proteins were tested alternatively as GST-
fusion protein, but also resulted in high GST 
pull-down effi ciencies. Five interactions were 
supported only by weak signals and were not 
reciprocal. Using a yeast-two-hybrid assay, 
Jiang and Altman have studied interactions 
between all human RNase P / RNase MRP 
protein subunits, except for hPop5 and Rpp25 
(1). Although they did not observe strong 
interactions, a series of weak interactions 
between pairs of these proteins were detected. 
A number of our GST pull-down data confi rm 
these two-hybrid results. Taking into account 
that hPop5 and Rpp25 were not included in 
the yeast two-hybrid study, all but two of the 
interactions detected by GST pull-down were 
also found in the two-hybrid system. The 
failure to detect the hPop4 (Rpp29)–Rpp38 
and hPop4–hPop4 interactions in the yeast 
two-hybrid system may be due to interference 
by the fused DNA-binding and/or transcription 
activation domains. Most of the very weak 
interactions in the yeast two-hybrid system 
were not observed in the GST pull-down 
assay. A systematic two-hybrid analysis was 
also performed for the protein subunits of the 
yeast RNase P complex (26). Interestingly, 
two of the strong interactions we observed, 
hPop1–hPop4 and hPop4–hPop5, were 
also reported for their yeast counterparts. 
The failure to detect all the other strong and 
moderate interactions observed for the human 
RNase P / RNase MRP subunits in yeast can 
be explained by the fact that these concern 
Rpp14, Rpp25, Rpp38 and Rpp40, for which 
no yeast orthologues are known. It should 
be stressed that due to the experimental 
approach, both the yeast two-hybrid system 
and the GST pull-down assay, the detection of 
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some interactions might have failed because 
in both cases at least one of the interacting 
partners is used as a fusion protein and the 
fusion part may interfere with the interaction. 
Nevertheless, we conclude that our data 
provide important and useful new insights into 
the assembly of protein subunits in the RNase 
P and RNase MRP complexes. 
The most effi cient protein-protein interaction 
observed in our experiments was that between 
Rpp20 and Rpp25: close to 100% of in vitro 
translated protein added bound to the GST-
tagged partner. The stability of the interaction 
between Rpp20 and Rpp25 was substantiated 
by increasing the salt concentration in the pull 
down assay. KCl concentrations up to 3 M 
hardly affected the effi ciency of this interaction. 
Recently, it has been reported that both 
Rpp20 and Rpp25 are members of the Alba 
superfamily of proteins, an ancient family of 
nucleic acid-binding proteins that has evolved 
to support a diversity of functions in RNA 
metabolism (31). An interesting phenomenon 
is the putative homodimerisation of hPop1 and 
hPop4, as suggested by our GST pull-down 
data. Homodimerisation (or multimerisation) of 
RNase MRP/P protein subunits is supported 
by yeast two-hybrid data on both the human 
and the yeast RNase MRP / RNase P proteins 
(26;28). While homodimerisation of Pop1 and 
Pop4 was observed for the human and yeast 
proteins, respectively, Rpr2-Rpr2 (the yeast 
counterpart of Rpp21) and Rpp30-Rpp30 and 
Rpp38-Rpp38 interactions were reported as 
well. Because little information is available 
on the protein stoichiometry in the human 
RNase MRP/P complexes, the physiological 
relevance of these interactions remains to be 
investigated. In this respect it is interesting to 
note that small subpopulations of RNase P and 
RNase MRP have been proposed to associate 
with each other (32).
Protein-RNA interactions
Previous UV-crosslinking and yeast three-
hybrid analyses have demonstrated that 
Rpp20, Rpp21, Rpp25, Rpp30 and Rpp38 
interact directly with the RNA subunit of 
human RNase P and/or RNase MRP. Also, 
Pop1p and Pop4p, the S. cerevisiae homologs 
of hPop1 and hPop4, were shown to interact 
directly with yeast RNase P RNA in a yeast 
three-hybrid system (25-27). Our GST pull-
down analyses indeed confi rm that these 
proteins can directly interact with the RNase 
MRP RNA, whereas hPop5 and Rpp14 can 
not. Due to the failure to express GST-fusion 
proteins for Rpp30 and Rpp40, we were unable 
to analyse these protein subunits in this assay. 
Surprisingly, hPop4 only detectably interacted 
with the RNase MRP RNA in the absence of 
magnesium ions (results not shown). Mg2+
concentrations of 2 mM already precluded 
the interaction of hPop4 with full length 
RNase MRP and RNase P RNA, whereas 
the RNA-binding by the other RNase MRP/P 
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subunits was not affected by magnesium 
concentrations up to 5 mM. This suggests that 
direct contacts between hPop4 and the RNase 
MRP or RNase P RNA are highly conformation 
dependent. Because hPop4 also displayed a 
number of strong protein-protein interactions 
with other RNase MRP subunits, this raises the 
question whether the binding of these subunits 
to the RNA may facilitate the formation of 
bonds between hPop4 and RNase MRP RNA 
in the presence of magnesium ions. Additional 
structural analyses will be required to shed 
more light on this issue. Recently, the NMR 
structure of an archaeal Rpp29 (Pop4) protein 
has been solved (33). The Archaeoglobus 
fulgidus Rpp29 protein was found to consists 
of a six-stranded anti-parallel β-sheet, carrying 
several conserved hydrophilic amino acids on 
its surface which are likely to be involved in 
intermolecular contacts with other protein and 
RNA components.
Our mutant RNase MRP RNA analyses 
demonstrated that hPop1 contacts multiple 
regions of the RNA, including the P3 and 
P12 regions and suggest that the P4 region 
is critically important. The requirement for 
multiple regions of the human MRP RNA for 
the association of hPop1 is consistent with 
the results of reconstitution experiments in 
HeLa cell extracts (25). Previously, the results 
of UV-crosslinking experiments indicated 
that the binding of Rpp20 and Rpp25 to the 
RNase MRP RNA was critically dependent 
on the region bordered by nucleotides 22 
and 66 (P3 region) (25). The data described 
here show that in addition to the P3 region 
the P8/P9 region is required for the stable 
association of Rpp20, whereas the RNA 
seems to contain two independent binding 
sites for Rpp25, one in the P3 region and 
a second one in the P4/P19 region. The 
apparent discrepancy between the results 
for Rpp25 association with fragment 67-267 
(containing the P4/P19 region) of the RNase 
MRP RNA as obtained by UV-crosslinking in 
HeLa cell extracts on the one hand and GST 
pull-down experiments on the other hand, may 
be due to UV-crosslinking effi ciency to the 
Rpp25 binding site in this region, masking of 
Rpp25 epitopes when bound to the P4/P19 
region, or to conformational changes in the 
mutant RNA induced by HeLa cell factors. 
Our hPop4 data show that the binding of 
hPop4 to the RNase MRP RNA is strongly 
dependent on the presence of the P3 domain. 
The deletion of the region between nucleotides 
198 and 267 in addition to the P3 domain 
completely abolished hPop4 binding. These 
data are consistent with the involvement of 
the P4/P19 region, in addition to the P3 
region, in the interaction between hPop4 
and RNase MRP RNA. In agreement with 
previous UV-crosslinking and reconstitution-
co-immunoprecipitation data, our GST pull-
down data indicate that the main determinants 
for the binding of Rpp38 are located in the 
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Figure 8. Model for the human RNase MRP complex.
Using the data obtained in this study and previously published UV-crosslinking data (25), a structural model for the human RNase 
MRP complex was generated. In this model all detected protein-RNA interactions, except for the interaction of Rpp21, which seemed 
to be non-specifi c, are combined with all detected protein-protein interactions, except for the most weak interactions. Note that the 
size of the depicted subunits is not proportional to their molecular masses.
   52                Chapter 2
P12 region. In spite of the limited degree of 
primary and secondary structure homology 
between this region of the RNA components 
of RNase MRP and RNase P, Rpp38 stably 
interacts with both of them. Therefore, it will 
be interesting to investigate the high resolution 
structures of these RNA domains, as well as 
the nucleotides and amino acids which are 
directly involved in the interaction of Rpp38 
with these RNA molecules. The RNase MRP 
RNA has been suggested to contain a kink-
turn motif, a protein binding module found in 
a variety of other RNAs (34). Interestingly, a 
major part of the Rpp38 protein shows 32% 
homology with the kink-turn binding ribosomal 
L7Ae protein of Haloarcula marismortui. 
Although these data suggest that Rpp38 binds 
to a kink-turn structure in RNase MRP RNA, 
such a motif cannot be discerned in the RNase 
P RNA. Detailed structural analyses of both 
protein and RNA subunits will be required to 
investigate this intriguing issue.
Human RNase MRP Model
The mutual interactions among RNase MRP/P 
subunits allowed us to generate a structural 
model for the human RNase MRP complex. 
The model displayed in Figure 8 is based upon 
all protein-RNA and the most effi cient protein-
protein interactions detected in the present 
study. This model provides new insights into 
the assembly of the complex. In addition, it 
will be useful in studying the role of single 
subunits in RNase MRP function and will 
provide a basis for RNase MRP reconstitution 
experiments. Recently, the fi rst in vitro
reconstitution experiments for the human 
RNase P complex were reported by Mann and 
colleagues (35). The results demonstrated 
that the reconstitution of a particle composed 
of the RNase P RNA and recombinant Rpp21 
and hPop4 generated a functionally active 
complex. Future studies will be needed to 
investigate whether a similarly reconstituted 
RNase MRP particle will be active as well.
Materials and Methods
GST-fusion proteins
To generate N-terminally GST-tagged 
fusion proteins, cDNAs encoding hPop1, 
hPop4, hPop5, Rpp14, Rpp20, Rpp21, 
Rpp25, Rpp30, Rpp38, Rpp40, were cloned 
into pGEX-2T’G (derived from pGEX-2T 
(Amersham Pharmacia Biotech), containing a 
modifi ed multiple cloning site). The construct 
encoding GST-hRrp42p was kindly provided 
by David Tollervey (University of Edinburgh, 
UK). GST-fusion proteins were produced in E. 
coli BL21(DE3)pLysS by standard procedures 
(36). Cell lysates were prepared by sonication 
of the bacteria in PBS using a Branson microtip. 
Subsequently, Triton X-100 was added to a 
fi nal concentration of 1%. After centrifugation, 
the supernatants were used to isolate GST-
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fusion proteins by glutathione-Sepharose 
affi nity chromatography. Glycerol was added 
to the GST-fusion protein containing fractions 
to a fi nal concentration of 10%. The purity and 
quantity of the recombinant proteins were 
determined by SDS-PAGE.
In vitro translation of RNase MRP proteins
hPop1, hPop4, hPop5, Rpp14, Rpp20, Rpp21, 
Rpp25, Rpp30, Rpp38 and Rpp40 cDNAs were 
cloned into the pCI-neo vector (Promega) in 
frame with a sequence encoding the vesicular 
stomatitis virus G protein epitope (VSV). 
Prior to in vitro translation, the constructs 
were linearised and mRNAs encoding the 
N-terminally VSV-tagged proteins were 
generated by in vitro transcription using T7 
RNA-polymerase. In vitro translation of the 
mRNAs was performed in a rabbit reticulocyte 
lysate translation system (Promega) in the 
presence of 35S-methionine.
RNase MRP RNA constructs and in vitro
transcription
RNase MRP constructs (MRP1-267, MRP1-
82, MRP67-267, MRP67-197, MRP67-167, 
MRPΔ87-115) and a human Y1 RNA construct 
have been described previously and were 
linearised as described before (25;37). 
MRPΔ132-176 was generated by substituting 
the corresponding fragment of the wild type 
construct (MRP1-267) with a PCR fragment 
lacking nucleotide 132-176. MRPΔ132-176 
was linearized as described for MRP1-267. 
For in vitro transcription 1 μg of linearized 
template DNA was incubated for one hour at 
37oC in 20 μl buffer containing 40 mM Tris-
HCl, pH 7.9; 6 mM MgCl2; 2 mM spermidine; 
10 mM NaCl; 10 mM dithiotreitol; 0.1 μg/μl 
bovine serum albumin; 40 U RNasin; 1 mM 
ATP; 1 mM GTP; 1 mM CTP; 0.1 mM UTP; 
6.6 fmol (20 μCi) [α-32P]UTP and 15 U T7 
RNA polymerase. After transcription, RNA was 
purifi ed by phenol/chloroform/isoamylalcohol 
extraction and by chromatography on a 
Sephadex G50 spin column.
GST pull-down assay
Ten microliters of glutathione-Sepharose 
beads were washed three times with 100 μl 
of pull-down buffer (PB-100: 20 mM HEPES/
KOH, pH 7.6; 100 mM KCl; 0.5 mM EDTA; 
0.05% NP-40; 1 mM DTE; 5 mM MgCl2; 
0.02% BSA, Complete protease inhibitor 
(Roche)). One μg GST or the appropriate 
amount of GST-fusion protein was coupled 
to the beads in 100 μl PB-100 by incubating 
at room temperature for 30 minutes. After 
centrifugation, the supernatant was discarded 
and the beads were resuspended in pull-down 
buffer. For the analysis of protein-protein 
interactions, the beads were resuspended 
in 100 μl PB-100. In vitro translated, 35S-
labeled protein was added and the mixture 
was incubated at 4oC for 2 hours under 
continuous agitation. After incubation, the 
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beads were washed three times with PB-150 
(composition like PB-100, but containing 
150 mM KCl) and the bound proteins were 
analysed by SDS-PAGE and autoradiography. 
For protein-RNA interaction analysis, the 
beads were resuspended in 100 μl PB-200 
(composition like PB-100, but containing 200 
mM KCl and lacking MgCl2). After the addition 
of in vitro transcribed 32P-labeled RNAs, 2 μg 
E. coli tRNA and 20 U RNasin, the mixture was 
incubated for 1 hour at 4oC under continuous 
agitation. The beads were washed three times 
with PB-200 and the co-precipitating RNAs 
were extracted and analysed by denaturing 
PAGE and autoradiography.
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RNase MRP is an eukaryotic endoribonuclease involved in nucleolar and mitochondrial RNA processing events. RNase MRP is a ribonucleoprotein particle, which is structurally related to RNase P, an endoribonuclease 
involved in pre-tRNA processing. Most of the protein components of RNase MRP have 
been reported to be associated with RNase P as well. In this study we determined 
the association of these protein subunits with the human RNase MRP and RNase P 
particles by glycerol gradient sedimentation and co-immunoprecipitation. In agreement 
with previous studies, RNase MRP sedimented at 12S and 60-80S. In contrast, only a 
single major peak was observed for RNase P at 12S. The analysis of individual protein 
subunits revealed that hPop4 (also known as Rpp29), Rpp21, Rpp20 and Rpp25 only 
sedimented in 12S fractions, whereas hPop1, Rpp40, Rpp38 and Rpp30 were also 
found in 60-80S fractions. In agreement with their co-sedimentation with RNase 
P RNA in the 12S peak, co-immunoprecipitation with VSV-epitope tagged protein 
subunits revealed that hPop4, Rpp21 and in addition Rpp14 preferentially associate 
with RNase P. In spite of the absence of Rpp20 and Rpp25 in 60-80S fractions, 
both RNase P and RNase MRP RNA were co-precipitated with the VSV-tagged 
versions of these subunits.  These data show that hPop4, Rpp21 and Rpp14 may 
not be associated with RNase MRP. Furthermore, Rpp20 and Rpp25 appear to be 
associated with only a subset of RNase MRP particles, in contrast to hPop1, Rpp40, 
Rpp38 and Rpp30 (and possibly also hPop5), which are probably associated with all 
RNase MRP complexes. Our data are consistent with a transient association of Rpp20 
and Rpp25 with RNase MRP, which may be inversely correlated to its involvement in 
pre-rRNA processing.
Introduction
Eukaryotic ribosome synthesis starts with 
the transcription of the rDNA-genes by RNA 
polymerase I. The human 18S, 5.8S and 28S 
rRNAs are transcribed as a long polycistronic 
RNA, designated 47S pre-rRNA. In order to 
yield the mature 18S, 5.8S and 28S rRNAs, 
the 47S pre-rRNA undergoes a series of endo- 
and exonucleolytic processing steps and in 
addition many nucleotides are chemically 
modifi ed. These post-transcriptional 
modifi cations include pseudouridinylation 
and 2’-O-ribose methylation. Most of these 
processing and maturation steps are 
catalyzed by small nucleolar ribonucleoprotein 
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complexes (snoRNPs). These protein-RNA 
complexes reside in the nucleolus and are 
typically composed of multiple protein subunits 
associated with a single snoRNA species which 
serves as a guide in substrate recognition. 
Based upon common characteristics in their 
RNA moiety, snoRNPs are categorized into 
three major classes (1;2). The fi rst class is the 
box H/ACA snoRNPs, which are involved in the 
pseudouridinylation of rRNA (3). The second 
class is the box C/D snoRNPs, which guide 
the modifi cation of rRNA by methylation of 
riboses (4). Some box C/D snoRNPs, e.g. the 
U3 snoRNP, are involved in endonucleolytic 
cleavage steps of the pre-rRNA (5). Two 
snoRNPs cannot be classifi ed as box H/ACA 
or box C/D snoRNPs (2). These snoRNPs are 
RNase MRP (ribonuclease for mitochondrial 
RNA processing) and RNase P. RNase P is 
a ubiquitous enzyme which functions in the 
maturation of tRNA by the removal of the 5’ 
leader sequence of pre-tRNAs (6;7). In the 
yeast Saccharomyces cerevisiae, RNase MRP 
has been reported to cleave site A3 within 
internal transcribed spacer 1 (ITS1) of pre-
rRNA, thereby contributing to the maturation 
of the 5’end of the 5.8S rRNA (8). In addition to 
this nucleolar function, RNase MRP has been 
reported to be involved in the generation of 
RNA primers for mitochondrial DNA replication 
by cleavage of an RNA transcript which 
originates from the mitochondrial origin of 
replication (9). Recently, a third function for S. 
cerevisiae RNase MRP, the cleavage of Clb2 
mRNA, has been described (10). In spite of the 
reported mitochondrial and mRNA cleavage 
functions, the vast majority of RNase MRP is 
found in the nucleolus, the site of pre-rRNA 
processing (11).
RNase MRP from human, Arabidopsis 
thaliana and Nicotiana tabacum has been 
reported to be associated with different 
complexes sedimenting at approximately 12S 
and 60-80S in glycerol gradients (12;13). For 
the U3 snoRNP, 12S (low molecular weight) 
complexes were identifi ed as core particles 
consisting of the U3 snoRNA and the most 
stably associated proteins, whereas also in 
this case high molecular weight (60-80S) 
complexes were observed, which most likely 
represent pre-ribosomes (14-16). Interestingly, 
Granneman and co-workers found that a 
subset of the human U3 snoRNP-associated 
proteins only co-sediments with the 60-80S 
complexes and not with the 12S complexes. 
Therefore, these proteins were proposed to 
be required for the function of the U3 snoRNP 
in ribosome synthesis. The sedimentation 
of the human RNase MRP RNA in similarly 
sized complexes suggested that the 12S 
and 60-80S complexes correspond to a core 
particle and the pre-ribosomal complexes, 
respectively. Today, ten proteins have been 
identifi ed as RNase MRP components 
in several organisms and it is generally 
believed that most of these proteins are stably 
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associated with both RNase MRP and RNase 
P (17-25). To obtain experimental evidence 
on the protein composition of these particles 
in humans, their sedimentation patterns in 
glycerol gradients were determined. The 
results of these experiments not only revealed 
striking differences between the sedimentation 
behavior of RNase MRP and RNase P, but 
also demonstrated extensive heterogeneity in 
the association of the protein subunits with the 
different complexes. Taken together, our data 
demonstrate for the fi rst time that differences 
in protein subunit composition between the 
human RNase MRP and RNase P complexes 
exist and in addition show that the protein 
composition of RNase MRP in part depends 
on its association with 60-80S pre-ribosomal 
complexes.
Results
Glycerol gradient sedimentation analysis 
of RNase MRP and RNase P
To investigate the heterogeneity of the human 
RNase MRP and RNase P ribonucleoprotein 
complexes, we fractionated total cell extracts 
from HEp-2 cells in 5-40% glycerol gradients. 
The sedimentation behavior of these 
complexes was fi rst visualized by northern 
blot hybridization using probes specifi c for the 
RNase MRP and RNase P RNA components. 
In parallel the fractionation of rRNAs was 
monitored by agarose gel electrophoresis and 
ethidium bromide staining; the positions of the 
18S and 28S rRNAs were used as markers 
for 40S and 60S complexes. A U3 snoRNA 
probe was used as an additional marker for 
the positions of 12S and 60-80S complexes 
in the gradient (Figure 1A) (14). As shown 
in Figure 1B, the majority of RNase MRP 
RNA and RNase P RNA was found in 12S 
fractions (fractions 6 - 10). Quantifi cation of 
the hybridization signals by phosphorimaging 
revealed that approximately 65% of the total 
pool of RNase MRP RNA and approximately 
75% of the RNase P RNA sedimented in 
these fractions. In addition, both RNase MRP 
RNA and RNase P RNA showed minor peaks 
sedimenting at approximately 40S (fraction 14, 
RNase P RNA and fraction 15, RNase MRP 
RNA). A third peak (containing about 17% of 
the total RNase MRP RNA pool) was observed 
for RNase MRP RNA in 60-80S fractions (18 
- 22). The glycerol gradient sedimentation 
analysis was carried out several times and 
the results appeared to be very reproducible. 
The sedimentation pattern of RNase P RNA in 
60-80S fractions was confi rmed by analyzing 
RNase P activity in the 12S, 40S and 60-80S 
fractions. Rpp38-containing complexes were 
immunoprecipitated from pooled 12S, 40S 
and 60-80S fractions (fractions 7-9; 13-15; 
19-21, respectively) and the presence of 
RNase P activity in the immunoprecipitated 
material was analyzed by an in vitro RNase P 
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activity assay using pre-tRNA as a substrate. 
The results in Figure 1C show that Rpp38-
containing complexes from 12S and 40S 
fractions were able to cleave the pre-tRNA into 
the 5’ leader sequence and the mature tRNA 
(lanes 4 and 5). The absence of the 5’ leader 
sequence in the reaction products of the 
precipitate from the 40S fractions is most likely 
due to the co-precipitation of an activity that is 
responsible for the degradation of the released 
5’ leader sequence. In contrast, anti-Rpp38 
immunoprecipitates from 60-80S fractions did 
not display RNase P activity (Figure 1C; lane 
6). Note that the lack of RNase P activity in the 
latter fractions was not due to the absence of 
Rpp38, because this protein was found in all of 
these fractions (see below). 
The differences observed in the sedimentation 
Figure 1. Analysis of the human RNase MRP and RNase P complexes by glycerol gradient sedimentation.
HEp-2 extracts were fractionated in 5-40% (v/v) glycerol gradients. Total RNA was isolated from the fractions and analyzed by 
northern blot hybridization. A: Northern blots were hybridized with a U3 snoRNA-specifi c riboprobe. The signals were visualized by 
autoradiography. The position of the U3 snoRNA is indicative for 12S fractions. B: Northern blots were hybridized successively with 
RNase MRP RNA and RNase P RNA specifi c probes. Signals were visualized by autoradiography and quantifi ed by phosphorimaging. 
The relative distributions of RNase MRP RNA and RNase P RNA were calculated. The sedimentation of 40S and 60S particles was 
determined by the presence of 18S and 28S rRNAs, respectively. (Figure 1 is continued on next page)
A
B
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behavior of RNase MRP RNA and RNase 
P RNA prompted us to investigate the 
RNase MRP and RNase P protein subunit 
distribution. To analyze the sedimentation 
behavior of these protein subunits, glycerol 
gradient fractions were separated by SDS-
PAGE and the proteins were visualized 
by immunoblotting using polyclonal rabbit 
antisera. Surprisingly, striking differences 
were observed between the sedimentation 
patterns of individual protein subunits. 
As shown in Figure 2A, substantial amounts 
of all RNase MRP and RNase P protein 
subunits sedimented at 12S (at which the 
RNase MRP and RNase P RNAs also showed 
major peaks). However, in contrast to hPop1, 
Rpp38, Rpp30 and Rpp40, which showed an 
RNase MRP RNA-like sedimentation pattern 
with a peak in the 60-80S region, Rpp20, 
Rpp25, hPop4 (also known as Rpp29) and 
Rpp21 did not detectably sediment in high-
molecular weight fractions (Figure 2B). In 
addition, more subtle differences between the 
sedimentation behavior of individual protein 
subunits were observed. Quantifi cation of 
the data by phosphorimaging demonstrated 
that the Rpp38 distribution was virtually 
indistinguishable from that of the RNase MRP 
RNA, with a major peak at 12S and a minor 
peak at 60-80S. The intensity of the hPop1 
peak at 60-80S on the other hand was about 
equal to that of the 12S peak. Rpp30 and 
Rpp40 both showed the three peaks observed 
also for the RNase MRP RNA and Rpp38, but 
in addition were present in fractions containing 
complexes/proteins sedimenting slower than 
12S.  These fractions may contain the free 
proteins. In addition to the sedimentation of 
Rpp20, Rpp25, hPop4 and Rpp21 in 12S 
fractions, we also detected weak signals for 
these proteins in the 40S fractions. The signals 
observed in the low molecular weight fractions 
(2 - 6) with antibodies against Rpp20, hPop4 
C
Figure 1. Analysis of the human RNase MRP and RNase P 
complexes by glycerol gradient sedimentation (continued).
C: Pooled fractions 7-9; 13-15 and 19-21 (representing the 
12S; 40S and 60-80S peaks, respectively) were subjected 
to anti-Rpp38 immunoprecipitation. Subsequently, the 
immunoprecipitated material was analyzed for the presence 
of co-precipitated RNase P activity (lanes 4-6). In lane 1, 
purifi ed pre-tRNA substrate (input) was loaded. As a positive 
control, pre-tRNA substrate cleaved by partially purifi ed HeLa 
RNase P is shown in lane 2. As a positive control for anti-
Rpp38 immunoprecipitation, the partially purifi ed RNase P was 
immunoprecipitated and the pre-tRNA processing assay was 
performed on the beads (lane 3). The positions of pre-tRNA, 
tRNA and the 5’ leader sequence are indicated on the left.
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and Rpp21 do not migrate at the positions of 
the respective proteins and therefore, most 
likely, are due to cross reactivity. Although 
antisera raised against Rpp14 and hPop5 
were available, these sera appeared to be 
unable to detect the respective proteins in 
the gradient fractions. Because of the small 
difference in peak-sedimentation of 12S 
RNase MRP and RNase P RNA (Figure 1B, 
lanes 8 and 8-9, respectively), we tried to 
obtain a higher resolution in this region of 
the gradients by running 12-18% glycerol 
gradients. Interestingly, the results of these 
analyses strongly suggested that hPop4 and 
Rpp21 completely co-sedimented with the 
RNase P RNA and not with the RNase MRP 
RNA (data shown in chapter 6, Figure 2). In 
summary, the RNase MRP / RNase P protein 
subunits can be divided into two major groups: 
proteins which co-sediment with 12S, 40S and 
60-80S complexes and proteins which solely 
co-sediment with 12S and 40S complexes.
A
B
Figure 2. Distribution of RNase MRP/RNase P protein subunits in glycerol gradients.
The protein distribution in 5-40% glycerol gradients was analyzed by immunoblotting using polyclonal rabbit sera against the individual 
subunits. A: Proteins which sedimented at 12S, 40S and 60-80S. B: Proteins which sedimented at 12S and 40S only. Note that the 
available polyclonal rabbit sera against hPop5 and Rpp14 failed to detect the corresponding proteins.
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Figure 3. Co-immunoprecipitation of RNase MRP RNA 
and RNase P RNA with transiently expressed VSV-tagged 
protein subunits.
Incorporation of VSV-tagged protein subunits in 12S and 60-
80S complexes was determined by fractionation of extracts 
from transiently transfected HEp-2 cells expressing VSV-Rpp25 
or VSV-Rpp38 on 5-40% glycerol gradients. In parallel these 
extracts were subjected to immunoprecipitation with anti-VSV-
tag antibodies. A: An in vitro pre-tRNA processing assay was 
performed with the immunoprecipitated material. The reaction 
products were separated by denaturing gel electrophoresis. In 
lane 1, 100% of the input pre-tRNA was loaded. Lane 2: as a 
positive control, pre-tRNA was incubated with partially purifi ed 
RNase P. As a negative control, lane 3 shows the reaction 
products after incubation with an immunoprecipitate from an 
extract of HEp-2 cells which was transiently transfected with 
the control VSV-tag vector. Lanes 4-12 show the results for the 
immunoprecipitated material from cells expressing VSV-hPop1, 
VSV-hPop4, VSV-hPop5, VSV-Rpp14, VSV-Rpp20, VSV-
Rpp21, VSV-Rpp25, VSV-Rpp30, VSV-Rpp38, respectively. The 
positions of the pre-tRNA, the mature tRNA and the released 
5’leader sequence are indicated on the left. B: The presence of 
VSV-tagged and endogenous proteins in gradient fractions was 
determined by immunoblotting using polyclonal antisera against 
Rpp25 or Rpp38. In lane 1, the input material was loaded. In 
lanes 2-4, 12S, 40S and 60-80S peak fractions were analysed 
(fractions 8, 15 and 20, respectively). The positions of the 
VSV-tagged and endogenous proteins are indicated on the left. 
(Figure 3 is continued on next page)
B
A
Differential association of protein subunits 
in transfected cells
To further investigate the presumptive 
differential association of the protein subunits 
with 12S RNase MRP and RNase P, cDNAs 
encoding all RNase MRP / RNase P protein 
subunits were cloned in the pCI-Neo vector, 
in frame with an N-terminal VSV-tag encoding 
sequence as described before (26). HEp-2 
cells were transfected with the individual 
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constructs and after culturing for 24 hours, the 
incorporation of the VSV-tagged proteins into 
RNase MRP / RNase P-sized complexes was 
checked by analyzing the glycerol gradient 
sedimentation behaviour of transiently 
expressed VSV-Rpp25 or VSV-Rpp38. 
Extracts from cells expressing VSV-Rpp25 
or VSV-Rpp38 were separated on 5-40% 
glycerol gradients and the fractionation of 
the VSV-tagged as well as the endogenous 
proteins was analyzed by western blotting 
using polyclonal rabbit sera against the 
respective proteins. The results showed that, 
like the endogenous proteins, VSV-Rpp25 
associated with complexes sedimenting 
at 12S and VSV-Rpp38 associated with 
Figure 3. Co-immunoprecipitation of RNase MRP RNA and RNase P RNA with transiently expressed VSV-tagged protein 
subunits (continued).
C: RNA co-immunoprecipitated with the anti-VSV antibodies was isolated and analyzed by northern blot hybridization using 
RNase MRP RNA and RNase P RNA specifi c probes. Lane 1 contains total RNA from 10% of input material. In lanes 2-11 co-
immunoprecipitated RNAs from cells transfected with the ‘empty’ VSV-vector or with constructs encoding VSV-hPop1, VSV-hPop4, 
VSV-hPop5, VSV-Rpp14, VSV-Rpp20, VSV-Rpp21, VSV-Rpp25, VSV-Rpp30 and VSV-Rpp38 were loaded. The positions of RNase 
MRP and RNase P RNA are indicated on the left. D: Relative ratios of co-precipitated RNase P and RNase MRP RNAs quantifi ed by 
phosphorimaging of northern blot hybridization data. The ratio of the signals of these RNAs in the input material was arbitrarily set at 
1. The ratios were determined for three independent experiments and the error bars indicate the standard deviation.
D
C
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complexes sedimenting at 12S and 60-80S 
(Figure 3A). These results indicated that the 
tags did not interfere with the incorporation of 
these proteins into RNase MRP and RNase P 
particles. In agreement with this, the RNAs 
associated with these particles co-precipitated 
with the tagged proteins when the latter 
were immunoprecipitated with anti-VSV-tag 
antibodies (see below). To further demonstrate 
the association of the VSV-tagged protein 
subunits with these ribonucleoprotein particles, 
extracts from transiently transfected cells 
were subjected to immunoprecipitation with 
anti-VSV-tag monoclonal antibodies and the 
RNase P acitivity in the immunoprecipitates 
was determined in vitro. As can be seen in 
Figure 3B, in contrast to the immunoprecipitate 
from the extract from cells transfected with the 
control VSV-tag vector, the immunoprecipitates 
from all cells transfected with the individual 
VSV-fusion proteins displayed RNase P 
activity. These data show that all VSV-tagged 
RNase MRP / RNase P protein subunits 
analyzed are capable to associate with 
enzymatically active RNase P particles. Note 
that Rpp40 was not included in these analyses, 
because we failed to express VSV-tagged 
Rpp40 to detectable levels in this system. To 
study the association of these VSV-tagged 
proteins with both RNase MRP and RNase 
P, the co-precipitating RNAs were isolated 
from anti-VSV-tag immunoprecipitates and 
analyzed by northern blot hybridization using 
riboprobes specifi c for the RNA components 
of RNase MRP and RNase P. The results in 
Figure 3C show that VSV-hPop1, VSV-hPop5, 
VSV-Rpp20, VSV-Rpp25, VSV-Rpp30 and 
VSV-Rpp38 all co-precipitate both RNase 
MRP RNA and RNase P RNA. The relative 
effi ciencies by which these two RNAs are 
co-precipitated are about equal for all of 
these proteins, indicating that these subunits 
are associated with both RNase MRP RNA 
and RNase P RNA. This was confi rmed by 
quantifi cation of the data by phosphorimaging 
of the RNase MRP RNA and RNase P RNA 
signals for three independent experiments 
(Figure 3D). Surprisingly, for VSV-Rpp21, VSV-
Rpp14 and VSV-hPop4 we never detected co-
precipitation of RNase MRP RNA. To exclude 
the possibility that VSV-Rpp21, VSV-Rpp14 
and VSV-hPop4 did not co-precipitate RNase 
MRP RNA due to interference of the VSV-tag, 
the experiment was repeated, but now with the 
VSV-tag fused to the C-terminus instead of the 
N-terminus of these proteins. Also in these 
cases no co-precipitation of RNase MRP RNA 
was observed (results not shown). The lack 
of RNase MRP RNA co-immunoprecipitation 
with VSV-tagged Rpp21 and hPop4 is 
consistent with results obtained by 12-18% 
glycerol gradient sedimentation analyses 
which showed the specifi c co-sedimentation of 
Rpp21 and hPop4 with the 12S RNase P RNA 
indicating that these proteins are preferentially 
associated with the RNase P holoenzyme.
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Discussion
Previous studies have identifi ed ten human 
proteins which are believed to be stably 
associated with RNase MRP and RNase 
P (18-25). For most of these proteins, 
co-immunoprecipitation experiments 
demonstrated that they are indeed associated 
with both RNase MRP RNA and RNase P RNA 
in human cell lines (27;28). Moreover, all ten 
proteins co-purifi ed with catalytically active 
RNase P suggesting that they are part of the 
core structure of the holoenzyme. Recently, we 
and others have identifi ed mutual interactions 
between protein subunits and interactions 
between protein subunits and the RNA 
components by two-hybrid analyses and in in 
vitro assays (26;29;30). In the study described 
here we have addressed the molecular 
composition of the complexes in HEp-2 cell 
lysates. Our data not only show a preferential 
association of hPop4, Rpp21 and Rpp14 with 
RNase P, but also provide evidence for the 
transient association of Rpp25 and Rpp20 
with RNase MRP. The results suggest that the 
latter proteins dissociate from the RNase MRP 
complex when it binds to 60-80S complexes.
When the RNA component is taken as a 
molecular marker for all particles, RNase 
MRP co-sedimented with 12S and 60-
80S complexes and a minority with 40S 
complexes, whereas RNase P was found 
mainly at 12S and a small amount at 40S. 
The co-sedimentation of RNase MRP with 
60-80S complexes in glycerol gradients has 
also been reported for RNase MRP from 
HeLa cells and from plants (12;13). This is 
consistent with its involvement in pre-rRNA 
processing, because these complexes are 
believed to represent ribosomal precursors 
associated with processing factors. The lack 
of RNase P RNA in 60-80S fractions does not 
support a role for RNase P in human pre-rRNA 
processing, which was previously suggested 
both in yeast (17) and in mammals (13). 
Up to now, most of the ten protein subunits 
identifi ed for the mammalian RNase MRP 
/ RNase P complexes were reported to 
be associated with both ribonucleoprotein 
particles. The only clear reported difference 
between both complexes is the identity of 
the associated RNA (31;32). Interestingly, in 
S. cerevisiae Snm1p and RMP1 have been 
identifi ed as unique protein components of 
RNase MRP (33;34) and Rpr2p as a unique 
protein component of RNase P (17). However, 
the recent purifi cation of RNase MRP from 
S. cerevisiae demonstrated that signifi cant 
amounts of Rpr2p are present in the purifi ed 
complex, suggesting that at least a subset of 
RNase MRP is also associated with Rpr2p 
(33). In agreement with the difference in 
protein composition, electron microscopic 
analyses of affi nity-purifi ed ‘POP complexes’ 
from yeast showed the existence of large 
and small complexes, which may refl ect 
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the size difference due to different protein 
compositions of both yeast complexes (35). 
The present results indicate that a subset of 
the ten protein subunits (hPop4, Rpp21 and 
Rpp14) are more effi ciently associated with 
RNase P than with RNase MRP. hPop4 and 
Rpp21 not only specifi cally co-fractionate with 
12S RNase P RNA (note that Rpp14 could not 
be detected in glycerol gradient fractions), 
but also preferentially associate with RNase 
P RNA in transfection experiments with VSV-
tagged proteins. Our results indicate that the 
separation of RNase MRP and RNase P in 
the 12S region may not only be due to the 
size differences between the RNAs, but may 
also be caused by the differential association 
of protein subunits. Alternatively, we cannot 
exclude the possibility that stoichiometric 
differences between RNase MRP and RNase 
P affect the distribution of protein components 
in glycerol gradient sedimentation. Most 
interestingly, in vitro RNase P reconstitution 
experiments have demonstrated that a particle 
composed of human RNase P RNA and 
recombinant hPop4 and Rpp21 generated 
a functionally active complex (36). Similarly, 
the archaeal hPop4 and Rpp21 orthologues of 
Pyrococcus horikoshii (Ph1771 and Ph1601, 
respectively) have been shown to be essential 
components of an active, reconstituted 
RNase P particle (37). In combination with 
the reported binding activities of Rpp14 to 
precursor tRNA (22) and hPop4 and Rpp21 
to both mature and precursor tRNA (22;38), 
these data suggest that the 12S RNase P 
particle represents the human holoenzyme. 
Indeed, the 12S fractions catalyzed the 
cleavage of a pre-tRNA substrate in vitro. 
In agreement with their preferential association 
with RNase P particles, the hPop4 and Rpp21 
proteins were undetectable in the 60-80S 
fractions. This suggests that these proteins 
are not required for the role of RNase MRP 
in pre-rRNA processing in human cells. In 
previous studies, hPop4 has been shown 
to interact with both the RNase P and the 
RNase MRP particle (24) and to display 
direct binding to the RNase P and RNase 
MRP RNAs (26). Moreover, the yeast Pop4p 
protein has been described to be required 
for pre-rRNA processing (39) and recently 
a TAP-tagged version of the Pop4p protein 
was used to purify the yeast RNase MRP 
complex (33). In part these confl icting results 
may be explained by a physical or functional 
link between subsets of the RNase MRP and 
RNase P complexes. In 60-80S complexes, a 
direct interaction between RNase MRP and 
RNase P was previously proposed by Lee 
and co-workers (13). Since we were not able 
to detect RNase P in 60-80S complexes, the 
interaction between subsets of the RNase 
MRP and RNase P may be relatively unstable 
or transient. Alternatively, a small amount of 
complexes containing both RNase MRP and 
RNase P may also sediment in regions of the 
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gradients that were not analyzed in detail in 
this study. Indeed, the sedimentation of both 
RNase MRP and RNase P at 40S indicates that 
additional complexes do exist. Finally, our data 
do not completely rule out the possibility that 
a small subset of RNase MRP particles does 
contain hPop4 (and Rpp21 and Rpp14). Such 
an interaction may be mediated by a direct 
interaction of hPop4 with the RNase MRP 
RNA, which we previously observed by in vitro
RNA-binding experiments (26). It should also 
be noted that signifi cant differences in RNase 
MRP and RNase P protein composition exist 
between the mammalian and yeast complexes 
(40). Therefore, the association of Pop4p 
with the yeast RNase MRP complex does 
not necessarily mean a similar association 
in mammalian cells as well. Protein subunits 
Figure 4. Differential association of protein subunits with the human 
RNase P and RNase MRP particles. 
The models used in this fi gure are adapted from and based upon a 
previously described model for the human RNase MRP complex (see 
Chapter 2, Figure 8 and (26)). Protein subunits which are associated with 
12S RNase P and both 12S and 60-80S RNase MRP are shown in light 
grey (1 = hPop1; 5 = hPop5; 30 = Rpp30; 38 = Rpp38 and 40 = Rpp40). 
In black the proteins associated with both 12S RNase P and 12S RNase 
MRP are depicted (25 = Rpp25 and 20 = Rpp20). In dark grey the subunits 
preferentially associated with 12S RNase P are shown (4 = hPop4, 14 = 
Rpp14 and 21 = Rpp21). Only the major complex compositions based upon 
the current data are shown. A minority of RNase MRP may also contain 
hPop4, Rpp21 and Rpp14. A: Schematic representation of the 12S human 
RNase P complex. B: Composition of the human RNase MRP complexes. 
The differential association of the Rpp25-Rpp20 heterodimer is based upon 
5-40% glycerol gradient sedimentation data (Figure 2). Note that because 
of the lack of glycerol gradient sedimentation data on hPop5, we could not 
assign this protein to either the 12S or the 60-80S RNase MRP species.
A B
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that are associated with both holoenzymes 
in yeast may by differentially associated with 
these enzymes in mammalian cells. 
Four of the other proteins that were found 
in 12S fractions were also present in the 
presumptive pre-ribosomal complexes at 60-
80S. Whereas the distribution over 12S and 
60-80S complexes for most of these proteins 
was similar to that of RNase MRP RNA, 
the relative abundance of hPop1 in 60-80S 
material seemed to be higher than that for 
the other proteins. Currently it is not known 
whether this is due to the association of hPop1 
with other complexes sedimenting at 60-80S 
or to substoichiometric amounts of this protein 
in 12S complexes. 
Surprisingly, Rpp25 and Rpp20 were not 
detected at all in 60-80S fractions, even though 
they have been demonstrated to be stably 
associated with RNase MRP (28). Rpp25 and 
Rpp20 are evolutionarily related proteins, both 
belonging to the Alba superfamily (41), which 
directly bind to each other (26) and most likely 
bind as a heterodimer to the P3 domain of 
RNase MRP RNA (27;28). In RNase MRP 
RNA this region is in close proximity to 
nucleotides 68-71 and the P4 stem, which 
are believed to be part of the catalytic center 
of the enzyme. Therefore, it is tempting to 
speculate that the Rpp25-Rpp20 heterodimer 
has to dissociate from the complex before 
the enzyme can associate with and cleave 
substrate RNAs, such as the pre-rRNA in the 
60-80S complexes. Previously, Rpp20 has 
been reported to contain ATPase activity (42). 
It would be interesting to investigate whether 
this activity is required for the dissociation 
of the Rpp25-Rpp20 heterodimer from the 
RNase MRP complex during pre-rRNA 
processing. Because previous studies showed 
that both Rpp25 and Rpp20 are associated 
with catalytically active RNase P, it is an 
interesting question whether the cleavage of 
substrate RNAs by RNase MRP is blocked 
by the association of the Rpp25-Rpp20 
heterodimer. Currently, it is unclear what the 
function of these proteins may be. They may 
be involved in stabilization of the ‘free’ RNase 
MRP (and RNase P) enzymes, they may play 
a role in their subcellular localization, they may 
be involved in the recruitment of RNase MRP 
/ RNase P to substrate RNAs, or they may 
regulate the storage and/or activity of these 
enzymes. An overview of the differences in 
human RNase MRP composition is given 
in Figure 4. Because of the lack of glycerol 
sedimentation data on hPop5, we could not 
specifi cally assign this protein to either the 
12S or the 60-80S RNase MRP populations. 
In addition to the complexes discussed 
above, a small subset of both RNase MRP 
and RNase P was reproducibly sedimenting 
at 40S. Both the RNAs and most of the 
protein components were detected in these 
fractions. Currently it is unknown with which 
other molecules or complexes the enzymes 
   74                Chapter 3
are associated in these 40S complexes. With 
regard to the 40S sedimentation of RNase 
MRP and RNase P it is interesting to note 
that the Bacillus subtilis RNase P particle has 
been reported to interact with the 30S small 
ribosomal subunit of this prokaryote (43).
A schematic representation of the differences 
observed in the composition of RNase MRP 
and RNase P complexes is presented in 
Figure 4. We conclude that hPop4, Rpp21 
and Rpp14 are preferentially associated 
with the human RNase P and that cells 
probably contain heterogeneous pools of 
RNase MRP complexes, which differ in their 
protein composition depending on either 
their functional activity or their association 
with other complexes. Taken together, our 
data provide the fi rst evidence for differences 
in protein composition of the human 
RNase MRP and RNase P complexes and 
indicate that Rpp20 and Rpp25 transiently 
associate with the RNase MRP complex. 
Further experiments will be required to 
shed light on the functional implication of 
these differences in particle composition.
Materials and Methods
Glycerol density gradient centrifugation
HEp-2 monolayer cells were grown in T75 
fl asks to 70% confl uence in DMEM (GibcoBRL) 
supplemented with 10% fetal calf serum. After 
harvesting, 107 cells were resuspended in 
750 μl gradient buffer (20 mM HEPES/KOH, 
pH 7.6, 150 mM NaCl, 0.5 mM DTE) and 
disrupted by sonication (Branson microtip). 
Subsequently, Triton X-100 was added to a 
fi nal concentration of 0.2% (v/v) and insoluble 
material was removed by centrifugation at 
15,000 x g in a microcentrifuge. The 5-40% 
(v/v) glycerol gradients were prepared using 
the Biocomp Gradient Master 107 in gradient 
buffer supplemented with 0.2% Triton X-
100. The cleared cell lysate (750 μl) was 
layered on a 12 ml gradient. The gradients 
were centrifuged in a Sorvall TH641 rotor 
for 17 hours at 100,000 x g at 4oC. After 
centrifugation, 500 µl fractions were collected 
manually and stored at -20oC. The 12-18% (v/v) 
glycerol gradients were prepared as described 
above. However, on the latter gradients 
lysate from only 106 HEp-2 cells was loaded.
RNA isolation and northern blotting
To isolate total RNA from the glycerol gradient 
fractions, 35 µl per fraction was subjected to 
Trizol (Invitrogen) extraction. The aqueous 
phase was collected and the RNA was 
precipitated by the addition of one volume 
of isopropanol in the presence of 100 µg 
glycogen. After centrifugation, the pellet was 
washed with 80% ethanol. Subsequently, 
the pellet was dissolved in 30 µl formamide 
loading buffer. The RNAs were separated 
by denaturing urea-PAGE and subsequently 
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transferred to Hybond-N membranes 
(Pharmacia) by electroblotting in 18.4 mM 
Na2HPO4, 6.5 mM NaH2PO4. After blotting, 
the RNAs were covalently bound to the 
membranes in a UV cross-linker and stored 
at 4oC.
SDS-PAGE and immunoblotting
To determine the distribution of the RNase 
MRP / RNase P protein subunits in the 
glycerol gradients, samples from gradient 
fractions were separated by SDS-PAGE and 
transferred to nitrocellulose membranes by 
electroblotting. Immunodetection of hPop1, 
hPop4, hPop5, Rpp14, Rpp20, Rpp21, Rpp25, 
Rpp30, Rpp38 and Rpp40 was performed 
using polyclonal rabbit antisera against 
these proteins (18-25) and a monoclonal 
mouse antibody against Rpp20 (ModiQuest, 
Nijmegen, The Netherlands). Horseradish 
peroxidase-conjugated polyclonal swine 
anti-rabbit immunoglobulin antibodies were 
purchased from Dako (Glostrup, Denmark) 
and applied as secondary antibody. Bound 
antibodies were visualized by enhanced 
chemiluminescence detection procedures.
In vitro transcription and antisense probing 
of RNAs
Antisense radiolabeled riboprobes were 
generated from plasmids carrying the 
sequences of the human RNase MRP RNA, 
RNase P RNA and U3 snoRNA (44;45). The 
plasmids were linearised with the appropriate 
restriction endonucleases and transcribed in 
vitro as described before (26). After purifi cation 
of the transcripts using a G-50 spin column 
the antisense RNAs were stored at -20oC or 
directly used in hybridization experiments. 
For probing with the antisense riboprobes, 
northern blots were blocked at 65oC with 
hybridization buffer (6 x SSC, 0.1 mg/ml 
sheared herring sperm DNA; 0.2 % SDS, 10 
x Denhardt’s). After blocking for 1 hour, the 
riboprobe was added and hybridization was 
performed overnight at 65oC. The blots were 
subsequently washed twice with 1 x SSC, 0.2 
% SDS and twice with 0.1 x SSC. The RNAs 
were visualized by autoradiography and the 
signals were quantifi ed using the BioRad GS-
363 phosphorimager.
Transfection constructs, transient 
transfection and immunoprecipitation
RNase MRP / RNase P protein cDNAs were 
cloned into a pCI-neo mammalian expression 
vector (Promega) containing the vesicular 
stomatitis virus (VSV) G epitope sequence as 
described before (26). HEp-2 monolayer cells 
were cultured in a T75 fl ask and harvested at 
70% confl uence. For transfection, 20 μg purifi ed 
plasmid DNA was added individually to 5 x 106 
HEp-2 cells in 800 μl culture medium. The cells 
were electroporated at 260 V at a capacity of 
950 μF using a Biorad Genepulser II. After 
transfection, the cells were cultured in a T75 
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fl ask and harvested 24 hours post-transfection. 
To check incorporation of the transiently 
expressed proteins into ribonucleoprotein 
particles, extracts were either loaded on 5-
40% glycerol gradients (as described above) 
or subjected to immunoprecipitation. For 
immunoprecipitation, the cells were washed 
with PBS and cell pellets were resuspended in 
700 μl lysisbuffer containing 25 mM Tris-HCl, 
pH 7.6, 100 mM KCl, 1 mM DTE, 2 mM EDTA, 
0.5 mM phenylmethylsulfonyl fl uoride, 0.05% 
NP-40. Subsequently, the cells were disrupted 
by sonication (Branson microtip) and insoluble 
material was removed by centrifugation 
(15,000 x g, 10 minutes). Simultaneously, 
anti-VSV mouse monoclonal antibodies or 
rabbit anti-Rpp38 antibodies were coupled 
to protein-A-agarose beads in 500 μl IPP500 
(500 mM KCl, 10 mM Tris-HCl, pH 8.0, 0.05% 
(v/v) NP-40). Prior to immunoprecipitation, the 
beads were washed with IPP150 (150 mM 
KCl, 10 mM Tris-HCl, pH 8.0, 0.05% (v/v) NP-
40). For immunoprecipitation, the beads were 
mixed with 500 μl total cell extract and IPP150 
was added to a total volume of 750 μl. After 2 
hours of incubation by end-over-end rotation 
at 4oC, the beads were washed 3 times with 
500 μl IPP150 and subsequently analyzed for 
pre-tRNA processing activity or subjected to 
RNA isolation and northern blot hybridization 
as described above.
pre-tRNA processing assay
RNase P activity in immunoprecipitated 
material was monitored by the ability 
to process a  pre-tRNA substrate from 
Schizosaccharomyces pombe tRNASer (46) 
to mature tRNA and the released 5’ leader 
sequence. The substrate was transcribed in 
vitro from a linearized template using SP6 RNA 
polymerase in the presence of α32P-UTP. The 
RNA was purifi ed from the reaction mixture by 
denaturing urea-PAGE, excision from the gel 
and elution (overnight) in a buffer containing 
100 mM NaCl and 0.1% SDS. After elution, 
the RNA was precipitated and dried pellets 
were stored at -20oC. For monitoring pre-tRNA 
processing activity in immunoprecipitated 
material, the beads containing the precipitates 
were resuspended in a buffer containing the 
purifi ed pre-tRNA substrate; 20 mM Tris-HCl, 
pH 7.6; 10 mM MgCl2; 1 mM DTE and 50 mM 
KCl. The cleavage reaction was carried out for 
20 minutes at 37oC under continuous agitation. 
The reaction was stopped and the reaction 
products were resolved by urea-PAGE. The 
RNAs were visualized by autoradiography.
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   85                                                                         Rpp20-Rpp25 heterodimerization
Rpp20 and Rpp25 are subunits of the human RNase MRP and RNase P endoribonucleases belonging to the Alba superfamily of nucleic acid binding proteins. These proteins, which bind very strongly to 
each other, transiently associate with RNase MRP. Here, we show that the 
Rpp20-Rpp25 heterodimer is resistant to both high concentrations of salt 
and a non-ionic detergent. The interaction of Rpp20 and Rpp25 with the P3 
domain of the RNase MRP RNA appeared to be strongly enhanced by their 
heterodimerization. Co-immunoprecipitation experiments demonstrated that 
only a single copy of each of these proteins is associated with the RNase MRP 
and RNase P particles in HEp-2 cells. Both proteins accumulate in the nucleoli, 
which in case of Rpp20 is strongly dependent on its interaction with Rpp25. 
Finally, the results of overexpression and knock-down experiments indicate that 
their expression levels are co-dependent. Taken together, these data indicate 
that the Rpp20-Rpp25 heterodimerization regulates their RNA-binding activity, 
subcellular localization and expression, which suggests that their interaction is 
also crucial for their role in RNase MRP/P function.
cellular endoribonucleolytic RNA processing 
events which are directly or indirectly linked 
to the cellular translation machinery. RNase P 
is an essential factor in tRNA maturation as it 
removes the 5’ leader sequence of pre-tRNA 
(6). RNase MRP is involved in the processing 
of pre-rRNA, more specifi cally the generation 
of the 5’end of 5.8S rRNA by cleaving the 
internal transcribed spacer 1 (ITS1) (7;8). 
Additional substrates for RNase MRP have 
been identifi ed in both mammals and yeast. In 
human, murine and bovine cells, RNase MRP 
has been reported to function in mitochondrial 
DNA replication by its involvement in the 
Introduction
The RNase MRP complex is a small 
ribonucleoprotein particle composed of an 
essential RNA subunit (normally around 
300 nucleotides (1;2)) and about 10 protein 
subunits. This macromolecular complex and 
its constituents has been identifi ed in several 
vertebrates, invertebrates, plants and lower 
eukaryotes (3), but not in eubacteria or 
archaebacteria (4). RNase P, a structurally and 
functionally related ribonucleoprotein complex, 
has been reported to occur in all three domains 
of life (5). Both complexes catalyze essential 
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endoribonucleolytic generation of an RNA 
species which is required for the priming of this 
process (9). Recently, a role for RNase MRP 
in yeast cell cycle regulation was reported by 
Schmitt and collaborators, who showed that 
RNase MRP plays a role in the degradation of 
the mRNA encoding the mitosis specifi c cyclin 
Clb2 (10). 
The RNA subunit of human RNase MRP, 
which has been shown to be essential for 
its enzymatic activity in a mouse and yeast 
system (11;12), can adopt a typical structure 
which is also found or predicted for the RNase 
MRP and RNase P RNAs from other species 
(13-16). Because of the structural similarities 
of the RNA subunits an evolutionary relation 
between RNase MRP and RNase P was 
proposed (4;14;17). This is further supported 
by the fact that both complexes share several 
protein subunits (5). 
Distinct structural elements of the RNase MRP 
and RNase P RNAs have been demonstrated 
to be required for protein subunit interactions 
(18-20) and to be involved in particle 
assembly (21), subcellular localization 
(22;23) and enzymatic activity (24). The 
P3 domain of RNase MRP RNA is not only 
a structural moiety where several protein 
subunits interact with the RNA (18;25), but 
is also important for the accumulation of 
the RNase MRP RNA in the nucleoli, where 
pre-rRNA processing occurs (22). The 
human P3 domain has also been reported 
to be involved in the recognition of RNase 
MRP by so-called anti-Th/To autoantibodies 
found in the serum of systemic sclerosis, 
polymyositis, Raynaud’s phenomenon and 
systemic lupus erythematosus patients (26). 
Although originally a 40 kDa protein subunit 
was believed to contain the major Th/To 
determinants, we showed that the 25 and 
20 kDa protein subunits Rpp25 and Rpp20, 
previously referred to as MRP25 and MRP20, 
represent the subunits most frequently targeted 
by such autoimmune sera (18;19). Rpp25 and 
Rpp20 both interact with the P3 domain of the 
RNase MRP RNA and are also associated with 
human RNase P, which explains why most 
anti-Th/To positive patient sera co-precipitate 
RNase MRP and RNase P (19;27-30). 
Recently, we showed that the recombinant 
Rpp20 and Rpp25 proteins very effi ciently 
bind to each other in vitro (20), suggesting that 
they may associate as a heterodimer with the 
RNase MRP and RNase P complexes. Rpp20 
was reported to exhibit ATPase activity and to 
interact with the proteins SMN, Hsp27 and 
KIAA0065 (24;31). Interestingly, in contrast to 
the other RNase MRP protein subunits, both 
Rpp20 and Rpp25 do not sediment at 60-80S 
in glycerol gradients and thus might dissociate 
from RNase MRP before or during its 
association with pre-rRNA containing particles, 
which sediment at this region of the gradients 
(32). Moreover, both Rpp20 and Rpp25 share 
sequence homology with archaeal proteins 
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from the Alba family (33), further supporting 
a putative functional relationship between 
Rpp20 and Rpp25. To obtain more insight 
into the role of the Rpp20 and Rpp25 proteins 
in the function of RNase MRP and RNase P, 
we studied their dimerization in more detail, 
their association with RNase MRP / RNase P 
particles, their subcellular localization, and the 
interdependence of their expression levels. 
Results
Rpp20 - Rpp25 heterodimerization
To further characterize the strong interaction 
between Rpp20 and Rpp25 (20), bacterially 
expressed GST-Rpp25 was incubated with 
in vitro translated, radiolabeled Rpp20 and 
precipitated with glutathione-Sepharose. In 
agreement with previous observations, Rpp20 
was almost quantitatively co-precipitated 
with GST-Rpp25, whereas no detectable co-
precipitation was observed with the control 
proteins GST and GST-Rrp41p (Rrp41p is a 
subunit of the exosome complex) (Figure 1A). 
Note that in vitro translated Rpp20 migrates 
as a doublet, which is most likely due to 
translation initiation at both the start codon at 
the 5’ end of the VSV-tag encoding sequence 
and at the start codon of the Rpp20 cDNA 
sequence. Similar results were observed for 
the reciprocal pull-down assay with GST-
Rpp20 and in vitro translated Rpp25 (data 
not shown). In the GST pull-down assay 
the GST-tagged recombinant proteins were 
used in a large excess (approx. 1000-fold) 
in comparison with the in vitro translated 
proteins. To investigate whether similar 
interaction effi ciencies are observed when 
both interacting proteins are used at relatively 
low and approximately equal concentrations, 
in vitro translated Rpp20 and Rpp25 were 
incubated and immunoprecipitated with 
polyclonal rabbit sera against Rpp20 or 
Rpp25. The specifi city of these antibodies was 
substantiated by the specifi c precipitation of 
the cognate in vitro translated proteins (Figure 
1B, lanes 1-3 and 5-7). When both proteins 
were mixed prior to the immunoprecipitations, 
Rpp25 was effi ciently co-precipitated with the 
anti-Rpp20 antibodies and vice versa (Figure 
1B, lanes 4 and 8, respectively). When the 
number of radiolabeled residues per molecule 
is taken into account (3 for VSV-Rpp20 and 
5 for VSV-Rpp25) it can be concluded that 
about the same number of Rpp20 and Rpp25 
molecules is precipitated by both antibodies. 
Thus also under these conditions Rpp20 and 
Rpp25 effi ciently interact with each other.
To gain more insight into the nature of the 
Rpp20-Rpp25 interaction, GST pull-down 
experiments were performed in the presence 
of increasing concentrations of salt or a non-
ionic detergent to interfere with hydrophilic 
and hydrophobic bonds, respectively. The 
results in Figure 1C show that the interaction 
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Figure 1. Rpp20-Rpp25 heterodimerization.
Rpp20 and Rpp25 were translated in vitro using a rabbit reticulocyte lysate system. The 35S-labeled proteins were separated by SDS-
PAGE and visualized by autoradiography. A: In vitro translated Rpp20 was incubated with GST-Rpp25 and GST and GST-Rrp41p as 
controls. GST-tagged and associated proteins were pulled down by glutathione-Sepharose. Lane 1: in vitro translated Rpp20 (input, 
100% of the amount incubated with the GST-tagged proteins). Lanes 2, 3 and 4: radiolabeled protein bound to GST, GST-Rrp41p 
and GST-Rpp25, respectively. B: In vitro translated Rpp20, Rpp25 or a mixture of these proteins was immunoprecipitated with 
polyclonal anti-Rpp20 and anti-Rpp25 rabbit sera. Lanes 1 and 5: Rpp20 and Rpp25, 10% input. Lanes 2 and 3: immunoprecipitates 
of Rpp20 with anti-Rpp20 and anti-Rpp25 antibodies, respectively. Lanes 6 and 7: immunoprecipitates of Rpp25 with anti-Rpp25 
and anti-Rpp20 antibodies, respectively. Lanes 4 and 8: immunoprecipitates of a Rpp20/Rpp25 mixture with anti-Rpp20 and anti-
Rpp25 antibodies, respectively. C: GST-Rpp25 and GST as a control were incubated with in vitro translated Rpp20 under standard 
conditions (100 mM KCl, no Triton X-100, lanes 2-3) and in the presence of increasing KCl (upper panel) or Triton X-100 (lower 
panel) concentrations. Lane 1: 100% of input material. Lanes 2-13: GST (even lanes) and GST-Rpp25 (odd lanes) bound material 
precipitated under the conditions indicated above the lanes. D: GST pull-down analysis of in vitro translated Rpp25 with equimolar 
amounts of GST-Rpp20 and GST-Rpp20 amino acid substitution mutants. Lane 1: in vitro translated Rpp25 (input). Lane 2-6: Material 
bound to GST, GST-Rpp20, GST-Rpp20D36E, GST-Rpp20N40Q and GST-Rpp20G59S, respectively. 
B
A
C
D
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between Rpp20 and Rpp25 is resistant to both 
high salt (up to 4M KCl) and high detergent 
(up to 20% Triton X-100) concentrations. 
A role for intermolecular disulfi de bridge 
formation was excluded by the addition of 
increasing concentrations (up to 700 mM) of 
β-mercaptoethanol (data not shown). Taken 
together, these data substantiate the very 
strong, non-covalent interaction between 
Rpp20 and Rpp25 and suggest that this 
heterodimerization is not mainly determined 
by either ionic or hydrophobic bonds.
Rpp20 was previously reported to exhibit 
ATPase and GTPase activity and substitution 
of amino acids in regions which show 
homology with the ABC ATPase signature 
motif or the DIxxN sequence element, which is 
homologous to the ATPase motif of the Upf1p 
subfamily of DEAD box RNA helicases, led to 
the inhibition of ATP hydrolysis by recombinant, 
bacterially expressed Rpp20 (24). Although the 
presence or absence of ATP did not affect the 
interaction between Rpp20 and Rpp25 (results 
not shown), we investigated whether the 
Rpp20 mutations in the ABC ATPase signature 
motif and DIxxN element interfere with Rpp20-
Rpp25 dimerization. Three different Rpp20 
substitution mutants were expressed as GST-
fusion proteins and equal amounts of GST-
Rpp20, GST-Rpp20D36E, GST-Rpp20N40Q 
and GST-Rpp20G59S were used in a GST 
pull-down assay with in vitro translated Rpp25 
in the absence of ATP (Figure 1D). As observed 
before, wild type GST-Rpp20 effi ciently 
interacted with Rpp25 (lane 3). Similar levels 
of Rpp25 co-precipitation were observed with 
mutants Rpp20D36E and Rpp20G59S. In 
contrast, substitution of asparagine-40 by a 
glutamine (Rpp20N40Q) strongly diminished 
the interaction with Rpp25 (lane 5). Similar 
results were obtained when ATP was included 
in this experiment. These results show that 
asparagine-40 of Rpp20 plays a crucial role 
in the interaction with Rpp25. The effi cient 
interactions between the ATPase defi cient 
Rpp20 mutants D36E and G59S (24) and 
Rpp25 substantiate that heterodimerization of 
these two proteins is independent of ATP.
The Rpp20 - Rpp25 heterodimer effi ciently 
interacts with the P3 domain of human 
RNase MRP RNA
Previously, UV-crosslinking and GST pull-
down analyses showed that both Rpp20 and 
Rpp25 interact with or are in close proximity 
to the RNA subunit of human RNase MRP, in 
particular the P3 domain of this RNA molecule 
(18;20;25). To investigate the binding of 
Rpp20, Rpp25 and/or the heterodimer of 
these proteins to the P3 RNA, streptavidin 
pull-down experiments were performed using 
in vitro transcribed, biotinylated P3 RNA 
and radiolabeled, in vitro translated Rpp20 
and Rpp25. Rpp20 alone did not detectably 
interact with the P3 RNA, whereas Rpp25 was 
reproducibly co-precipitated, albeit at relatively 
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low levels (Figure 2A). The co-precipitation of 
Rpp25 was specifi c, because in the absence 
of the biotinylated P3 RNA no co-precipitation 
was observed. The effi cient heterodimerization 
of in vitro translated Rpp20 and Rpp25 (Figure 
1B) allowed us to investigate the interaction 
of the dimer with the P3 RNA. The results 
in Figure 2A show that this dimer indeed 
effi ciently associated with the P3 domain. 
Signifi cant amounts of Rpp20 were now co-
precipitated with the P3 RNA and the effi ciency 
by which Rpp25 interacted with P3 RNA was 
strongly enhanced (note that equal amounts 
of Rpp25 were added to the incubations in 
the absence and in the presence of Rpp20). 
These results not only indicate that, in contrast 
to Rpp20, Rpp25 is able to interact directly 
and independently with the P3 domain, but 
also demonstrate that the Rpp20-Rpp25 
heterodimer binds more strongly to the P3 
Figure 2. Interaction of Rpp20 and Rpp25 with the P3 
domain of human RNase MRP RNA.
Biotin-labeled P3 RNA was incubated with in vitro translated 
Rpp20 and/or Rpp25. Subsequently, P3 RNA-bound 
material was isolated by precipitation with streptavidin-
agarose and analysed by SDS-PAGE and autoradiography. 
A: Lanes 1 and 2: in vitro translated Rpp20 and Rpp25, 
respectively (100% of the amount used for P3 binding). 
Lane 3: control without P3 RNA. Lanes 4 and 5: precipitated 
material after incubation with only Rpp20 or only Rpp25. 
Lane 6: precipitated material after incubation with a mixture 
of Rpp20 and Rpp25. Lanes 7-11: precipitated Rpp25 
after incubation with P3 RNA in the presence of purifi ed, 
bacterially expressed GST-Rpp20, GST-Rpp20D36E, GST-
Rpp20N40Q, GST-Rpp20G59S and GST, respectively. B: Binding of in vitro translated Rpp20 and Rpp25 to biotinylated P3 RNA 
after incubations with decreasing amounts of Rpp25 (upper panel) or Rpp20 (lower panel) and constant amounts of Rpp20 (upper 
panel) or Rpp25 (lower panel). Lanes 1-5: 100% of (diluted) input material (3-fold dilution series of the respective proteins in lanes 
2-5). Lanes 6-9: precipitated material of mixtures of Rpp20 and Rpp25 corresponding to the amounts in lane 1 in combination with 
that in lanes 2-5.
B
A
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domain than Rpp25 alone.
To substantiate the importance of Rpp20-
Rpp25 dimerization for effi cient interactions 
with the P3 domain, the effect of the Rpp20 
amino acid substitution mutations was 
studied using the GST-Rpp20 mutants in 
the streptavidin pull-down assay. Indeed, the 
presence of mutant Rpp20N40Q, which did 
not effi ciently dimerize with Rpp25 (see Figure 
1D), did not lead to an enhanced interaction 
between Rpp25 and the P3 domain (Figure 2A, 
lane 9). In contrast, the Rpp20 mutations that 
did not affect dimerization, resulted in wild type 
levels of Rpp25-P3 RNA interaction (lanes 7, 8 
and 10). Thus, the dimerization of Rpp20 and 
Rpp25 is necessary for the effi cient interaction 
of these proteins with the P3 domain of human 
RNase MRP RNA.
To further investigate the importance of Rpp20-
Rpp25 heterodimerization for their interaction 
with the P3 domain, a pull down experiment 
was performed with decreasing amounts of 
either Rpp20 or Rpp25. Decreasing the amount 
of Rpp25 in the presence of a constant amount 
of Rpp20 led to a concomitant decrease in the 
co-precipitation of Rpp20 (Figure 2B, upper 
panel). Similarly, decreasing the amount 
of Rpp20 in the presence of a constant 
amount of Rpp25 gradually decreased the 
co-precipitation of Rpp25 (Figure 2B, lower 
panel). These results are fully consistent with 
the binding of Rpp20 and Rpp25 as a dimer to 
the P3 domain of RNase MRP RNA. 
Stoichiometry of Rpp20 and Rpp25 
interaction with RNase MRP / RNase P
The results of the experiments described above 
indicated that Rpp20 and Rpp25 bind in a one-
to-one ratio to the P3 domain of RNase MRP 
RNA in vitro, which may refl ect the situation 
in the RNase MRP / RNase P particles. To 
investigate the stoichiometry of the Rpp20 
and Rpp25 association with RNase MRP and 
Figure 3. Stoichiometry of Rpp20 and Rpp25 binding to the 
RNase MRP and RNase P complexes.
HEp-2 cells were transiently transfected with constructs 
encoding VSV-tagged variants of both Rpp20 and Rpp25. As 
a control, the ‘empty’ VSV-tag vector was used in parallel. Cell 
lysates were subjected to immunoprecipitation with anti-VSV-
tag antibodies and immunoprecipitated material was analyzed 
by SDS-PAGE and western blotting using polyclonal antisera 
against Rpp30, Rpp40, Rpp20 and Rpp25 as indicated on the 
left of each panel. Two percent of the input material was loaded 
in lanes 1-3 and the immunoprecipitated material was loaded 
in lanes 4-6. Lane 1, 4: lysate from cells transfected with the 
control vector; lanes 2, 5: lysate from cells expressing VSV-
Rpp20; lanes 3, 6: lysate from cells expressing VSV-Rpp25. 
Note that the VSV-tagged proteins have a somewhat higher 
molecular weight than their endogenous counterparts.
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RNase P particles, we transfected HEp-2 cells 
with constructs encoding VSV-tagged versions 
of both proteins or an ‘empty’ VSV-tag vector 
as a control. Subsequently, extracts from 
cells expressing the tagged proteins were 
subjected to immunoprecipitation with anti-
VSV-tag antibodies. The immunoprecipitated 
material was separated by SDS-PAGE and 
analyzed by western blotting. Staining with 
anti-Rpp20 and anti-Rpp25 antisera showed 
that the expression levels of VSV-Rpp20 
and VSV-Rpp25 were similar to those of the 
corresponding endogeneous proteins (Figure 
3, input lanes). The VSV-tags of Rpp20 and 
Rpp25 did not interfere with their incorporation 
in ribonucleoprotein complexes, as evidenced 
by the co-precipitation of endogenous Rpp30 
and Rpp40 (Figure 3) with anti-VSV-tag 
antibodies, and by the co-precipitation of the 
RNase MRP and RNase P RNAs (results not 
shown; (32)). The lack of co-precipitation of 
the endogeneous Rpp20 and Rpp25 proteins 
with their respective VSV-tagged counterparts 
indicated that in these cells the RNase MRP 
and RNase P ribonucleoprotein complexes 
contain only a single copy of these proteins. 
Subcellular distribution of Rpp20 and 
Rpp25
The results described above raised the 
question whether heterodimerization of 
Rpp20 and Rpp25 is important for their proper 
subcellular localization. To be able to study the 
Rpp20 localization by immunofl uorescence 
a newly developed mouse monoclonal 
antibody (mAb) against Rpp20 (1F11) was 
characterized. mAb 1F11 is specifi c for 
Rpp20 and is reactive with Rpp20 in both 
immunoblotting and immunoprecipitation 
(Supplementary Figure 1).
Immunofl uorescent staining of HEp-2 cells with 
1F11 showed that the highest concentrations 
of Rpp20 are found in the nucleoli (Figure 
4A,B). The subcellular localization of Rpp25 
was visualized by the polyclonal anti-Rpp25 
antibodies. As can be seen in Figure 4C,D 
also Rpp25 accumulates in the nucleoli. Both 
Rpp20 and Rpp25 seemed to be enriched 
in specifi c subnucleolar compartments. To 
investigate whether these subnucleolar 
staining patterns are identical for both 
proteins, which would be expected based 
upon their effi cient interaction, cells were 
stained with both antibodies in combination 
with Alexa Fluor 488 and Alexa Fluor 555 
conjugated secondary antibodies. The overlay 
of both staining patterns obtained by confocal 
laser scanning microscopy demonstrated 
that Rpp20 and Rpp25 almost completely 
co-localize in these cells (Figure 4E-H). To 
investigate whether the subnucleolar regions 
showing the strongest staining with anti-Rpp20 
and anti-Rpp25 antibodies corresponded to 
either the dense fi brillar component (DFC) or 
the granular component (GC) of the nucleoli, 
double immunofl uorescence experiments 
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Figure 4. Subcellular localization of Rpp20 and Rpp25.
Immunofl uorescence staining of HEp-2 cells with antibodies to Rpp20 (B; mAb1F11) and Rpp25 (D; polyclonal rabbit serum). A and 
C show the phase contrast images corresponding to B and D, respectively. The bars in A and C correspond to 10 μm. E-H. Double 
immunofl uorescence staining of Rpp20 (E, G, H) and Rpp25 (F, G, H). I-L. Double immunofl uorescence staining of Rpp25 (I, K, L) 
and fi brillarin (J, K, L). M-P. Double immunofl uorescence staining of Rpp25 (M, O, P) and nucleophosmin/B23 (N, O, P). The images 
in panels E-P were recorded by confocal microscopy. Bars in panels E-P correspond to 1 μm.
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were performed with antibodies to fi brillarin 
as a marker for the DFC and with antibodies 
to nucleophosmin/B23 as a marker for the 
GC. The results (Figure 4I-P) showed that the 
regions containing the highest concentrations 
of Rpp20 and Rpp25 correspond to the GC. 
The specifi c (sub)nucleolar localization of 
Rpp20 does not refl ect the previously reported 
subcellular localization of Rpp20 fused to three 
Flag-tags overexpressed in transfected HeLa 
cells (31). In that study the overexpressed 
Rpp20 protein diffusely distributed throughout 
the cytoplasm and nucleus, with higher 
concentrations in the nucleus. Since this 
might be due to overexpression of the human 
Rpp20 protein, we generated an expression 
construct encoding a GFP-Rpp20 fusion 
protein to study whether overexpression of 
the Rpp20 fusion protein results in a different 
subcellular distribution pattern. Indeed, in 
transiently transfected HEp-2 cells, GFP-
Rpp20 diffusely distributed throughout the cell 
with a somewhat higher concentration in the 
nucleus, very similar to the previously reported 
localization of overexpressed Rpp20 (Figure 
5B). The expression level of GFP-Rpp20 was 
determined by western blotting using both 
anti-GFP and anti-Rpp20 antibodies. These 
results confi rmed that the GFP-Rpp20 fusion 
protein, migrating at 45 kDa in agreement 
with its predicted molecular mass, was 
indeed overexpressed in comparison with 
the endogenous Rpp20 protein (Figure 5E). 
Importantly, it should be noted that only a 
subset of the cells will express the GFP-
tagged protein. Similarly, the localization of 
overexpressed Rpp25 was determined using 
a construct encoding a VSV-tagged Rpp25 
protein. In contrast to Rpp20, VSV-Rpp25, 
which like GFP-Rpp20 was expressed to 
higher levels than its endogenous counterpart, 
showed the strongest staining in the 
nucleoli (Figure 5C). In addition, a diffuse 
nucleoplasmic staining was observed for VSV-
Rpp25. Because the levels of endogenous 
Rpp25 were not detectably affected in the 
cells overexpressing GFP-Rpp20 (Figure 5E), 
the differences between the distributions of 
the endogenous and overexpressed Rpp20 
might be due to the limiting amounts of Rpp25 
which do not allow effi cient heterodimerization 
of the overexpressed Rpp20 protein. To 
investigate this possibility, Rpp20 and Rpp25 
were simultaneously expressed to higher 
levels in the same cells. HEp-2 cells were 
co-transfected with constructs encoding GFP-
Rpp20 and VSV-Rpp25 and the localization 
of GFP-Rpp20 was studied by fl uorescence 
microscopy. The high expression level of 
VSV-Rpp25 in GFP-Rpp20 expressing cells, 
which was confi rmed by western blotting 
(Figure 5E), indeed affected the subcellular 
distribution of GFP-Rpp20. In these cells GFP-
Rpp20 not only accumulated in the nuclei, 
but an enrichment in nucleolus-like regions 
was observed as well (Figure 5D). These 
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Figure 5. Overexpression of Rpp20 
and Rpp25.
HEp-2 cells were transfected with 
constructs encoding GFP (A), GFP-Rpp20 
(B), GFP-Rpp25 (C) or both GFP-Rpp20 
and VSV-Rpp25 (D) and after 24 hrs the 
localization of GFP(-tagged) proteins was 
visualized by fl uorescence microscopy 
(upper panels). The corresponding phase 
contrast images are shown in the lower 
panels. The bar in A. corresponds to 10 
μm. E: The expression of GFP-Rpp20 
and VSV-Rpp25 in the transfected cells 
was analyzed by western blotting using 
antibodies to Rpp38, GFP, Rpp20 and 
Rpp25 (from top to bottom). Lane 1: 
extract from mock-transfected cells; 
lanes 2-4: extracts from cells transfected 
with GFP, GFP-Rpp20 and VSV-Rpp25, 
respectively; lane 5: extract from cells 
co-transfected with GFP-Rpp20 and VSV-
Rpp25. The positions of molecular mass 
markers is indicated on the left (kDa) 
and the positions of the endogenous 
and ectopically expressed proteins are 
marked by arrows on the right.
BA C D
E
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results strongly suggest that the interaction 
with Rpp25 is required for the effi cient nuclear 
entry of Rpp20 as well as for its accumulation 
in the nucleoli. 
Rpp20 and Rpp25 expression levels are 
dependent on each other
The observation that heterodimerization 
of Rpp20 and Rpp25 is important for their 
correct subcellular distribution raised the 
question whether their expression levels 
are interdependent. The results in Figure 
5E already suggested that co-expression of 
VSV-Rpp25 led to increased GFP-Rpp20 
expression levels and vice versa. This may be 
explained by stabilization of these proteins by 
their heterodimerization, thereby decreasing 
their turnover rates. To further investigate this 
issue, the expression levels of the endogenous 
Rpp20 and Rpp25 proteins were knocked-
down by RNA interference. Transfection of 
HEp-2 cells with siRNAs specifi c for the Rpp20 
and Rpp25 mRNAs resulted in effi cient knock-
down of the target proteins within 48 hours. 
Re-transfection of these cells at 48 hours with 
the same siRNAs resulted in nearly complete 
knock-down of both proteins, as demonstrated 
by western blotting of cell lysates obtained 
after 96 hours (Figure 6). Strikingly, an almost 
equally effi cient co-depletion of Rpp25 with 
the siRNA for Rpp20 and of Rpp20 with the 
siRNA for Rpp25 was observed. In contrast, 
the expression levels of other RNase MRP / 
RNase P proteins, Rpp30, Rpp38 and Rpp40, 
and of an unrelated protein, Rrp4p, were 
not detectably affected by Rpp20 or Rpp25 
knockdown. These results indeed indicate that 
the expression levels of Rpp20 and Rpp25 are 
co-dependent.
Figure 6. Downregulation of Rpp20 and Rpp25 expression 
by RNAi.
The expression of either Rpp20 or Rpp25 was inhibited by 
transfection of HEp-2 cells with corresponding siRNAs. After a 
second transfection with the same siRNAs at 48 hrs, cells were 
lysed at 96 hrs and the lysates analyzed by western blotting. An 
extract from mock transfected cells was generated in parallel 
as a control. Rpp20 was detected using mAb 1F11 and Rpp25 
was detected with a polyclonal rabbit serum against Rpp25. The 
expression of other RNase MRP / RNase P subunits (Rpp30, 
Rpp38 and Rpp40) and of an exosome subunit (Rrp4p) in these 
cells was analyzed using polyclonal rabbit sera specifi c for each 
of these proteins.
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Discussion
In this study we present evidence that the 
heterodimerization of Rpp20 and Rpp25 is 
not only extremely stable, but also important 
for various aspects of their biological function 
as subunits of RNase MRP and RNase P. The 
intimate relationship between these proteins 
is further substantiated by the fact that their 
expression levels seem to be highly co-
dependent. 
The Rpp20-Rpp25 heterodimer is associated 
with both RNase MRP and RNase P. Recent 
evidence suggests that the association with 
RNase MRP is dynamic, because these 
proteins were not found in 60-80S complexes 
isolated from HEp-2 cells, in contrast to 
other RNase MRP subunits. Because these 
high molecular weight complexes most 
likely represent pre-ribosomal complexes, 
we proposed that the Rpp20-Rpp25 dimer 
dissociates from RNase MRP either before 
or during its assembly with pre-ribosomes and 
reassociates after the RNase MRP catalysed 
processing event of pre-rRNA (32). Currently, 
it is unknown whether a similar transient 
dissociation of the Rpp20-Rpp25 dimer from 
RNase P complex may occur during pre-tRNA 
processing by this enzyme. 
The association of Rpp25 with the human 
RNase MRP and RNase P complexes is 
most likely mediated by a combination of 
protein-RNA and protein-protein interactions. 
In agreement with its RNA-binding capacity, 
Rpp25 directly contacts the P3 domain of the 
RNase MRP and RNase P RNAs (18-20;27) 
and has been shown to bind to several protein 
subunits (20). Yuan and co-workers showed 
that the Rpp25 protein most likely interacts 
with the distal stem-loop of the P3 domain 
(25). Also for Rpp20 direct contacts with the 
P3 domain have been reported (18), but in 
addition Rpp20 binds only to Rpp25 and none 
of the other protein subunits in vitro (20). Taken 
together, these data strongly suggest that the 
association of the Rpp20-Rpp25 heterodimer 
with the RNase MRP and RNase P RNAs is 
mediated by multiple interactions, most of 
which involve Rpp25. Although the association 
of Rpp20 with RNase MRP seems to be mainly 
mediated by Rpp25, additional protein-protein 
interactions between Rpp20 and other subunits 
may contribute to the association of Rpp20, 
which is supported by the results of yeast two-
hybrid experiments (34). The results in Figure 
2 indicate that the binding affi nity of Rpp25 
for the P3 domain is much higher than that of 
Rpp20. In agreement with these observations, 
Guerrier-Takada and co-workers showed that 
Rpp20 is not able to interact directly with the 
P3 domain of RNase P RNA in vitro (27), and 
Jiang and colleagues did not detect a direct 
interaction of Rpp20 with full-length RNase 
P RNA in a yeast-three-hybrid screening (35). 
Nevertheless, Rpp20 is predicted to contribute 
to the binding of the Rpp20-Rpp25 dimer to the 
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P3 domain, because (i) close contacts have 
been detected by UV-crosslinking (18;19) 
and (ii) Rpp20 enhances the effi ciency of 
Rpp25 binding to the P3 domain. Alternatively, 
the enhanced binding effi ciencies may be 
explained by conformational changes in the 
proteins induced by their heterodimerization or 
by structural changes in the P3 RNA resulting 
from their binding.
Attempts to obtain more insight in the mode 
of the interaction between Rpp20 and Rpp25 
failed, because under conditions where either 
ionic, hydrophobic or both types of interactions 
were destabilized, heterodimerization was 
still observed at levels very similar to those 
observed under milder conditions. The 
previously reported ATPase activity associated 
with Rpp20 did not appear to be important for 
its interaction with Rpp25, because amino 
acid substitutions that abrogated the ATPase 
activity did not affect the binding to Rpp25. 
Moreover, the addition of a non-hydrolyzable 
analog of ATP (AMP-PNP) did not affect 
Rpp20-Rpp25 heterodimerization (data not 
shown). However, substitution of asparagine-
40 by glutamine, which led to a moderate 
reduction of the ATPase activity (24), severely 
reduced the affi nity of Rpp20 for binding to 
Rpp25. Since the conservative amino acid 
mutation at position 40 is not expected to 
cause major structural changes in the Rpp20 
protein, this residue is predicted to play a 
crucial role in the interaction with Rpp25. Our 
data do not exclude the possibility that the 
binding of Rpp25 to Rpp20 blocks the binding 
of NTP. Further studies will be required to 
investigate this issue.
The heterodimerization of Rpp20 and Rpp25 
and their transient association with RNase MRP 
raised the question whether these phenomena 
are specifi c for the human enzymes or are also 
seen in other organisms. As a fi rst approach to 
obtain more insight into this issue, database 
searches where performed to identify Rpp20 
and Rpp25 homologues in other eukaryotes. 
Several new vertebrate Rpp20 and Rpp25 
sequences were found, which display a high 
degree of sequence similarity (Supplementary 
Figure 2A/B). Besides their partial sequence 
homology with the Alba-family of nucleic 
acid binding proteins (33) and a proline-rich 
C-terminal domain in Rpp25, no known 
motifs were identifi ed in Rpp20 and Rpp25. 
Previous studies reported the sequence 
homology between Rpp20 and the yeast 
RNase MRP / RNase P Pop7/Rpp2 protein 
(36;37). However, for the Rpp25 protein, no 
yeast homologue has been identifi ed. These 
data suggest that the Rpp25 protein may 
only be expressed in vertebrates and that the 
Rpp20-Rpp25 heterodimer may be vertebrate 
specifi c. Interestingly, our database searches 
also identifi ed a Rpp25 paralogue, which was 
previously also detected by Guerrier-Takada 
and colleagues (27). We designated this 
paralogue Rpp25 like protein (Rpp25lp). The 
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human Rpp25lp sequence is 43% identical 
to that of the human Rpp25 protein. Rpp25lp 
sequences were found in several vertebrates 
(Supplementary Figure 2B). Subcellular 
localization studies with the human Rpp25lp 
showed that this protein, like Rpp25, 
accumulates in the nucleoli of HEp-2 cells (data 
not shown). Additional co-immunoprecipitation 
and GST pull-down analyses showed that 
unlike Rpp25, Rpp25lp is not associated with 
RNase MRP and/or RNase P and also is not 
capable to form dimers with Rpp20 (data 
not shown). As a consequence, it remains 
unknown whether Rpp25lp plays a role in the 
functioning of RNase MRP and/or RNase P. 
Despite extensive knowledge on their 
protein composition, the stoichiometry of 
protein subunit binding to the human RNase 
MRP and RNase P complexes has not 
been documented so far. The results of the 
experiments in which VSV-tagged versions 
of Rpp20 and Rpp25 were expressed next 
to the endogenous non-tagged counterparts 
(Figure 3) indicated that the vast majority, if 
not all, of these ribonucleoprotein complexes 
contains only a single copy of each of these 
proteins. This is consistent with the binding of 
a single Rpp20-Rpp25 heterodimer to RNase 
MRP and RNase P. Further experiments will 
be required to investigate whether the same is 
true for the other protein subunits. The results 
shown in Figure 3 also show that under these 
conditions RNase MRP and RNase P are not 
physically associated with each other and that 
both complexes exist as monomers.
In agreement with their effi cient 
heterodimerization, the expression levels 
of Rpp20 and Rpp25 appeared to be co-
dependent, as indicated by the results of 
overexpression and knock-down experiments. 
Regulation of their expression levels most 
likely occurs on the protein level. Since similar 
amounts of plasmid DNA were transfected 
and the overexpressed proteins are under 
transcriptional control of constitutively active 
CMV promoters, the increased signals of 
co-expressed GFP-Rpp20 and VSV-Rpp25 
can be explained by a reduced turnover rate, 
which is most likely resulting from an increased 
stability due to their heterodimerization. 
The functional relevance of Rpp20-Rpp25 
heterodimerization is further emphasized by 
the Rpp25-dependent subcellular localization 
of Rpp20. This phenomenon may also 
explain the localization observed for the 
Flag-tagged human Rpp20 protein reported 
by Hua and colleagues (31). They observed 
a very similar subcellular distribution of 
overexpressed Flag-tagged Rpp20 protein as 
we observed for GFP-Rpp20. In both cases 
the limited amount of Rpp25 present in the 
transfected cells is likely to be insuffi cient for 
the effi cient accumulation of tagged Rpp20 in 
the nucleoli. The colocalization of Rpp25 with 
nucleophosmin/B23 demonstrated that the 
highest concentrations of  the Rpp20-Rpp25 
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dimer are found in the granular component of 
the nucleolus. The GC is believed to be the 
area of the nucleolus where the late processing 
of pre-rRNA and ribosome assembly takes 
place. RNase MRP has been demonstrated 
to play a role in late steps of ITS1 processing 
(38;39), consistent with its accumulation in 
the GC (40). Paradoxically, we have recently 
observed that the Rpp20-Rpp25 dimer is not 
present in 60-80S complexes, which are most 
likely pre-ribosomal complexes containing 
processing factors like RNase MRP. The 
transient association of the Rpp20-Rpp25 
heterodimer with RNase MRP and possibly 
RNase P may play a crucial role in the 
regulation of their endonucleolytic activities. 
One possibility is that the binding of Rpp20 and 
Rpp25 to the P3 domain of the RNase MRP 
and RNase P RNAs target these complexes to 
the GC. Indeed, the P3 domain was previously 
demonstrated to be required for their nucleolar 
accumulation (22;23). Another possibility 
is that the association of the Rpp20-Rpp25 
dimer blocks the endonucleolytic activity of 
these enzymes, and that their dissociation 
leads to their activation. Interestingly, the P3 
domain is located close to the region of the 
RNA that is believed to be directly involved in 
substrate binding and cleavage. Alternatively, 
the Rpp20-Rpp25 heterodimer may also be 
involved in the correct assembly of the RNase 
MRP and RNase P complexes by recruiting 
the RNAs via their binding to the P3 domain. 
In this regard, Li and Altman reported that 
the human RNase P RNA, when lacking the 
P3 region, is not able to assemble into intact 
ribonucleoprotein complexes (21). A fi nal 
possibility is that the main function of Rpp25 
is to mediate and stabilize the association of 
Rpp20 with RNase MRP and RNase P and 
that Rpp20 is acting as a functional bridge (24), 
which mediates the recruitment of additional 
factors that are temporarily, and possibly only 
under certain conditions, required for optimal 
functioning of these enzymes. Candidates for 
such factors are SMN, Hsp27 and KIAA065, 
which all have been reported as interacting 
partners for Rpp20 (31;34).
Materials and Methods
GST-fusion proteins
The cDNAs of Rpp20 (wildtype and mutants) 
and Rpp25 were cloned into vector pGEX2T’G 
(20). The cDNAs encoding the Rpp20 amino 
acid substitution mutants (D36E; N40Q and 
G59S) were kindly provided by Yong Li and 
Sidney Altman (Yale University, USA). GST-
fusion proteins were expressed in Escherichia 
coli BL21(DE3)pLysS and purifi ed by standard 
procedures. The purity and concentrations 
of the GST-fusion proteins were determined 
by SDS-PAGE and Coomassie Brilliant 
Blue staining. The purifi ed proteins were 
supplemented with 10% glycerol (fi nal 
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concentration) and stored at -70oC.
In vitro translation of RNase MRP proteins
The coding sequences of Rpp20 and Rpp25 
were cloned into the pCI-Neo vector in-
frame with a sequence encoding a vesicular 
stomatitis virus glycoprotein-epitope (VSV-tag) 
(20). For in vitro transcription, these constructs 
were linearized with NotI, isolated by gel 
electrophoresis and transcribed using T7 RNA 
polymerase in the presence of the GpppG cap 
analog. Subsequently, the transcripts were 
used to produce N-terminally VSV-tagged 
Rpp20 and Rpp25 in a rabbit reticulocyte 
lysate translation system (Promega) in the 
presence of 35S-labeled methionine.
In vitro transcription and biotinylation of 
P3 RNA
To generate in vitro transcribed and 
biotinylated P3 RNA a previously described 
transcription construct was used which 
encodes nucleotides 22-67 of the human 
RNase MRP RNA (18). After linearization with 
HindIII, in vitro transcription was performed 
according to standard procedures using 
T7 RNA polymerase. The P3 RNA was co-
transcriptionally biotinylated by the addition 
of biotin-11-UTP (PerkinElmer Life Sciences) 
in the transcription reaction. The transcription 
reaction was stopped by phenol/chloroform/
isoamylalcohol extraction and the remaining 
mononucleotides were removed by a 
Sephadex G-50 spin column. Finally, the RNA 
was precipitated with isopropanol and after 
washing the pellet was dissolved in water to 
a fi nal concentration of 0.1 μg/μl and stored 
at -70oC.
GST pull-down experiments
GST pull-down experiments were performed 
essentially as described before (20). 
Glutathione-Sepharose beads were incubated 
with GST (fusion) protein in a buffer containing 
20 mM HEPES/KOH, pH 7.6; 100 mM KCl; 0.5 
mM EDTA; 0.05% NP-40; 1 mM dithiotreitol; 
5 mM MgCl2; 0.02% BSA, Complete protease 
inhibitor (Roche) for 30 minutes at room 
temperature. Subsequently, the coated 
beads were incubated with in vitro translated, 
35S-labeled protein at 4oC for 2 hours under 
continuous agitation in the presence or 
absence of 1 mM ATP. Finally, the bound 
proteins were analysed by SDS-PAGE and 
autoradiography. 
Expression of tagged Rpp20 and Rpp25 in 
transfected HEp-2 cells
The coding sequences of Rpp20 and Rpp25 
were cloned in the mammalian expression 
vectors pCI-Neo and pEGFP-C3 in-frame 
with the VSV-tag (see above) and the coding 
sequence for green fl uorescent protein (GFP), 
respectively. For transient expression of 
N-terminally tagged proteins, 4x106 HEp-2 
cells were transfected with 10 μg purifi ed 
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plasmid DNA by electroporation using the 
Biorad GenePulser II at 260V; 950μF. After 
transfection, the cells were cultured in a 
CO2 incubator at 37
oC in Dulbeccos Minimal 
Essential Medium (GibcoBRL) supplemented 
with 10% fetal calf serum on glass slides or 
in T75 culture fl asks. After 24 hours the cells 
were processed for fl uorescent microscopy 
or harvested for immunoprecipitation 
experiments.
Immunoprecipitation
Transiently transfected HEp-2 cells were 
homogenized by sonication in a buffer 
containing 20 mM Tris-HCl pH 8.0; 100 mM 
KCl; 2 mM EDTA; 0.05% Nonidet P-40 (NP-
40) and 1 mM dithioerytritol (DTE). For anti-
VSV-tag immunoprecipitations 100 μg rabbit-
anti-mouse immunoglobulin antibodies (Dako) 
were coupled to 20 μl Protein-A-agarose beads 
(Kem-En-Tec) at room temperature for 1 hour in 
500 μl buffer containing 500 mM NaCl; 20 mM 
Tris-HCl pH 8.0 and 0.05% NP-40 (IPP500). 
After coupling, the beads were washed 3 times 
with IPP500 and subsequently a monoclonal 
anti-VSV-tag antibody was coupled to the 
rabbit-anti-mouse coated protein-A-agarose 
beads under identical conditions as described 
above. For immunoprecipitations with 
polyclonal antisera 5 μl rabbit serum was 
coupled to 10 μl Protein-A-agarose beads at 
room temperature for 1 hour in 500 μl IPP500. 
The beads were washed 3 times with IPP500 
and once with IPP150 (identical to IPP500, but 
with 150 mM NaCl). The clarifi ed cell lysates 
or in vitro translated proteins were added to 
the beads and the immunoprecipitation was 
performed under continuous agitation at 4oC 
in a total volume of 750 μl. After 2 hours the 
beads were washed three times with IPP150 
and the immunoprecipitated material was 
either dissolved in SDS-PAGE sample buffer 
or subjected to RNA isolation using Trizol 
(Invitrogen). 
Streptavidin-biotin pull-down
Biotinylated P3 RNA (100 ng) was mixed with 
1 μl ten-fold concentrated pull-down buffer 100 
(PB100: 100 mM KCl; 20 mM HEPES/KOH 
pH7.6; 0.5 mM EDTA; 0.05% NP-40 and 1 
mM DTE), 1 μg calf thymus competitor tRNA 
and appropriate amounts of in vitro translated, 
35S-labeled, Rpp20 and/or Rpp25. Water was 
added to a fi nal reaction volume of 10 μl. 
The mixture was incubated at 0oC for 1 hour. 
Subsequently, 10 μl Streptavidin-Sepharose 
(Amersham Biosciences) was added together 
with 100 μl PB100 and incubated at 4oC under 
continuous agitation for 1 hour. The beads 
were washed three times with PB100, and the 
precipitated proteins were dissolved in SDS-
PAGE sample buffer, separated by SDS-PAGE 
and visualized by autoradiograph
Indirect immunofl uorescence
HEp-2 cells were cultured to 70% confl uency 
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on glass slides and fi xed with methanol. 
The fi xed cells were rehydrated in PBS for 5 
minutes. Protein-A purifi ed mouse monoclonal 
antibody against Rpp20 (1F11, ModiQuest) 
was used in a 200-fold dilution, polyclonal 
rabbit serum against Rpp25 was 100-fold 
diluted and culture supernatants containing 
mouse monoclonal antibodies against fi brillarin 
(ASWU1) (41) and nucleophosmin/B23 (37/
5.1) (42) were 10-fold diluted in PBS. The cells 
were incubated with the primary antibodies for 
1 hour at room temperature. Subsequently, 
the slides were washed 5 times with PBS and 
incubated with 100-fold diluted Alexa Fluor 
488-conjugated goat-anti-rabbit antibodies or 
Alexa Fluor 555-conjugated goat-anti-mouse 
antibodies (Molecular Probes, Leiden, The 
Netherlands). For double stainings, the 
procedure was repeated as described above. 
Stained cells were mounted in fl uorescent 
mounting medium (Dako, Glostrup, Denmark) 
and visualized by fl uorescence microscopy 
using an Olympus BH-2 microscope or a 
Leica DM IRBE confocal laser scanning 
microscope.
RNA interference
For knockdown of Rpp20 by RNAi, an siRNA 
duplex targeting Rpp20, si-Rpp20-1, was 
designed using standard guidelines (43): 
5’-CCAUCAACCGCGCCAUCAATT-3’. The 
siRNA duplex sequence targeting Rpp25, 
si-Rpp25-1, was adapted from the siRNA 
sequence described by Zhang and Altman 
(44): 5’-GUGCGCCGAGAUCCUCAAGTT-
3’. Both duplexes were purchased from 
Eurogentec and contain 3’ dTdT overhangs. 
For siRNA transfection, 5 x 104 HEp-2 cells 
were transfected with 20 pmol siRNA duplex 
using Oligofectamine transfection reagent 
(Invitrogen) according to the protocol provided 
by the manufacturer. After 48 hours the cells 
were harvested, lysed and processed for 
western analysis or re-transfected with siRNA 
using the protocol described above.
Western blotting
Cell extracts, recombinant or 
immunoprecipitated proteins were 
separated by SDS-PAGE and transferred to 
nitrocellulose membranes by electroblotting. 
Immunodetection of Rrp4p, GFP, Rpp20, 
Rpp25, Rpp30, Rpp38 and Rpp40 was 
performed using polyclonal rabbit antisera 
against these proteins (27;28;45-47) and a 
monoclonal mouse antibody against GST 
and Rpp20 (ModiQuest, Nijmegen, The 
Netherlands). Horseradish peroxidase-
conjugated polyclonal swine anti-rabbit and 
rabbit anti-mouse immunoglobulin antibodies 
were purchased from Dako (Glostrup, 
Denmark) and applied as secondary antibody. 
Bound antibodies were visualized by enhanced 
chemiluminescence detection procedures.
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Supplementary Figures
Supplementary Figure 1. Reactivity and specifi city of anti-Rpp20 monoclonal antibody 1F11.
A mouse monoclonal antibody (1F11) was raised against bacterially expressed GST-Rpp20. A: The reactivity of mAb 1F11 with 
recombinant GST (lanes 1, 3, 5) and GST-Rpp20 (lanes 2, 4, 6) was analyzed by western blotting. Lanes 1, 2: staining with an 
anti-GST monoclonal antibody. Lanes 3, 4 and 5, 6: staining with a polyclonal anti-Rpp20 antiserum and mAb 1F11, respectively. 
The arrowhead indicates the position of free GST and the arrows indicate the position of full-length GST-Rpp20 fusion protein 
and degradation products of GSTRpp20. On the left, the positions of molecular mass markers (kDa) are indicated. B: Western 
blot containing total HEp-2 cell extract incubated in the absence (lane 1) and presence (lane 2) of mAb 1F11. The arrow indicates 
the position of the Rpp20 protein. C: In vitro translated Rpp20 (lane 1; 10% of the amount used for immunoprecipitation) was 
immunoprecipitated with mAb 1F11 (lane 4). Lanes 2, 3: control immunoprecipitations with mAbs against GST and hRrp4. The arrow 
marks the position of the in vitro translated Rpp20 protein. D: RNA was isolated from immunoprecipitated material from a total HEp-2 
cell extract and analyzed by northern blot hybridization using riboprobes specifi c for the human RNase MRP and RNase P RNAs. 
Lane 1 contains the total RNA isolated from the extract (10% of the amount used for immunoprecipitation). Lanes 2-4: RNAs co-
precipitating with a normal human serum (NHS), a human anti- Th/To patient serum (L122) and mAb 1F11, respectively. The positions 
of the RNase MRP and RNase P RNAs are shown on the left.
D
A
B
C
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Supplementary Figure 2A. Multiple sequence alignment of Rpp20 sequences from vertebrates. 
Species abbreviations and GenBank accession numbers are as follows: H.s., Homo sapiens (NM_005837); P.t., Pan troglodytes
(AADA01308850); M.mul., Macaca mulatta (AANU01190468); M.mus., Mus musculus (AK002782); R.n., Rattus norvegicus
(AAHX01071658); B.t., Bos taurus (AAFC02037647); S.s., Sus scrofa (AY610322); C.f., Canis familiaris (AAEX02011494); O.c., 
Oryctolagus cuniculus (AAGW01222680); E.t., Echinops telfairi (AAIY01616027); D.n., Dasypus novemcinctus (AAGV01210835); 
C.p., Cavia porcellus (AAKN01329349); M.d., Monodelphis domestica (AAFR03049778); F.r., Fugu rubripes (CAAB01007644, 
incomplete); D.r., Danio rerio (BM571356); X.l., Xenopus laevis (CK804865); X.t., Xenopus tropicalis (CR420902). The asterisks (*) 
indicate the aminoacids which show homology with the Alba family of nucleic acid binding proteins (33).
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Supplementary Figure 2B. Multiple sequence alignment of Rpp25 and Rpp25lp sequences from vertebrates. 
Species abbreviations and GenBank accession numbers for Rpp25 are as follows: H.s., Homo sapiens (Rpp25: AY034074, 
Rpp25lp: NP_680544); P.t., Pan troglodytes (Rpp25: XM_510676, Rpp25lp: AADA01217985); M.mul., Macaca mulatta (Rpp25: 
AANU01184571, Rpp25lp: AANU01164955); M.mus., Mus musculus (Rpp25: NP_598743, Rpp25lp: NP_081554); R.n., Rattus 
norvegicus (Rpp25: XP_236286, Rpp25lp: XP_216375); B.t., Bos taurus (Rpp25: XM_609164, Rpp25lp: XP_589663); S.s., Sus 
scrofa (Rpp25: CF722611 / CJ033578, Rpp25lp: CJ022593 (incomplete)); C.f., Canis familiaris (Rpp25: XP_854362, Rpp25lp: 
XP_538708); O.c., Oryctolagus cuniculus (Rpp25: AAGW01660761, Rpp25lp: AAGW01320933); D.n., Dasypus novemcinctus
(AAGV01374063); L.a., Loxodonta africana (AAGU01444585); M.d., Monodelphis domestica (Rpp25: AAFR03042823, Rpp25lp: 
AAFR03028748); G.g., Gallus gallus (Rpp25: XM_428398, Rpp25lp: XP_424977); X.l., Xenopus laevis (Rpp25(lp): AAH80077); X.t., 
Xenopus tropicalis (Rpp25(lp): CX360971). The asterisks (*) indicate the amino acids which show homology with the Alba family of 
nucleic acid binding proteins. The proline residues marked with (+) are part of the proline-rich C-terminus of Rpp25 (33).
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Cartilage-hair hypoplasia (CHH) is caused by mutations in the gene encoding the RNA component of RNase MRP. Currently it is unknown how these mutations affect the function of this endoribonuclease. 
In this study we investigated the effect of mutations in the P3 domain on 
protein binding and RNA folding. Our data demonstrate that a number of P3 
nucleotide substitutions reduced the effi ciency of its interaction with Rpp25 
and Rpp20, two protein subunits binding as a heterodimer to this domain. The 
CHH-associated 40G>A substitution, as well as the replacement of residue 47, 
almost completely abrogated Rpp25 and Rpp20 binding in different assays. Also 
other CHH-associated P3 mutations reduced the effi ciency by which the RNase 
MRP RNA is bound by Rpp25-Rpp20. These data demonstrate that the most 
important residues for binding of the Rpp25-Rpp20 dimer reside in the apical 
stem-loop of the P3 domain. Structural analyses by NMR not only showed that 
this loop may adopt a pseudo-triloop structure, but also demonstrated that the 
40G>A substitution alters the folding of this part of the P3 domain. Our data 
are the fi rst to provide insight into the molecular mechanism by which CHH-
associated mutations affect the function of RNase MRP.
Introduction
Cartilage-hair hypoplasia (CHH: OMIM 
#250250) (1) was the fi rst human autosomal 
recessively inheritable developmental disorder 
described to be caused by mutations in a non-
coding structural RNA. The affected gene, 
fi rst identifi ed by Ridanpää and co-workers 
(2), codes for the 267 nucleotides long RNA 
component of the RNase MRP small nucleolar 
ribonucleoprotein complex (snoRNP) (3;4). 
The major CHH-pathogenic mutation in the 
RNA component of the RNase MRP complex 
is the single nucleotide substitution 70A>G 
(2). This mutation can be detected in more 
than 90% of all reported CHH-cases (5) and 
was calculated to originate from a single 
mutation event, which took place 3900-4800 
years ago (6;7). In contrast to most known 
snoRNPs, the RNase MRP complex is not 
involved in posttranscriptional nucleotide 
modifi cation of ribosomal RNA (rRNA), but 
in the endonucleolytic cleavage of precursor 
5.8S rRNA (8;9) and other ribonucleolytic 
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cleavage events (4;10). RNase MRP is highly 
related to the pre-tRNA processing factor 
RNase P (11;12). Both complexes share 
several subunits and are essential for cell 
viability (13;14). Although the RNA subunit of 
Escherichia coli RNase P was the fi rst RNA 
for which ribozyme activity was described 
(15), both RNA subunits of eukaryotic RNase 
MRP and RNase P require specifi c proteins to 
cleave substrate RNAs (16).
To understand the molecular mechanism 
behind CHH it is important to know that the 
major RNase MRP RNA mutation that is 
associated with CHH is situated close to the 
crucial P4 long-range interaction of RNase 
MRP RNA and is part of a short single 
stranded nucleotide stretch referred to as 
the J3/4 domain (17;18) (Figure 1). The J3/4 
domain is highly conserved among all known 
RNase MRP and RNase P RNA species and 
previous studies on the J3/4 domain in the 
E. coli RNase P RNA provided evidence for 
divalent metal ion binding sites in this domain 
that are crucial for the enzymatic activity of the 
RNA (19). As a consequence, it is likely that the 
major CHH-related mutation 70A>G directly 
affects the catalytic activity of RNase MRP. 
Recently, it was shown that overexpression of 
the RNase MRP RNA 70A>G mutant in human 
fi broblasts indeed reduced the expression 
level of 5.8S rRNA (20). 
In addition to the 70A>G mutation, a high 
number of other mutations in the RNase 
MRP RNA gene have been described, 
which are located either in the promoter or 
in the transcribed region of the gene. In the 
transcribed part 52 different CHH-associated 
insertions and substitutions have been found 
to date (reviewed by Bonafé et al. (5), (20) and 
unpublished data), which means that almost 
20% of the nucleotides may be implicated in 
CHH. Most of these alleles, like 70A>G, are 
expected to diminish the catalytic activity of 
RNase MRP. Insight into the secondary and 
tertiary structures of RNase MRP and RNase 
P RNA has been obtained by nuclear magnetic 
resonance, X-ray crystallography, chemical/
enzymatic structure probing and phylogenetic 
comparison (21-23). Interestingly, the vast 
majority of the CHH mutations is located in 
evolutionarily highly conserved regions, many 
of which are involved in intramolecular base 
pairing (5). Similarly, mutations in the RNA 
component of human telomerase RNA (hTR), 
which are associated with the genetic disorder 
dyskeratosis congenita (DKC), are located 
in highly conserved domains of hTR. Subtle 
alternative hTR structures, caused by DKC-
associated mutations, are thought to explain 
DKC at least in a number of cases (24;25). 
One of the RNase MRP RNA domains, which 
has been reported to be involved in the 
interaction with protein subunits, is the so-
called P3 domain. A phylogenetic comparison 
showed that there is a high degree of 
sequence similarity among the RNase MRP 
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P3 domains of several vertebrate species. 
The hPop1, Rpp20 and Rpp25 proteins bind to 
this domain (26-28), which is essential for the 
nucleolar localization of the RNase MRP RNA 
(29) and is important for ribonucleoprotein 
particle assembly (30). In accordance with 
these important functions, CHH-associated 
mutations were originally not found in the 
P3 domain (6). However, recently Bonafé 
and collaborators showed the occurrence of 
several different P3 mutations in CHH patients 
(5). One of the P3 domain-binding proteins, 
Rpp25, associates with the P3 domain in a 
manner that is dependent on the proper folding 
of this domain (31). 
To provide more insight into the molecular 
mechanism by which (CHH-associated) 
mutations in the P3 domain affect RNase MRP 
function, we investigated the effect of these 
mutations on its recognition by the protein 
subunits and on its structure. Our results 
show that a number of P3 domain mutations 
drastically affect the binding of Rpp20 and 
Rpp25, two protein subunits which are likely to 
play a crucial role in the biological function of 
RNase MRP (28;32). At least for some of the 
mutations the interference with Rpp25-binding 
appears to be caused by structural alterations 
in the P3 domain.
Results
Evolutionary conservation of the P3 
domain
The P3 domain of RNase MRP RNA is one 
of the most highly conserved elements of 
this RNA and a structurally very similar 
element is also found and conserved in 
RNase P RNA. To investigate to what extent 
the mutations in the P3 domain found in 
CHH patients concerned the most highly 
conserved nucleotides, nucleotide databases 
were screened with the human RNase MRP 
and P RNA sequences. Besides previously 
described RNase MRP RNA sequences for 
Mus musculus (33), Rattus norvegicus (34), 
Bos taurus (35), Canis familiaris (Young, 
A.E. and Bannasch, D.L. unpublished results) 
and Xenopus laevis (36;37) we found RNase 
MRP RNA sequences from Pan troglodytes, 
Macaca mulatta, Sus scrofa, Loxodonta 
africana, Dasypus novemcinctus, Echinops 
telfairi and Oryctolagus cuniculus. The 
sequence identity of the RNase MRP RNA 
from these species in comparison with the 
human sequence is at least 79%, whereas the 
sequence identity of the P3 domain varies is at 
least 85%. In addition to previously described 
vertebrate RNase P RNA sequences from Pan 
troglodytes, Pongo pygmaeus, Gorilla gorilla, 
Macaca mulatta, Mus musculus, Rattus 
norvergicus (38) and Canis familiaris (39), 
new RNase P RNA sequences were identifi ed 
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for Bos taurus, Dasypus novemcinctus and 
Oryctolagus cuniculus. The sequence identity 
of the RNase P RNA from these species in 
comparison with the human sequence is at 
least 86%, and for its P3 domain at least 87%. 
When the P3 domain of RNase MRP RNA is 
compared with that of RNase P RNA a high 
degree of sequence conservation is observed 
(Figure 1A). In the proposed secondary 
structures for RNase MRP and RNase P RNA, 
the P3 domain adopts a stem loop structure in 
which the stem contains a large internal loop 
(Figure 1B). All new sequences support this 
conformation for the P3 domain. The most 
prominent differences between the P3 domains 
of RNase MRP and RNase P are the length of 
stem P3a, the size of the hairpin loop, and the 
nucleotide sequence of the internal loop. The 
Figure 1. Conservation of 
the P3 domain.
A: Nucleotide sequences of 
the P3 domain of mammalian 
RNase MRP and RNase P 
RNAs. The stem and loop 
regions of the P3 domain are 
schematically illustrated above 
the sequences. The regions 
involved in formation of the 
proximal stem are designated 
P3a and the regions involved 
in basepairing of the apical 
hairpin are labelled P3b. 
Abbreviations and GenBank 
accession numbers: H.s.: 
Homo sapiens, MRP: 
NR_003051, P: X16524; 
P.t.: Pan troglodytes, MRP: 
AADA01035511 (14292-
14557), P: L08686; P.p.: 
Pongo pymaeus, P: L08688; 
G.g.: Gorilla gorilla, P: 
L08685; M.mul.: Macaca mulatta, MRP: AANU01164883 (1955-2214), P: L08687; S.s.: Sus scrofa, MRP: CC936439; B.t.: Bos 
taurus, MRP: Z25280, P: AAFC02061173 (16781-17131); C.f.: Canis familiaris, MRP: AY953321, P: AY609124 and AY624998, 
L.a.: Loxodonta africana, MRP: AAGU01244828 (7656-7938); D.n.: Dasypus novemcinctus, MRP: CC935687 and AAGV01247640 
(621-900),P: AAGV01440578 (45-385); E.t.: Echinops telfairi, MRP: AAIY01269613 (2071-2335); O.c.: Orynctolagus cuniculus, 
MRP: AAGW01261685 (263-539), P: AAGW01230666 (77-404); R.n.: Rattus norvegicus, MRP: J05014, P: L08800; M.mus.: Mus 
musculus, MRP: J03151, P: L08802. Nucleotides that are more than 80% conserved are highlighted by a black box. Nucleotides that 
are 100% conserved are depicted in the consensus line. Below the consensus sequence for the RNase MRP P3 RNA, the human 
CHH-associated mutations are depicted. (Figure 1 is continued on next page)
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3’half of the latter is also the least conserved 
part of the P3 domain among RNase MRP 
and RNase P RNA, although its sequence 
is predominantly pyrimidine-rich. In spite of 
the divergence of the hairpin loop, without 
exception this loop always contains a cytidine 
at its 5’end and ends with a guanosine followed 
by a uridine at its 3’end. 
All reported CHH-associated mutations in 
the P3 domain of RNase MRP RNA occur in 
sequences which are completely conserved 
among vertebrate RNase MRP RNAs and 
sometimes even between RNase MRP and 
RNase P RNAs. Based on these conservation 
Figure 1. Conservation of the P3 domain (continued).
B: Secondary structure of the P3 domain of human RNase MRP and RNase P RNA. Nucleotides that are fully conserved are indicated 
in black, highly conserved (80-100%) nucleotides in grey, moderately conserved (60-80%) nucleotides in black and small font, and 
weakly conserved (< 60%) nucleotides in grey and small font. The positions of CHH-associated mutations in the RNase MRP RNA 
P3 domain are indicated by arrows. The complete human RNase MRP and RNase P RNAs are shown on the right. Nucleotide and 
domain numbering (according to Frank et al. (40)) are indicated.
B
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data we not only analysed the effect of CHH-
associated P3 mutations on protein binding, 
but also mutated other conserved nucleotides 
to study their importance.
Binding of Rpp25 to the P3 domain of 
RNase MRP
Recently we have shown that Rpp25 and 
Rpp20 form a stable heterodimer that binds to 
the P3 domain of RNase MRP (28;41). Rpp25 
appeared to display the highest binding affi nity 
and to interact with the P3 domain also in the 
absence of Rpp20. To investigate whether the 
P3 domain is suffi cient for the interaction with 
Rpp25, an RNA molecule comprising only the 
P3 domain was generated and its interaction 
with Rpp25 studied using a GST pull-down 
approach. GGP3AAGCU RNA, derived from 
a previously described transcription construct 
for the P3 domain (26), contains two additional 
guanosines at the 5’end that form part of the 
T7 RNA polymerase promoter and a residual 
AAGCU sequence at the 3’end that originates 
from linearizing the plasmid DNA template with 
HindIII. The results in Figure 2 (lanes 1-3) 
show that this GGP3AAGCU RNA interacts 
specifi cally with GST-Rpp25, although the 
effi ciency of the interaction appeared to be 
lower than that with the full length RNase MRP 
RNA (41). To investigate whether this was 
due to the additional nucleotides at the 5’ or 
3’ends, a P3 RNA (referred to as P3) lacking 
any extra nucleotides was generated by in 
vitro transcription. Surprisingly, the absence of 
fl anking nucleotides did not lead to a detectable 
interaction of the P3 domain with GST-Rpp25 
(lanes 4-6). These data suggested that at least 
some fl anking nucleotides are required for the 
binding of Rpp25. Therefore, three additional 
P3 RNA variants were generated, containing 
either two G’s at the 5’end, four nucleotides 
at the 3’end (GGAA, corresponding to the 
fl anking sequence in the wild type RNase MRP 
RNA), or both. The addition of 2 G’s at the 
5’end (lanes 10-12) restored the interaction 
with GST-Rpp25, and the effi ciency of 
precipitation was comparable to that observed 
with GGP3AAGCU. In contrast, the addition 
of GGAA to the 3’end did not seem to lead 
to detectable binding (lanes 7-9). However, 
the combination of 5’GG and 3’GGAA further 
enhanced the effi ciency of binding (lanes 13-
15) to levels comparable with those observed 
with the complete RNase MRP RNA (not 
shown). These results show that additional 
bases at the 5’ and 3’end of P3 are required 
for the effi cient interaction between Rpp25 and 
the P3 domain of RNase MRP RNA in vitro.
Because the identity of these nucleotides, at 
least at the 3’end, did not seem to be important, 
these effects may be explained by stabilization 
of the P3 structure by the fl anking nucleotides. 
Because of its high precipitation effi ciency we 
decided to use the GGP3GGAA confi guration 
for the analysis of the P3 mutants.
In total, 15 different P3 RNA mutants, 5 of 
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whom corresponded to CHH-associated 
mutations, were generated (Figure 3A). 
As a control, wild type MRP1-82 RNA was 
transcribed from a plasmid template and 
combined with each of the P3 mutants in the 
GST pull-down assay. The relative pull-down 
effi ciencies (RPE) calculated from the results 
of three independent experiments are shown in 
Figure 3B. Most of the P3 mutations had no or 
only a small effect (less than two-fold change) 
on the precipitation effi ciency by GST-Rpp25. 
Interestingly, the substitution of nucleotides 
29-31 (UAC to CGU; mutant no. 2) and the 
substitution of nucleotide 35 (C to U; mutant 
no. 4) had a positive effect on the precipitation 
effi ciency. It should, however, be noted that 
mutant no. 2 displayed a great variability in 
precipitation effi ciency. Although mutant no. 4 
Figure 2. Binding of GST-Rpp25 to the RNase MRP RNA P3 domain.
Radiolabeled P3 domain-containing RNAs were transcribed in vitro and incubated with recombinant bacterially expressed GST-
Rpp25 or GST as a control. After precipitation with glutathione-Sepharose, co-precipitating RNAs were analysed by denaturing gel 
electrophoresis and autoradiography. For each RNA, 10% of the amount used in the pull-down was analysed in parallel. The positions 
of the RNAs are indicated by asterisks (*). Lanes 1-3: P3 RNA transcribed from linearized plasmid DNA with two T7 RNA polymerase 
promoter (5’ GG) and HindIII restriction site (3’ AAGCU) nucleotides (26). Lanes 4-6: P3 RNA without additional nucleotides. Lanes 
7-9: P3 RNA with four additional 3’ nucleotides derived from of RNase MRP (GGAA). Lanes 10-12: P3 RNA with two additional 5’ 
nucleotides derived from the T7 RNA polymerase promoter (GG). Lanes 13-15: P3 RNA with both GG at the 5’ end and GGAA at the 
3’ end.
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was bound more effi ciently than wild type P3 
RNA, the substitution of both nucleotides 34 
and 35 (AC to GU; mutant no. 3) had almost 
no effect on binding of Rpp25. For 5 mutants 
we observed relative precipitation effi ciencies 
of less than 50% as compared to wild type P3 
RNA. These mutations are: 40G>A (no. 5), 
42C>G/47U>A (no. 8), 46G>C (no. 9), 47U>C 
(no. 10) and 63C>U (no. 13). Because the 
47U>C substitution reduced the precipitation 
effi ciency to 12% and the 42C>U (no.7) 
substitution has only a moderate effect (72% 
RPE), it is very likely that the low precipitation 
effi ciency observed for the mutant in which 
both residues are changed, 42C>G/47U>A, 
(13%) is caused by the alteration at position 
47. Also the 46G>C substitution signifi cantly 
reduced the precipitation effi ciency (37%). Both 
residues 46 and 47 are located in the hairpin 
loop of the P3 domain and are among the most 
highly conserved residues in the P3 domain of 
the vertebrate RNase MRP and RNase P 
RNAs (see Figure 1A/B). The guanosine at 
position 40 is part of the P3b stem. Although 
the nucleotides in this stem are not completely 
conserved, a guanosine is found at this 
Figure 3. Interaction of human RNase MRP RNA P3 
mutants with Rpp25.
A: Schematic representation of the secondary structure of 
the P3 domain (nucleotides 22-67) of human RNase MRP 
RNA with the sequence and numbering of the mutations 
indicated. B: Radiolabeled (mutant) RNAs were transcribed 
in vitro and incubated with recombinant GST-Rpp25 or 
GST as a control. After precipitation with glutathione-
Sepharose, co-precipitating RNAs 
were analysed by denaturing gel 
electrophoresis and quantifi ed 
by phosphor-imaging. For each 
mutant the relative pull-down 
effi ciency (RPE) was determined 
for three independent experiments. 
The error bars indicate the standard 
deviation (note that the standard 
deviation of mutant 13 is very 
small). The numbers below the 
graph correspond to the numbering 
of the mutants, as depicted in 
Figure 3A. The results for CHH-
associated mutants are indicated 
in dark grey.
A
B
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position in each of the RNase MRP RNAs 
and a substitution is always compensated by 
a complementary substitution, maintaining the 
capacity to form a stem.
The effect of P3 mutations on RNase MRP 
complex formation
To investigate whether the reduced binding 
effi ciency of Rpp25 with some of the P3 
mutants also affected RNase MRP particle 
assembly, mutations were introduced into 
the full-length human RNase MRP RNA and 
the capacity to reconstitute into RNase MRP 
complexes was investigated. Reconstitution of 
RNase MRP complexes was performed with 
RNase MRP complexes partially purifi ed from 
a HEp-2 cell extract and was monitored by the 
analysis of RNAs co-immunoprecipitated with 
antibodies to RNase MRP protein subunits. To 
discriminate between the endogenous (HEp-2 
cell) and exogenous RNA, an S1-aptamer (80 
nt.) was introduced into the latter between 
nucleotide 158 and 159. The insertion of the 
S1 aptamer tag at this position did not affect 
Rpp38 binding (data not shown and Figure 
4A). To allow reconstitution to take place, 
the RNase MRP complexes in the HEp-2 cell 
fractions were disrupted by increasing the 
KCL concentration to 1 M. After the addition 
of the in vitro transcribed S1-tagged RNAs 
reconstitution was initiated by adjusting the 
salt concentration to physiological levels. 
The concentration of KCl required for this 
reconstitution procedure was empirically 
determined by performing a reconstitution 
experiment at different KCl concentrations. 
We observed effi cient reconstitution with 
S1-tagged human RNase MRP RNA after 
Figure 4. Reconstitution of RNase MRP in HEp-2 cell fractions.
A: Partially purifi ed 12S RNase MRP particles from HEp-2 cells were disassembled by increasing KCl-concentrations, as indicated 
below the lanes (42). In vitro transcribed S1-tagged human RNase MRP RNA was added and allowed to reconstitute at 150 mM KCl. 
Reconstituted complexes were subjected to immunoprecipitation using polyclonal antibodies specifi cally recognizing hPop1, Rpp25 
or Rpp38. As controls normal rabbit serum (NRS) and anti-55K serum (55K is a protein subunit of the U3 snoRNP) were used. Co-
immunoprecipitated RNAs were isolated and separated by denaturing polyacrylamide gel electrophoresis. RNAs were detected by 
northern blotting using radiolabeled riboprobes and visualized by autoradiography. The positions of the RNAs are indicated on the left. 
From 10% of the reconstituted material RNA was isolated and analysed in parallel (10% input). (Figure 4 is continued on next page)
A
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Figure 4. Reconstitution of RNase MRP in HEp-2 cell fractions (continued). 
B: RNase MRP reconstitution was performed after disassembly of 12S particles in the presence of 1.0 M KCl. In vitro transcribed 
S1-tagged (mutant) human RNase MRP RNA was reconstituted and analysed as described above. The positions of the RNAs are 
indicated on the left. Lanes 1-6: wild type S1-tagged MRP RNA, Lanes 7-12: mutant 35C>U, Lanes 13-18: mutant 40G>A, Lanes 
19-24: mutant 47U>C, Lanes 25-30: mutant 63C>U), Lanes 31-36 mutant 64U>C. C: The results of the reconstitution as shown in 
B were quantifi ed by phosphor-imaging. For each mutant the relative reconstitution effi ciency (RRE) with Rpp20, Rpp25 or Rpp38 
was determined for two independent experiments. The error bars indicate the spreading. CHH-associated mutations are indicated 
in dark grey.
B
C
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complex dissociation with 1 M KCl and 
subsequent dilution (Figure 4A, lane 17). 
Under these conditions not only Rpp25, 
but also hPop1 and Rpp38 were found to 
associate with the S1-tagged RNase MRP 
RNA (lanes 16, 18). 
Although the effi ciency of reconstitution was 
even higher after treatment with 1.5 M KCl, 
and subsequent dilution, for practical reasons 
we decided to choose 1 M KCl for the analysis 
of P3 mutants. The specifi city of this assay was 
established by the lack of RNase MRP RNA 
coprecipitation with anti-U3-55K antibodies 
(directed to a U3 snoRNP component which 
is also present in RNase MRP containing 
fractions used for this experiment) and the lack 
of U3 snoRNA co-precipitation with antibodies 
against hPop1, Rpp25 and Rpp38. 
Five P3 mutations (35C>U, 40G>A, 47U>C, 
63C>U and 64U>C), which were CHH-
associated and/or had a signifi cant effect 
on Rpp25-binding to the P3 domain, were 
introduced into the S1-tagged RNase MRP 
RNA and their reconstitution was analysed 
by co-immunoprecipitation with Rpp20, 
Rpp25 and Rpp38. Note that, whereas 
Rpp25 directly interacts with the P3 domain, 
the association of Rpp20 with this domain is 
strongly dependent on its heterodimerization 
with Rpp25 (28) and that Rpp38 interacts 
with another part of the RNase MRP RNA 
and was included as a control. As negative 
controls normal rabbit serum and rabbit 
anti-U3-55K serum were used. Figure 4B 
shows the northern blot hybridization data 
of the reconstitution experiments with these 
mutants. Again the endogenous RNase MRP 
RNA was effi ciently precipitated, as is the wild 
type S1-tagged RNase MRP RNA (lanes 4-6). 
After quantifi cation by phosphorimaging, the 
relative reconstitution effi ciency (RRE) of the 
wild type S1-tagged RNase MRP RNA with 
Rpp20, Rpp25 and Rpp38 was calculated. 
Subsequently, these ratios were used to 
determine the RRE of the mutant RNase 
MRP RNAs (lanes 7-36). As expected, the 
P3 mutations had no or only a small effect 
on Rpp38 association with full-length RNase 
MRP RNA. However, the P3 mutations 
signifi cantly affected the association of Rpp20 
and Rpp25 with full-length RNase MRP RNA 
(Figure 4B,C). For most of the mutations, the 
Rpp25 RRE corresponded to the P3 RNA-
binding data obtained with the GST pull-down 
experiments described above. Relatively low 
levels of reconstitution were observed for 
mutants 35C>U, 40G>A, 47U>C and 63C>U, 
whereas the reconstitution with 64U>C was 
comparable to that of the wild type RNA. A 
striking difference, however, was observed for 
mutant 35C>U, which appeared to enhance 
the binding of GST-Rpp25 to the P3 domain 
(Figure 3B), but had a negative effect on the 
reconstitution with full-length RNase MRP 
RNA. The results obtained with the anti-Rpp20 
antibodies were very similar to the results 
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for the anti-Rpp25 antibodies, which is most 
likely related to the stable heterodimerisation 
of Rpp20 and Rpp25. In this regard it is 
important to note that 1 M KCl will not lead 
to the dissociation of the Rpp20-Rpp25 dimer 
(28). Neither (S1-tagged) RNase MRP RNA 
nor U3 snoRNA was precipitated with the 
normal rabbit serum and only U3 snoRNA was 
specifi cally precipitated from the reconstitution 
mixture with anti-U3-55K antibodies. The 
specifi city of this assay was further confi rmed 
by the lack of U3 snoRNA coprecipitation with 
the antibodies to Rpp20, Rpp25 and Rpp38. 
The effect of the 40G>A mutation on the 
structure of the P3 hairpin
The effect of mutations on the association of 
protein subunits may be either due to the loss 
of direct contacts and the resulting decrease 
in binding affi nity, or to structural changes in 
the conformation of the RNA molecule caused 
by the nucleotide substitutions. For obvious 
reasons, conformational changes are more 
likely caused by the alteration of nucleotides 
involved in basepairing interactions. The 
secondary structure of the P3 domain depicted 
in Figure 1B and Figure 5 is supported by 
both phylogenetic and biochemical structure 
probing data. The data presented above 
indicate that the binding of Rpp25 to the P3 
domain is primarily mediated by interactions 
with the apical hairpin of the P3 domain. One 
of the CHH-associated mutations situated in 
the stem of this hairpin, 40G>A, had a drastic 
effect on Rpp25-binding and RNase MRP 
complex formation. To shed more light on the 
potential structural changes induced by this 
mutation, we decided to study the structure of 
the apical stem-loop by NMR.
Figure 5. Secondary structure of the apical stem-loop of 
the P3 domain.
The upper panel shows the mfold structure prediction of the 
apical stem-loop of the wild type (wt) P3 domain of the human 
RNase MRP RNA. The numbers correspond to the nucleotides 
of the complete human RNase MRP RNA. The lower panel 
shows the mfold structure prediction of mutants 47U>C and 
40G>A. For mutant 40G>A two possible structures with similar 
free energy values were predicted. Note that for NMR analysis 
an additional G-C clamp was placed at the ends of the RNAs (G 
at 3’end and C at 5’end).
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First the structural effect of the 40G>A 
substitution was evaluated by using the mfold 
algorithm (43;44). We also looked at the effect 
of a loop mutation, 47U>C, which also strongly 
affected Rpp25-binding. Whereas the 47U>C 
substitution in the hairpin loop did not lead 
to a potential alternative secondary structure 
of the hairpin, the mfold prediction of the 
40G>A stem variant revealed two alternative 
secondary structures, both different from the 
wild type hairpin (Figure 5).  Two structures 
are predicted for this variant by possible 
slippage of a G-C base pair with the bulged C. 
RNA molecules corresponding to the wild type 
and 40G>A P3 RNAs were synthesized and 
investigated by NMR.
The existence of the proposed structure of 
the wild type apical P3 hairpin was confi rmed 
by the NMR spectra. The 1-dimensional (1D) 
spectrum reveals fi ve strong peaks between 
12 and 15 ppm, i.e. in the region where 
typically the imino protons of Watson-Crick 
base pairs resonate (Figure 6A). Four of these 
could be assigned to specifi c residues from a 
classic sequential imino to imino proton walk in 
the 2D NOESY spectrum (Figure 6B). Besides 
the fi ve strong peaks also two weak peaks are 
visible in the 1D spectrum. One at 14 ppm, 
a typical position for a uridine imino proton 
involved in an U-A base pair, and another at 
10.8 ppm, in the region where typically imino 
protons of non-canonical base pairs resonate. 
These probably originate from U48 and a loop 
uridine, respectively. The strong peak at 13.4 
ppm, which does not show a connectivity in 
the 2D NOESY spectrum most probably arises 
from the loop G46 residue, forming a base pair 
with the loop C42 residue. Formation of this 
G46-C42 base pair leaves a so-called pseudo-
triloop with the UCU residues in the loop and 
bulged U47. 
The NMR spectra of the 40G>A variant are 
markedly different from the wild type, and 
feature characteristics corresponding to the 
predicted structural differences (Figure 5). 
The 1D imino proton spectrum of the 40G>A 
hairpin shows enhanced broadening of several 
resonances (Figure 6A). This broadening 
effect originates from enhanced imino proton 
exchange with solvent water, most probably 
caused by weakening of the stem due to the 
introduction of a bulged C. The 2D NOESY 
of this hairpin only shows connectivities 
between two different G-C / A-U base pair 
steps (results not shown). Again interruption 
of the sequential walk, preventing assignment 
of resonances, is caused by the presence of 
the bulged C, which renders the imino proton 
signals of adjacent base pairs too weak to be 
detected in this experiment. Thus, although 
we were not able to assign these spectra or to 
distinguish between the proposed forms, the 
NMR data clearly indicate structures different 
from the wild type hairpin and satisfactorily 
match the structures depicted in Figure 5.
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Discussion
The most frequently occurring CHH-associated 
mutation in the human RNase MRP RNA, 
70A>G, which is located in a region of the 
RNA (the J3/4 domain) that is predicted to be 
essential for its catalytic activity (17;18), has 
been suggested to impair the RNase MRP 
function directly (2). In addition to 70A>G, 
currently 57 other CHH-associated mutations 
in the coding sequence of the RMRP gene 
have been reported (5;45). The mechanisms 
by which these mutations affect the structure 
and function of RNase MRP have not been 
addressed experimentally yet. Here we present 
for the fi rst time evidence for an impairment of 
RNase MRP assembly by CHH-associated 
(and other) mutations in the P3 domain. 
The P3 domain of RNase MRP RNA
Several lines of evidence indicate that the P3 
domain is among the most important elements 
of the RNase MRP and RNase P RNA. It 
contains the major binding sites for protein 
subunits and is required for assembly of the 
ribonucleoprotein particles (26;30) and their 
nucleolar accumulation (29;46). Because of its 
crucial importance for the function of both the 
RNase MRP and RNase P complexes (30;47), 
it is no surprise that the P3 domain belongs to 
the most highly conserved structural elements 
of these RNAs (40). Its secondary structure, 
which is supported by phylogenetic (Figure 
1A) and biochemical structure probing data, 
consists of a hairpin of which the stem is 
interrupted by an internal loop. A comparison 
of the P3 nucleotide sequences of RNase 
MRP RNA and RNase P RNA demonstrates 
that, although their secondary structures seem 
to be very similar, their primary structures 
are diverged (Figure 1). The results of our 
NMR experiments strongly suggest that 
a pseudo-triloop is formed in the apical 
stem-loop of the RNase MRP P3 domain 
as a result of basepairing between C42 and 
G46. A comparable pseudo-triloop present 
in the encapsidation signal of hepatitis B 
virus yields a comparable chemical shift 
signature (48) giving further support to our 
interpretation of the spectra. In this respect it 
is also important to note that the C residue at 
the most 5’ position and the G residue at the 
one but last position in the hairpin loop of the 
P3 domain are fully conserved in vertebrate 
RNase MRP and RNase P RNAs (Figure 1A). 
This distinct loop folding principle (49;50) has 
been recognized as a protein recognition site 
in various RNA-protein complexes and was 
found to be essential for hepatitis B virus 
and brome mosaic virus replication (48;49). A 
pseudo-triloop has also been reported to occur 
in another nucleolar endoribonuclease, the 
Saccharomyces cerevisiae U3 snoRNA (51).
To understand the effects of CHH-associated 
mutations on RNase MRP function, it is 
important to know whether they induce 
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structural alterations in the folding of the RNA. 
The nucleotide substitutions at positions 35 
and 63, and the duplication of nucleotides 
45-53 are not predicted to alter the secondary 
structure. However, mutations 40G>A and 
64U>C are expected to have more severe 
effects, because they disrupt the basepairing 
at these positions. Our NMR analysis of 
mutant 40G>A indeed confi rmed the existence 
of an alternative secondary structure in the 
apical stem-loop of P3. Importantly, the 
pseudo-triloop structure can not be formed 
in the alternative confi guration of the apical 
stem-loop. 
The binding of the Rpp25-Rpp20 dimer to 
the P3 domain
Previously, we have demonstrated that the 
Rpp25 and Rpp20 subunits of RNase MRP 
form a stable heterodimer for which the main 
binding site resides in the P3 domain (27;28). 
Our data also suggested that the association 
of the Rpp25-Rpp20 dimer with RNase MRP 
is transient. The Rpp20-Rpp25 dimer was 
proposed to dissociate from RNase MRP 
either before or during its assembly with 
pre-ribosomes and to reassociate after the 
RNase MRP catalysed processing event of 
pre-rRNA (32). Rpp25 directly contacts the 
P3 domain of the RNase MRP and RNase P 
RNAs and Yuan and co-workers showed that 
this protein most likely interacts with the apical 
stem-loop of the P3 domain (31). The results 
we obtained with the P3 mutants support this 
suggestion, because a strong reduction of 
the Rpp25 binding effi ciency was observed 
with mutants 40G>A, 47U>C, 46G>C and 
42C>G/47U>A. Moreover, these data are 
fully consistent with the binding of Rpp25 to 
the putative pseudo-triloop structure, because 
each of these mutations will interfere with the 
formation of the latter structure. Note that the 
42C>U mutation, which had only a minor effect 
on Rpp25 binding, still allows the pseudo-
triloop to be formed, although it may be less 
stable. The sequence of the stem of the apical 
stem-loop is probably not very important for 
Rpp25 binding, because mutations 6 and 
11, which alter the sequence of the stem 
but still allow basepairing, appeared to have 
only mild effects on Rpp25 binding. Also the 
duplication of nucleotides 45-53 (mutant 15) 
may still allow a pseudo-triloop-like structure 
to be formed, although the loop in this case 
will contain 12 rather than 3 nucleotides. 
The lack of conservation of the length of this 
loop (2 - 3 nucleotides in RNase MRP RNA 
and 2 - 5 nucleotides in RNase P RNA; see 
Figure 1A) indeed suggests that the number 
of nucleotides in this region is not important 
for Rpp25 binding. Taken together, our data 
strongly suggest that 42C-46G basepairing 
generates a pseudo-triloop-like structure 
which is required for Rpp25 binding, and 
that the bulged U-residue (47U) is critically 
important for this interaction. 
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In the cellular environment, Rpp25 most likely 
binds as part of the Rpp25-Rpp20 heterodimer 
to the P3 domain of RNase MRP RNA. In 
agreement with this, the effects of the RNase 
MRP RNA mutations on the association of 
Rpp25 and Rpp20 in the reconstitution assay 
(Figure 4) are very similar. Rpp20 is predicted 
to contribute to the binding of the Rpp20-
Rpp25 dimer to the P3 domain, because close 
contacts between Rpp20 and the RNA have 
been detected by UV-crosslinking and Rpp20 
enhances the effi ciency of Rpp25 binding to 
the P3 domain (26-28). Our data do not provide 
insight into the region of the P3 domain that 
might be contacted by Rpp20. However, based 
upon a comparison of the results of the GST 
pull-down and the ribonucleoprotein particle 
reconstitution experiments, it is tempting 
to speculate that residue 35C is involved 
in the Rpp20-RNA interaction. Mutation of 
this residue into a U signifi cantly reduced 
the effi ciency of reconstitution, whereas this 
mutation did not reduce the binding by GST-
Rpp25.
CHH-associated mutations in the P3 
domain
Up to now, fi ve CHH-associated mutations 
have been reported to occur in the P3 domain 
of RNase MRP RNA. The effect of each of 
these mutations on the binding of Rpp25 was 
investigated in the present study. In agreement 
with the structure of the proposed binding site 
for Rpp25 (see above) the 40G>A mutation 
severely affected the binding of this protein 
to the RNA, whereas the other four mutations 
had no or much less effect. Only 63C>U 
partially reduced the effi ciency by which GST-
Rpp25 binds to the P3 RNA. This effect may be 
caused by a destabilisation of the proximal P3 
stem. Indeed the results presented in Figure 
2 suggest that the stability of the secondary 
structure in this region is important for Rpp25 
binding. However, 64U>C is expected to 
reduce the stability of the proximal stem more 
severely than 63C>U, but this mutation did 
not detectably affect the binding of Rpp25. 
Therefore, the molecular basis for the reduced 
binding effi ciency of Rpp25 to mutant 63C>U 
is currently unclear.
In the reconstitution assay all CHH-associated 
P3 mutations analysed affected the association 
of both Rpp25 and Rpp20, whereas the 
association of Rpp38, which is known to 
interact with another region of the RNase MRP 
RNA (26;41), was not affected. These results 
indicate that in the context of the complete 
RNase MRP RNA and in the presence of all 
RNase MRP proteins not only 40G>A, but 
also the CHH-associated mutations 35C>U, 
63C>U and 64U>C reduce the binding 
effi ciency of Rpp25 and Rpp20, which under 
our experimental conditions most likely bind 
as a dimer. These data suggest that most, if 
not all of the CHH-mutations in the P3 domain 
interfere with the assembly of the RNase MRP 
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ribonucleoprotein particle. Since the Rpp25-
Rpp20 heterodimer is believed to go through a 
cycle of dissociation and reassociation during 
the conversion of a substrate RNA by RNase 
MRP, the P3 mutations will interfere with this 
cycle, thereby reducing the functional activity 
of RNase MRP. It should be noted that also the 
hPop1 protein has been reported to require the 
P3 region for its association with RNase MRP 
(41;47). This protein may either bind to the P3 
RNA directly or to proteins, e.g. Rpp25 and/or 
Rpp20 which bind to the P3 RNA. Although we 
did not fi nd an effect on the hPop1 interaction 
effi ciency for any of the P3 mutations tested 
(our unpublished data), further studies will be 
required to investigate to what extent the CHH-
associated P3 mutations affect the association 
with hPop1. The lack of interference of the P3 
mutations that affect Rpp25-Rpp20 binding 
with hPop1 association and the association 
of hPop1 with 60-80S pre-rRNA complexes 
(32), which are devoid of Rpp25-Rpp20, 
strongly suggest that hPop1 associates with 
the P3 domain in a Rpp25-Rpp20 independent 
manner.
In most CHH patients a mutation in the 
coding sequence of the RNase MRP RNA is 
accompanied by a mutation in the promoter 
region of the other allele. The latter mutation 
is believed to silence this allele, meaning that 
only the mutated RNA is expressed in such 
patients. An interesting exception is a patient 
in which one allele carries the 40G>A and the 
other the 63C>U mutation (5). In this patient 
probably two mutant RNase MRP RNAs are 
expressed, both of which display an impaired 
P3-dependent ribonucleoprotein assembly 
phenotype.
In conclusion, our data not only shed more light 
on the interaction of the Rpp25 (and Rpp20) 
protein with the RNase MRP RNA, but also 
provide insight into the molecular mechanism 
by which mutations in the P3 domain of RNase 
MRP may lead to cartilage-hair hypoplasia. 
It will be interesting to investigate whether 
such mechanisms are also relevant for other 
diseases caused by mutations in (structural) 
RNAs (e.g. dyskeratosis congenita (52) and 
myotonic dystrophy (53)).
Materials and Methods
GST pull-down assay
GST and GST-Rpp25 were bacterially 
expressed and purifi ed as described before 
(41). The protein concentration and purity of 
the affi nity-purifi ed recombinant proteins was 
determined by SDS-PAGE and Coomassie 
Brilliant Blue staining. Glycerol was added to a 
fi nal concentration of 10% (v/v) and the proteins 
were stored in aliquots at -70 oC. Protein-
RNA interaction analysis was performed by 
coupling 0.5 pmol GST or GST-Rpp25 to 10 μl 
glutathione-Sepharose beads (GE Healthcare) 
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in 500 μl PB-200 (20 mM HEPES/KOH, pH 
7.6; 200 mM KCl; 0.5 mM EDTA; 0.05% 
Nonidet P-40; 1 mM dithioerytritol (DTE); 
5 mM MgCl2) under continuous agitation 
at room temperature. After 30 minutes, the 
supernatant was discarded, the beads were 
resuspended in 100 μl PB-200 and 10 μl 
RNA mixture (composition: 50 ng (mutant) 
P3 RNA; 50 ng MRP1-82 RNA; 40U RNasin; 
5 μg E. coli tRNA) was added. After incubation 
for 1 hour under continuous agitation at 4oC, 
the supernatant was discarded, the beads 
were washed 3 times with 500 μl PB-200 
and resuspended in 15 μl urea-dye/phenol 
(7M urea; 1x TBE; 0.083% xylene cyanol FF; 
0,083% bromophenol blue; 20% (v/v)  phenol). 
The samples were heated for 5 minutes at 
100 oC and the co-precipitating RNAs were 
separated by denaturing gel electrophoresis 
(15% polyacrylamide gels). The RNAs were 
visualized by autoradiography and quantifi ed 
by phosphorimaging. The MRP1-82 RNA 
was used as an internal positive control for 
precipitation by GST-Rpp25. To determine 
the precipitation effi ciency of the (mutant) 
P3 RNA, the phosphorimaging signals of 
the precipitated MRP1-82 and (mutant) P3 
RNA were corrected for the GST background 
and the ratio of the precipitated RNAs was 
compared to the ratio of the input RNAs to 
calculate the relative pull-down effi ciency 
(RPE). 
In vitro transcription of P3 RNAs
The RNase MRP RNA constructs MRP1-82 
and MRP22-67 have been described previously 
and were linearized as described before (26). 
For in vitro transcription, 1 μg template DNA 
was incubated for 1 hour at 37 oC in 20 μl of 
buffer containing 40 mM Tris-HCl, pH7.9; 6 
mM MgCl2; 2 mM spermidine; 10 mM NaCl; 
10 mM dithiotreitol; 1 mM ATP; 1 mM CTP; 1 
mM GTP; 0.1 mM UTP; 6.6 fmol (20 μCi) [α-
32P]UTP and 15 U T7 RNA polymerase. After 
transcription, the RNA was purifi ed by phenol/
chloroform/isoamylalcohol (25:24:1) extraction 
and unincorporated nucleotides were removed 
using a Sephadex G50 spin column. Templates 
for mutant P3 RNAs were generated by PCR 
using overlapping oligonucleotides containing 
the T7 RNA polymerase promoter sequence in 
the ‘forward’ oligonucleotide. Combinations of 
the oligonucleotides used (see Table 1) are as 
follows: P3: P3f5 x P3r2; P3GGAA: P3f5 x P3r7; 
GGP3: TH-8 x P3r2; GGP3GGAA/wt: TH-8 x P3r7; 
1: P3f6 x P3r8; 2: P3f7 x P3r9; 3: P3f8 x P3r9; 
4: P3f9 x P3r10; 5: TH-8 x P3r11; 6: TH-8 x 
P3r12; 7: TH-8 x P3r13; 8: P3f10 x P3r9; 9: 
P3f11 x P3r15; 10: P3f12 x P3r16; 11: P3f13 
x P3r15; 12: TH-8 x P3r17; 13: TH-8 x P3r18; 
14: TH-8 x P3r19; 15: TH-8 x P3r20. The 
oligonucleotides (50 pmol each) were annealed 
and elongated using Taq DNA polymerase and 
0.5 mM dNTPs in a standard PCR-buffer. The 
reaction products were separated on a 3 % 
agarose gel and isolated from the gel using 
   134                Chapter 5
the QIAquick Gel Extraction kit (Qiagen). For 
in vitro transcription and radiolabeling, one 
μg of PCR template was incubated with T7 
RNA polymerase for 1 hour in transcription 
buffer supplemented with [α-32P]UTP and the 
products were purifi ed as described above.
Generation of S1-aptamer tagged RNase 
MRP RNA
A pcDNA3 (Invitrogen) -based construct 
encoding an S1 streptavidin-aptamer 
tagged (54) human RNase MRP RNA under 
transcriptional control of the original promoter 
of the human gene for RNase MRP RNA was 
generated. The aptamer tag was inserted 
between nucleotides 158 and 159 of RNase 
MRP RNA by PCR-directed mutagenesis using 
oligonucleotide MRP-S1-158 (see Table 1). A 
spacer element between the RNase MRP RNA 
and the tag was included, as described for a 
similar tagged human RNase P RNA construct 
(30). The sequence integrity was confi rmed 
Table 1. Oligonucleotides used for NMR and mutational analysis of the P3 domain.
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by dideoxynucleotide-based sequence 
analysis. Similar constructs containing 
mutations in the P3 domain were obtained 
from the tagged wild type RNase MRP RNA 
construct by PCR-based mutagenesis using 
the following oligonucleotides: fwdCHH35C>T, 
fwdCHH40G>A, fwd47T>C, fwdCHH63C>T, 
fwdCHH64T>C, and fwdCHHdup (see Table 
1). The products of PCR reactions with these 
oligonucleotides in combination with a general 
reverse oligonucleotide (MRPgenrev) were 
used to substitute the corresponding fragment 
of the wild type construct. Sequence analysis 
confi rmed the introduction of P3 substitutions. 
Templates for in vitro transcription were 
generated from these constructs by PCR 
using a forward oligonucleotide (MRPfwd) 
corresponding to the 5’end of the RNase MRP 
RNA and containing the promoter sequence 
for T7 RNA polymerase and a reverse 
oligonucleotide (MRPrev) complementary to 
the 3’end of the RNase MRP RNA. In vitro
transcription was performed essentially as 
described above. After transcription, the 
RNA was purifi ed by phenol/chloroform/
isoamylalcohol extraction and precipitated 
with ethanol.
Reconstitution of S1-tagged RNase MRP 
complexes 
RNase MRP particles were partially purifi ed 
from a HEp-2 cell extract by glycerol density 
gradient sedimentation as described previously 
(32). Gradient fractions (500 μl) were collected 
and the separation was monitored by 
analyzing the presence of RNase MRP RNA, 
U3 snoRNA and RNase P activity in each of 
the fractions. Peak fractions 5-9 (12S peak) 
were pooled and stored in small aliquots 
at -70oC. The 12S RNase MRP complexes 
were (partially) disrupted by increasing the 
KCl concentration to a fi nal concentration of 
1 M (unless stated otherwise) and incubating 
for 30 minutes at 0 oC. One microgram of 
purifi ed S1-tagged (mutant) RNase MRP RNA 
(see above) was added and subsequently 
the KCl concentration was reduced to 150 
mM by adding water and buffer components 
(150 mM KCl; 10 mM HEPES/KOH, pH7.6 
and 0.5 mM DTE) to a total volume of 7.5 ml. 
Reconstitution was performed for 20 minutes 
at 30 oC. Simultaneously, protein A-agarose 
beads were coupled with normal rabbit serum, 
rabbit anti-U3-55K antiserum (55), mouse anti-
Rpp20 monoclonal antibody 1F11 (ModiQuest, 
Nijmegen, The Netherlands), rabbit anti-
Rpp25 antiserum (56) or rabbit anti-Rpp38 
antiserum (57) in IPP500 (10 mM Tris-HCl, pH 
8.0; 0.05% NP-40; 500 mM NaCl) and under 
continuous agitation at room temperature for 
1 hour. The beads were washed twice with 
IPP500 and once with IPP150 (like IPP500, 
but with 150 mM NaCl). Immunoprecipitations 
were performed with 1250 μl reconstitution 
mixture under continuous agitation at 4 oC. 
After 2 hours, the supernatant was discarded 
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and the beads were washed three times 
with IPP150. Total RNA was isolated from 
the immunoprecipitated material using Trizol 
reagent (Invitrogen) followed by isopropanol 
precipitation. Co-precipitated RNAs were 
analysed by denaturing gel electrophoresis 
and northern blot hybridization using 
radiolabeled riboprobes recognizing the 
(S1-tagged) RNase MRP RNA and the U3 
snoRNA. The results were quantifi ed by 
phosphorimaging and processed to determine 
the relative reconstitution effi ciencies (RRE) 
of the tagged full-length RNAs with Rpp20, 
Rpp25 and Rpp38. First, the reconstitution 
effi ciency of the tagged wild type RNase 
MRP RNA was determined by comparing the 
precipitated S1-tagged MRP RNA/endogenous 
MRP RNA ratio with the ratio of these RNAs in 
the reconstituted material. The reconstitution 
effi ciency for each of the proteins with the 
mutant RNAs was determined similarly and 
compared with the effi ciency of the wild type 
RNase MRP RNA to yield the RREs.
NMR spectroscopy
The 18-mer RNA oligonucleotides representing 
the wild type apical stem-loop of P3 and its 
40G>A variant were purchased from IBA 
GmbH (Göttingen, Germany). To stabilize 
the short hairpins used for the NMR studies 
an additional G-C base pair was added to 
the stems. The RNAs were directly dissolved 
in 90% H2O / 10% D2O, briefl y heated for 2 
minutes at 85 oC followed by snap-cooling in 
iced water to promote hairpin formation. The 
pH was adjusted to 6.8 (meter reading). Final 
concentration of the RNA samples was 0.5 
mM. NMR spectra were acquired on Varian 
Inova 500 MHz and 800 MHz spectrometers. 
For the assignment of exchangeable imino 
protons two-dimensional NOESY spectra 
were recorded at 800 MHz with a 300 ms 
mixing time using a jump return pulse for water 
suppression (58).
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The identifi cation and characterization of small nucleolar ribonucleoprotein particles (snoRNPs) was largely initiated and supported by the availability of sera of patients suffering from an autoimmune disease. 
A special class of autoimmune sera, the so-called Th/To sera, specifi cally 
recognizes two different snoRNPs: RNase MRP and RNase P. In the last 
decade prior to the start of the study described in this thesis, major efforts have 
been made to further elucidate the composition, localization, architecture and 
function of these particles. Although these efforts increased our understanding 
of the biochemical characteristics of these particles, many questions are 
still unanswered. The aims of the project described in this thesis were (1) to 
unravel the network of intermolecular interactions between subunits of these 
complexes, (2) to provide more insight into the function of individual protein 
subunits and (3) to study the relation between the RNase MRP particle and the 
human disease cartilage-hair hypoplasia (CHH).
 In this chapter the results of our studies will be discussed.
Interactions between subunits 
of RNase P and RNase MRP
complexes
The fi rst attempts to gain insight into the 
way the multiple protein and RNA species 
of the RNase P and RNase MRP complexes 
interact with each other were performed in 
the Saccharomyces cerevisiae system by 
Engelke and colleagues (1). The network of 
intermolecular protein-protein interactions 
between the yeast Pop1p, Pop3p, Pop4p, 
Pop5p, Pop6p, Pop7p, Pop8p, Rpp1, Rpr2p 
and Snm1p proteins (Figure 1 and Table 1, 
Chapter 1) was investigated using a yeast-
two-hybrid approach, while the interaction 
of these proteins with the RNA subunits of 
RNase P (RPR1 RNA) and RNase MRP 
(NME1 RNA) was studied by yeast-three-
hybrid analysis. Later, Altman and colleagues 
studied the interactions between the proteins 
and RNA of human RNase P using similar 
approaches (2;3). Recently, progress has 
been made to determine the protein-protein 
interactions between Archaeal RNase P 
proteins (Figure 1) (4). Almost all the studies 
described above were performed using yeast-
two- or three-hybrid technology and only very 
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few interactions could be confi rmed using 
other experimental approaches (2;4;5). To 
generate a more accurate subunit-subunit 
interaction dataset, which is required for in 
vitro enzyme reconstitution experiments, we 
studied the interactions between RNase MRP 
/ RNase P subunits in vitro using recombinant 
proteins and in vitro transcribed RNAs. The 
results described in Chapter 2 of this thesis 
identifi ed a complex network of intermolecular 
interactions between RNase MRP / RNase P 
subunits in vitro (Figure 1). Many interactions 
which were found by other investigators via 
the two- and three-hybrid systems were also 
detected in our experiments. However, we also 
found interactions that were not detected in 
previous studies and vice versa. Some novel 
observations will be discussed below.
Protein-protein interactions
hPop4 and hPop1
The homodimerization (or multimerization) 
found for Pop4p in S. cerevisiae was also 
detected in vitro for the human homologue. 
In addition hPop1 and Rpp14 appeared to 
form homodimers. These observations raise 
questions about the stoichiometry of these 
proteins within the RNase P and RNase 
MRP particles. Although there is no direct 
experimental evidence for the presence of 
multiple subunits of these proteins within one 
snoRNP, recent observations suggest that 
the yeast Pop4p and Pop1p proteins and the 
human hPop4 protein may occur in more than 
one copy per RNase P / RNase MRP particle 
(9;10). These results can, however, also be 
explained by higher order complex formation 
between RNase P and RNase MRP particles, 
as was suggested by the observations of Lee 
et al. who showed that a small subpopulation of 
RNase P and RNase MRP particles associate 
with each other (11). 
The hPop1 protein is the largest polypeptide 
present in the RNase MRP and RNase P 
complexes. It has previously been suggested 
to be associated with the human RNase MRP 
complex via protein-protein contacts with two 
different parts of the ribonucleoprotein particle, 
namely the P3 and the P12 regions (7). The 
P12 region is also known to support the 
association with Rpp38, another RNase MRP 
/ RNase P protein. Therefore it was interesting 
to fi nd that hPop1 interacts effi ciently with 
Rpp38 in vitro. Whether the homodimerization 
or multimerization of hPop1 plays a role in the 
interaction with Rpp38 remains a question to 
be answered.
Rpp21, Rpp20 and Rpp25
Jarrous and colleagues showed that a complex 
of human RNase P RNA, hPop4 and Rpp21 is 
suffi cient to reconstitute the pre-tRNA cleaving 
activity of RNase P in vitro (12). Although 
other investigators observed an interaction
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Figure 1. Schematic overview of protein-protein and protein-RNA interactions between RNase MRP and RNase P subunits.
Protein subunits are represented by white circles, RNA subunits by grey circles. Homologous subunits are placed at the same relative 
position. Proteins for which no homologues are found in other species are shown below the double line. Protein-protein interactions 
are depicted as lines. Protein-RNA interactions are shown in dashed lines.  Abbreviations: Y-2/3-H: yeast-two-hybrid and yeast-three-
hybrid, EMSA: electrophoretic mobility shift assay, GST PD: GST pull-down, UV-X: UV-crosslinking.  References: Saccharomyces 
cerevisiae (upper panel left) (1); Pyrococcus horikoshii OT3 (upper panel, right) (4-6); Homo sapiens (lower panel, left) (7;8); Homo 
sapiens (lower panel, right) (2;3). Note that hPop5 and Rpp25 were not included in the study by Jiang (white dashed circles).
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between hPop4 and Rpp21 (or Pop4p and 
Rpr2p in yeast), we could not detect such a 
specifi c interaction between hPop4 and Rpp21 
in vitro. This discrepancy might be explained 
by interference of the GST-tags with this 
interaction. On the other hand, recombinant 
Rpp21 appeared to have a sticky nature. 
Therefore experiments with Rpp21 were 
performed under more stringent conditions, 
which may have affected the stability of the 
interaction between hPop4 and Rpp21, and 
possibly also interactions of Rpp21 with other 
subunits. 
Based on the co-immunoprecipitation 
of Rpp20 with autoimmune sera mainly 
recognizing Rpp25, it was suggested that 
Rpp20 and Rpp25 proteins interact with each 
other (7;13). Indeed, using the GST pull-down 
system, we could defi nitively show that Rpp20 
and Rpp25 are able to form a very stable 
heterodimer (Chapters 2 and 4). The Rpp20-
Rpp25 heterodimer will be discussed in more 
detail below.
Protein-RNA interactions
We showed that the largest protein of the 
human RNase P and RNase MRP complexes, 
hPop1, directly interacts with the RNA subunit 
of the RNase P complex and with the P3 and 
P12 domains of the RNA subunit of RNase 
MRP (Chapters 2 and 5). Previous work 
suggested that hPop1 indirectly interacts 
with these domains (7) and also protein-RNA 
interaction studies using a yeast-three-hybrid 
system did not reveal evidence for a direct 
interaction between hPop1 and the RNA 
subunit of human RNase P (2). In contrast, 
Houser-Scott and colleagues showed that 
yeast Pop1p was able to interact with RPR1 
RNA (RNase P RNA) but not with NME1 RNA 
(RNase MRP RNA) (1). In addition, Ziehler et 
al. showed that the interaction of Pop1p with 
the P3 domain of yeast RPR1 RNA appeared 
to be dependent on specifi c nucleotides in the 
P3 domain (14). These contradicting results 
may be explained by the different experimental 
approaches used for these studies. The 
sensitive GST pull-down method is able to 
detect weak protein-RNA interactions which 
may easily be missed by the procedures used 
by Pluk and Jiang. 
Specifi c determinants in the P12 domain 
involved in direct protein-RNA interactions 
have not been described yet and would be 
an interesting topic for future research. In 
particular it  would be interesting to analyse in 
more detail the interaction of the hPop1 and 
Rpp38 proteins with this RNA structure. Rpp38 
is homologous to the L7Ae kink-turn binding 
protein and may bind to the putative kink-turn 
motif present in the P12 domain of the RNase 
MRP RNA molecule (15). 
Both Rpp20 and Rpp25 were previously 
reported to associate with the P3 domain of 
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the RNase MRP RNA (7). We could extend 
these observations by showing that the P8/9 
region may contain an additional binding site 
for Rpp25. The P8/9 region is located relatively 
close to the P3 domain but it seems to support 
the Rpp25 interaction independently of the P3 
domain. Because we could confi rm that Rpp25 
occurs in only one copy per RNase MRP / 
RNase P particle (Chapter 4), Rpp25 most 
probably has two regions involved in RNA 
binding. It would be interesting to characterize 
the interaction of Rpp25 with the P8/9 domain 
in more detail and to determine which part 
of Rpp25 binds with either of the two RNA 
domains.
RNase MRP and its different 
substrates
RNase MRP (mitochondrial RNA processing) 
was fi rst described in 1987 as a murine 
endoribonuclease involved in the generation 
of an RNA species necessary for the initiation 
of mammalian mitochondrial heavy strand 
DNA replication (16;17). Purifi ed human, rat, 
bovine and yeast RNase MRP showed similar 
endoribonucleolytic activities on corresponding 
substrates (16;18-20). For the processing of 
mitochondrial primer RNA, conserved regions 
known as conserved sequence blocks (CSB) II 
and III were found to be critically important for 
cleavage of the substrate by RNase MRP (21). 
RNase MRP RNA contains a short decamer 
sequence complementary to a conserved part 
of the substrate RNA, which is located close 
to the cleavage site (22). Paradoxically, it has 
been shown that RNase MRP is not located 
within mammalian mitochondria or is present 
in only very low levels (one particle per 100 
organelles (23)). The endonuclease which 
instead is hold responsible for the generation 
of mitochondrial RNA primers is endonuclease 
G (24;25). Further investigations on the 
localization and function of RNase MRP in 
mitochondria are needed to clarify this issue. 
The majority of the cellular RNase MRP pool 
resides in the nucleolar compartment. Early 
localization experiments using anti-Th/To 
patient sera already showed a strong nucleolar 
staining which suggested a role in ribosome 
synthesis (26). Indeed, several groups 
demonstrated the involvement of RNase 
MRP in yeast pre-rRNA processing (27-29). 
Conditional expression of RNase MRP RNA 
revealed that it is involved in the generation of 
the 5’ end of 5.8S rRNA (29). More specifi cally, 
cleavage of pre-5.8S rRNA by RNase MRP 
yields the short form of 5.8S rRNA and 
suppression of RNase MRP by blocking the 
expression of its RNA component resulted in 
an accumulation of the long form of 5.8S rRNA. 
Additional evidence came with the fi nding that 
specifi c point mutations in the RNA component 
of S. cerevisiae RNase MRP (NME1) altered 
the pre-rRNA processing cascade by 
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interfering with the 5’ end processing of 5.8S 
rRNA (27). A role for RNase MRP RNA in pre-
rRNA processing in mammalian and plant cells 
was previously suggested by its association 
with pre-ribosomes (11;30) (Chapter 3), but 
only recently direct experimental evidence 
could be obtained in the human system 
(31;32). Our attempts to set up an assay, in 
which the in vitro cleavage activity of human 
RNase MRP using a human ITS1 derived 
substrate could be monitored (in analogy with 
a previously published yeast assay (28)), were 
not successful so far (our unpublished data). 
The S. cerevisiae and Homo sapiens ITS1 
sequences differ strongly in sequence and 
size; whereas the average length of the human 
ITS1 is 1300 nucleotides, the mean yeast 
ITS1 size is only 300 nucleotides. A possible 
explanation for the lack of in vitro cleavage of 
the human ITS1 may be an incorrect folding 
of the in vitro transcribed substrate RNA. Due 
to an extremely high GC-content (>80%), 
misfolding of the ITS1 can easily occur and 
structural elements are likely to be important 
for the recognition of the substrate by RNase 
MRP (29).
A third function for RNase MRP comes from 
recent studies in S. cerevisiae where it was 
found that RNase MRP RNA mutants which 
display an “exit from mitosis” defect have 
enhanced levels of CLB2 mRNA (33). RNase 
MRP appeared to cleave the 5’UTR of this 
mRNA (34). For this S. cerevisiae substrate 
also an in vitro assay has been developed. 
Currently, it is unknown whether RNase MRP 
in higher eukaryotes is able to cleave this or 
other mRNAs.
The cleavage of these diverse types of 
substrate RNAs by RNase MRP is intriguing 
because no obvious sequence homology 
can be found between these substrates. 
Their subcellular localizations are also very 
different. It is therefore likely that RNase MRP 
recognizes structural elements rather than 
specifi c nucleotide sequences. At this stage 
we can not exclude the possibility that certain 
protein subunits or other trans-acting factors 
play a role in the selection of substrate RNAs. 
A fi nal, perhaps less likely possibility that 
would explain why no sequence homology 
between the different substrates can be 
detected is that different parts of the RNase 
MRP particle could be involved in recognizing 
and/or catalyzing the cleavage of different 
types of substrates (32). 
RNase P and RNase MRP (specifi c) 
subunits
Already since the discovery of the anti-Th/To 
autoimmune sera, investigators discuss 
the possibility that human RNase MRP and 
RNase P share all of their protein subunits 
and that the only difference between the two 
particles is the identity of their RNA subunits. 
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However, this idea does not seem to be very 
logical in the light of the different substrate 
specifi cities. Like in the human system, the 
protein compositions of the yeast RNase P 
and RNase MRP particles are very similar 
(35). Nevertheless, there are well documented 
differences between these two particles in 
yeast. The fi rst protein which was found 
to specifi cally associate with RNase MRP 
was termed Snm1 (suppressor of nuclear 
mitochondrial endoribonuclease I) (36). 
Although the exact function of this protein is 
not known, mutational analysis revealed that it 
is essential for yeast viability and RNase MRP 
function (5.8S rRNA processing). Recently, 
a second RNase MRP specifi c protein has 
been identifi ed in yeast: YLR145w, also 
known as RMP1 (RNase MRP protein 1)(9). 
Unexpectedly, the identifi cation of RMP1 as a 
yeast RNase MRP-specifi c protein revealed 
also that considerable amounts of Rpr2p are 
associated with the RNase MRP complex. 
Previously, the Rpr2p protein, was reported 
to be exclusively associated with the yeast 
RNase P complex (35). A search for human 
counterparts of Snm1 and RMP1 failed to 
identify potential orthologues, which suggests 
that these proteins are not conserved among 
eukaryotes. For Rpr2p however, a human 
homologue was identifi ed and designated 
Rpp21 (37). Our results presented in Chapter 
3 show that Rpp21, like RNase P RNA, 
specifi cally co-sediments with low molecular 
weight 12S particles. High resolution density 
gradient analysis subsequently revealed 
that Rpp21 specifi cally co-sediments with 
the RNase P RNA peak rather than with the 
RNase MRP RNA peak (Figure 2). In contrast, 
the sedimentation behaviour of Rpp30 and 
Rpp40, two proteins that are believed to 
Figure 2. High resolution glycerol gradient analysis of the 
12S RNase MRP and RNase P complexes.
A total HEp-2 cell extract was fractionated on a 12-18% (v/v) 
glycerol gradient. In total 22 fractions were collected; fraction 1 
corresponds to the top of the gradient, fraction 22 to the bottom. 
Only the fractions containing 12S RNase MRP/P subunits 
(4 - 9) are shown. RNA was isolated from the fractions and 
the presence of RNase MRP RNA and RNase P RNA was 
monitored by northern blot hybridization (upper panel). The 
protein subunit distribution was determined by immunoblotting 
using subunit-specifi c antisera (as indicated on the left of each 
panel). Proteins displaying a similar sedimentation behaviour 
are grouped by boxes.
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be associated with both RNase MRP and 
RNase P, indeed was consistent with the 
presence in both particles. Moreover, co-
immunoprecipitation experiments showed 
that Rpp21, when overexpressed in human 
cells, exclusively associated with RNase P 
RNA. In agreement with our fi ndings, Jarrous 
and colleagues recently showed that Rpp21, 
immunoprecipitated from a HeLa cell extract, 
specifi cally interacts with RNase P RNA (38). 
Taken together, these results point to Rpp21 
as the fi rst human protein that preferentially 
associates with the RNase P complex. In 
addition to Rpp21, we found that hPop4 
and Rpp14 display a strong preference to 
associate with RNase P (Chapter 3 and Figure 
2). For hPop4 this is surprising because this 
protein was previously reported to associate 
with both RNase MRP and RNase P in yeast 
(Pop4p) as well as in human cells (39;40). 
Further studies will be required to clarify 
this situation, but it is interesting to note that 
Rpp21, hPop4 and Rpp14 are involved in 
binding (pre-)tRNA (10;37), and that Rpp21 
and hPop4 are the only two protein subunits 
which are required to reconstitute RNase 
P activity in vitro together with RNase P 
RNA (12). Besides protein subunits which 
preferentially associate with RNase P, the 
density gradient analyses (Chapter 3 and 
Figure 2) indicated that the composition of 
the 12S RNase MRP complex might be more 
dynamic than was thought before. Although 
the data presented in this thesis (Chapter 3) 
and data from other authors (7) show that 
hPop1, hPop5, Rpp20, Rpp25, Rpp30, Rpp38 
and Rpp40 are stably associated with the 
12S RNase MRP and RNase P particles, the 
sedimentation behaviour of hPop1, Rpp20, 
Rpp25 and Rpp38 points to a preferential 
association of these proteins with RNase MRP. 
In contrast, as noted above, the sedimentation 
behaviour of Rpp30 and Rpp40 is consistent 
with their presence in both particles.
The Rpp20-Rpp25 heterodimer
The architectural integrity, the assembly 
and the dynamic composition of the RNase 
MRP and RNase P complexes depends, in 
addition to the tertiary structure of the RNA 
components, largely on the complex network 
of protein-protein interactions. From all the 
protein-protein interactions between protein 
subunits of the human RNase P and RNase 
MRP complexes, the interaction between 
Rpp20 and Rpp25 seems to be the most 
stable one (Chapters 2 and 4).
Previously, Rpp20 was reported to act as an 
enzyme with ATPase and GTPase activity 
(41). This raised the question whether 
dimerization of Rpp20 and Rpp25 was 
dependent on ATP or GTP and to what extent 
this could be affected by the ATP/GTP-binding 
and ATPase activity of Rpp20. Our data show 
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that neither the presence of ATP nor that 
of non-hydrolysable ATP analogs affect the 
Rpp20-Rpp25 dimerization (our unpublished 
observations). The reverse question, whether 
the association with Rpp25 affects the ATPase 
activity of Rpp20 still has to be answered. 
Another intriguing, yet unanswered question 
is how these proteins interact and why 
their interaction is so extraordinary stable. 
Experiments to shed more light on this issue 
have been initiated in collaboration with NMR 
spectroscopists. It can be expected that 
the ultrastructural data will also provide an 
explanation for the observation that a single 
Figure 3. Rpp20-Rpp25 dimerization and interaction with the P3 domain of RNase MRP RNA.
Schematic representation of potential mechanisms by which Rpp20 and Rpp25 interact with the P3 domain of human RNase MRP 
RNA. The left panel shows the Rpp25-P3 interaction as a fi rst step, followed by the association of Rpp20 which stabilizes the Rpp25-
P3 interaction. The right panel illustrates a mechanism in which the Rpp20-Rpp25 dimerization precedes the binding of the dimer to 
the P3 domain.
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amino acid substitution at position 40 of Rpp20 
completely abrogates heterodimerization 
(Chapter 4).
We and others (7) showed that both Rpp20 
and Rpp25 bind to the P3 domain of RNase 
MRP RNA (Chapters 2 and 4, and Figure 3). 
In addition, Guerrier-Takada and colleagues 
reported that Rpp25 was able to interact with 
a part of the human RNase P RNA containing 
the P3 domain, whereas Rpp20 did not 
detectably interact with this RNA fragment 
(42). Furthermore, Li and Altman showed 
that the human RNase P RNA lacking the 
P3 domain can not assemble into a mature 
snoRNP (43), whereas the yeast RNase 
MRP/P P3 domain and Pop1p protein were 
previously described to be required for particle 
assembly (14;44). The involvement of the P3 
domain in assembly (or localization) is also 
supported by studies which show that the P3 
domain targets both human RNase MRP RNA 
and RNase P RNA to the nucleolus (45;46).
It is evident that the P3 domain and its 
associated proteins are important for RNase 
MRP / RNase P assembly and for the 
regulation of their functions. The formation of 
a yeast U3 snoRNA-containing subcomplex 
which is required for 40S ribosomal subunit 
assembly has been shown to be dependent on 
the GTP hydrolyzing Rcl1-Bms1 heterodimer 
(47). In view of the reported ATPase and 
GTPase activity of Rpp20, the Rpp20-Rpp25 
heterodimer might function in a similar way. 
In Chapter 3 we showed that Rpp20 and 
Rpp25, in contrast to RNase MRP RNA and 
other RNase MRP protein subunits, are not 
present in high molecular weight complexes 
corresponding to pre-ribosomes. This 
suggests that both proteins are not directly 
required for the pre-rRNA processing event(s) 
catalysed by RNase MRP. Interestingly, a 
small amount of free (non-particle associated) 
Rpp20-Rpp25 heterodimer has been detected 
in HEp-2 cell extracts (our unpublished 
results), which may refl ect heterodimers 
that are temporarily dissociated from RNase 
MRP. Our preliminary data show that siRNA 
mediated knockdown of Rpp20 or Rpp25 in 
HEp-2 cells has no detectable effect on RNase 
P RNA sedimentation, but in contrast leads to 
a decrease in the sedimentation of RNase 
MRP RNA and U3 RNA in the region of the 
high molecular weight complexes (Figure 4). 
These results strongly suggest that Rpp20 and 
Rpp25 are involved in the assembly of high 
molecular weight complexes (pre-ribosomes), 
even though they are not stably associated 
with them. Also the sedimentation profi le of 
the 5.8S rRNA is altered upon Rpp20 / Rpp25 
knock-down. This change to lower sedimenting 
complexes is probably related to an impaired 
RNase MRP function. The enhanced 
interaction effi ciency of the Rpp20-Rpp25 
dimer with the P3 domain and its absence 
from 60-80S pre-ribosome associated RNase 
MRP, supports the previously suggested 
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“add-on” role for Rpp20 (41). Rpp20 has been 
reported to interact with several non-RNase 
MRP/RNase P proteins: SMN, KIAA0615 
and Hsp27 (3;48). It will be interesting to 
investigate whether the interaction of Rpp20 
with these proteins is related to a particular 
function of RNase MRP.
RNase MRP and cartilage-hair 
hypoplasia
Disease causing mutations in structural 
RNAs have been reported for mitochondrial 
tRNA genes. Over 150 mutations on different 
tRNAs have now been documented and 
although it seems impossible to pinpoint the 
effect of every mutation, it appears that most 
Figure 4. Effect of Rpp20 and Rpp25 depletion on glycerol gradient sedimentation of RNase MRP/P complexes.
Total extracts from HEp-2 cells transfected with a control siRNA (upper panel), an siRNA targeting Rpp20 (si-Rpp20; middle panel) or 
an siRNA targeting Rpp25 (si-Rpp25; lower panel) were fractionated in a 5-40% (v/v) glycerol gradient. RNA was extracted from the 
gradient fractions and the fractionation of RNase P RNA, RNase MRP RNA, U3 RNA and 5.8S RNA was monitored by northern blot 
hybridisation. The positions of these RNAs are indicated on the left of each panel. Below the panels, the positions of reference RNAs 
(12S, 40S and 60-80S) are indicated.The use of the si-Rpp20 RNA leads to an effect in the high molecular weight region: RNase MRP 
and U3 RNA show a less pronounced peak sedimentation. This effect is more evident when Rpp25 was depleted. Both siRNAs lead 
to lower sedimentation values of 5.8S rRNA.
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mutations affect the structural integrity of the 
tRNAs, thereby interfering with tRNA function 
(reviewed by (49;50)). The RNase MRP RNA 
gene has been identifi ed as the fi rst nuclear 
encoded structural RNA gene associated 
with an inherited disease (51). The most 
frequently found CHH-related mutation in the 
RNase MRP RNA is the 70A>G substitution 
(52). This substitution is situated within the 
catalytically important J3/4 junction domain 
in the RNA (Figure 5) (53-55) and is therefore 
predicted to interfere directly with RNase MRP 
function. However, evidence for an impaired 
pre-rRNA processing pathway or a disturbed 
ratio of the long form of 5.8S rRNA versus the 
short form of 5.8S rRNA has not been found 
(our unpublished results and (51)). Also, the 
analysis of CLB2 mRNA expression levels 
in primary fi broblasts from CHH patients and 
from their fi rst degree relatives did not show 
any correlation with the manifestation of CHH 
(our unpublished results, and Hermanns 
and colleagues (56)). On the other hand, it 
has been described that introduction of the 
70A>G mutation at the equivalent position in 
the S. cerevisiae RNase MRP RNA leads to 
lower levels of the short form of 5.8S rRNA 
in yeast (56). In addition, overexpression of 
mutated human RNase MRP RNA affects 
the processing of the 5’ end of 5.8S rRNA 
in human fi broblasts and results in changes 
in CLB2 mRNA levels (32). Possible effects 
on the mitochondrial function of RNase MRP 
were not assessed in these studies. Human 
fi broblasts and other cultured primary human 
cells have a limited lifespan which is generally 
referred to as the “Hafl ick limit” (57-59). After 
approximately 50 population doublings, 
fi broblasts reach a point of replicative 
senescence and lose their replication capacity. 
Since the passage number of the fi broblasts 
used in the experiments described above is 
not always clear, senescence of these cells 
should be taken into account to explain (in 
part) the inconsistent results obtained in 
different studies.
Figure 5. The J3/4 region of RNase MRP RNA.
A detailed view of the J3/4 domain of the human RNase MRP 
RNA. Nucleotides 14-80 are shown, which also comprise the P3 
domain and part of the P2 and P4 domains. The J3/4 domain 
(grey box) is located between the P3 and P4 domains and 
contains nucleotide 70A (white circle). 
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Other CHH-causing mutations in the 
RNase MRP RNA occur mainly within the 
evolutionarily most highly conserved regions 
(52). Besides a direct effect on the catalytic 
activity, such mutations may directly interfere 
with macromolecular interactions or may 
lead to structural alterations in the RNA. 
Structural alterations can have diverse effects, 
like decreasing the optimal structure of the 
catalytic centre, reducing the effi ciency by 
which substrate RNAs are recognized, and 
interfering with the association of protein 
subunits. The CHH-causing mutation 91G>C, 
for example, is situated within a loop that 
matches the consensus sequence of the 
GNRA-tetraloop and is known to be involved in 
protein-RNA binding (32). The reported CHH-
mutations in the P12 domain of RNase MRP 
RNA (e.g. 168G>A and 218A>G), a region 
that is required for the interaction with hPop1 
and Rpp38, do not seem to affect the binding 
of these proteins as measured by GST pull-
down experiments (E. Nakashima, manuscript 
accepted for publication). 
The lack of CHH-mutations in the P3 domain 
was originally believed to be consistent with its 
critical role in RNase MRP function. However, 
four novel P3 mutations in CHH-patients were 
described recently (52). Most interestingly, 
one patient was heterozygous for two different 
P3 mutations (40G>A / 63C>U). The data in 
Chapter 5 clearly show that mutations located 
in the apical stem-loop of the P3 domain can 
severely affect Rpp20 and Rpp25 binding. 
One of the mutations leads to structural 
changes in this stem-loop, which may explain 
why both proteins cannot bind to this RNA. 
Interestingly, the interaction of hPop1 with 
these mutant RNAs was not affected, which 
suggests that CHH is caused in these patients 
by an impaired binding of Rpp20, Rpp25, or 
the Rpp20-Rpp25 heterodimer. These data 
provide the fi rst evidence of impaired protein 
binding to RNase MRP RNA caused by CHH-
related mutations. Further in vivo analyses 
of patient derived cell lines, combined with 
functional characterization of the Rpp20-
Rpp25 heterodimer will elucidate the precise 
mechanism by which these mutations reduce 
RNase MRP function and cause CHH.
Future perspectives
Our knowledge on the biochemistry of the 
human RNase P and RNase MRP particles 
has strongly increased over the past few years. 
Although our results allowed us to generate a 
model for the architecture of the human RNase 
MRP complex, more detailed insight into the 
structure of the complex at atomic resolution 
should be provided by ultrastructural analyses 
such as NMR, X-ray crystallography and/or 
cryoelectron microscopy. Since highly purifi ed 
RNase MRP is required to study the complex 
by these techniques, special procedures have 
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to be developed to achieve this, in particular 
in view of the high similarity of RNase MRP 
and RNase P. As a fi rst approach, we tried 
the streptavidin-binding S1 aptamer tag in 
the RNase MRP RNA (60). Although we were 
able to express the tagged RNA transiently 
and stably in different cell lines, attempts 
to purify the complex by this approach in 
suffi cient quantities were unsuccessful (data 
not shown). Purifi cation of the RNase MRP 
complex to apparent homogeneity would 
also be benefi cial for studies on the different 
functions of the complex. For these studies 
it will be important to take into account that 
certain subunits may only be transiently 
associated with the particle and that the 
composition of RNase MRP in different cellular 
compartments may vary as well.
Insight into the function of the individual 
subunits is one of the major challenges in 
RNase P / RNase MRP research. Although 
some proteins already have been implicated 
into specifi c functional activities, detailed 
information about their contributions to RNase 
P / RNase MRP function is not yet available. 
In this regard the Rpp20-Rpp25 heterodimer 
and the subunits preferentially associated with 
RNase P (hPop4, Rpp21 and Rpp14) seem to 
be the most interesting proteins to focus on in 
the near future. Also the existence of splice 
variants of Rpp21 (Rpp21i (37) and Rpp21ter 
(our unpublished data)) and the fi nding of a 
paralogue of Rpp25 ((Rpp25lp) Chapter 4) are 
largely unexplored topics.
The identifi cation of protein subunits 
preferentially or exclusively interacting with the 
human RNase P particle raised the question 
whether such subunits also exist for the 
human RNase MRP complex. There are some 
experimental data pointing into this direction. In 
contrast to the Th/To autoimmune sera, which 
recognize both RNase P and RNase MRP, two 
patient sera have been described (designated 
“Wa” and “B195”), which specifi cally recognize 
the RNase MRP particle (26;61) and thus might 
be valuable tools in the search for RNase MRP 
specifi c proteins.
As described above several studies showed 
that RNase MRP has multiple cellular functions. 
There are, however, reasons to assume that 
additional functions exist. For example, it has 
been described that mutations in the yeast 
RNase MRP specifi c protein Snm1p causes a 
chromosomal missegregation via a prolonged 
telophase arrest (62). Currently it is not known 
whether this phenomenon is related to the 
previously described function in Clb2 mRNA 
degradation (34) or whether this can be linked 
to the recently described temporal asymmetric 
MRP (TAM) bodies (63). 
Although more insight into the role of RNase 
MRP in the disease CHH has been obtained, 
the exact aetiology of CHH is not clarifi ed yet. 
Indeed, the number of CHH-related mutations 
in the gene encoding the RNA component 
of human RNase MRP is steadily growing. 
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Analyzing the effect of all known CHH-related 
RNase MRP RNA mutations on protein binding 
and RNase MRP function will be a challenging 
task that will not only give a complete overview 
of the mutations related to this disease, but may 
also reveal new detailed information about the 
function of specifi c regions in the RNase MRP 
RNA and their associated proteins.
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The human RNase MRP complex is a 
macromolecular complex consisting of a 267 
nucleotides long RNA subunit and at least 7 
protein subunits. RNase MRP is a so-called 
small nucleolar ribonucleoprotein particle 
(snoRNP). Depending on common structural 
RNA elements and shared protein subunits, 
snoRNPs are divided into three classes: Box 
C/D, Box H/ACA and RNase P / RNase MRP 
snoRNPs. In agreement with their nucleolar 
localization, snoRNPs are mainly involved in 
the synthesis and maturation of ribosomal RNA 
(rRNA). RNase MRP was originally discovered 
as an endoribonuclease essential for the 
generation of RNA primers for mitochondrial 
DNA replication. Later, additional functions 
(cleavage of pre-rRNA and mRNAs encoding 
cell cycle regulatory proteins) were described. 
RNase MRP is highly related to RNase P, 
an essential endoribonuclease involved in 
the maturation of pre-tRNAs. The secondary 
and tertiary structures of the RNA subunits of 
RNase MRP and RNase P are very similar and 
they share several protein subunits.
In Chapter 1, an overview of the currently 
available knowledge on the functions of the 
RNase MRP and RNase P complexes is 
provided, together with the architecture and 
composition of these snoRNPs from several 
species. The association of RNase MRP with 
human autoimmune and genetic diseases is 
also described.
To gain more insight into the structure and 
the intermolecular interactions between the 
proteins and the RNA subunit of the human 
RNase MRP complex, a series of in vitro
interaction studies were performed. By means 
of a GST pull-down approach, mutual protein-
protein and protein-RNA interactions were 
analyzed and the results of these experiments 
are described in Chapter 2. A total of 19 
protein-protein interactions were identifi ed. 
Especially hPop1, hPop4 and Rpp25 
displayed an extensive interaction profi le. Of 
all protein-protein interactions, the interaction 
between Rpp20 and Rpp25 appeared to be 
the most effi cient one. Regarding protein-RNA 
interactions, mutational analysis showed the 
involvement of specifi c RNA domains (e.g. 
the P3 domain) in the interaction with RNase 
MRP proteins. Based on the data described 
in this chapter, a two-dimensional model for 
the architecture of the human RNase MRP 
complex was generated.
Previously published work, especially in the 
yeast system, provided strong evidence that 
the RNase MRP and RNase P complexes 
share several protein subunits. However, not 
much experimental data were available for the 
human complexes and therefore this issue 
was addressed in detail. Density gradient 
sedimentation was applied to separate 
pre-ribosome-associated RNase MRP from 
free RNase MRP / RNase P complexes. In 
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addition, immunoprecipitation experiments 
from cell extracts containing tagged protein 
subunits were conducted. 
The data described in Chapter 3 show that 
RNase P, in contrast to RNase MRP is not 
detectably associated with pre-ribosomal 
particles. A differential association of Rpp20 
and Rpp25 with RNase MRP was found and 
several protein subunits which were previously 
described or suggested to associate with 
both RNase P and RNase MRP were found 
to preferentially associate with RNase P. The 
results suggest that the protein composition 
of RNase MRP is dynamic and related to its 
function or catalytic activity.
In line with the work described above, the 
relation between the Rpp20 and Rpp25 
proteins was further investigated and the 
results obtained in these experiments are 
described in Chapter 4. The subcellular 
localization of Rpp20 and Rpp25, their 
association with RNase MRP and their 
expression level appeared to depend on 
their heterodimerization. These data provided 
important insight into the suggested regulatory 
function of the Rpp25-Rpp20 dimer in RNase 
MRP biology.
In Chapter 5, mutations in the RNase MRP 
RNA associated with the disease cartilage-
hair hypoplasia (CHH) were investigated. The 
analyses were focussed on the P3 domain 
to which, amongst others, Rpp20 and Rpp25 
bind. It was found that the CHH-associated 
40G>A mutation completely abrogated 
Rpp25 binding as well as the association 
of the Rpp25-Rpp20 dimer. Also other P3 
nucleotides appeared to play a role in the 
interaction with Rpp20 and Rpp25. Additional 
structural analyses of the RNase MRP RNA P3 
domain provided evidence for the importance 
of the tertiary structure of this domain for 
Rpp25-binding. A structural alteration caused 
by the CHH-associated 40G>A mutation, or 
other CHH-associated P3 mutations, most 
likely interferes with Rpp25-binding, which in 
turn may cause its functional defect. 
In Chapter 6, the results described in this 
thesis are discussed and some additional 
experimental data are provided. Suggestions 
for future research to further explore the 
structure and function of the human RNase 
MRP complex are given.
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Samenvatting
Het menselijke RNase MRP complex is een 
macromoleculair complex dat bestaat uit 
een RNA molecuul van 267 nucleotiden en 
tenminste 7 verschillende eiwitten. RNase 
MRP is een zogenoemd klein nucleolair 
ribonucleo-eiwitpartikel (small nucleolar 
ribonucleoprotein particle; snoRNP). 
Afhankelijk van gemeenschappelijke RNA 
structuren en overeenkomstige eiwitten 
worden snoRNPs ingedeeld in drie klassen: 
Box C/D, Box H/ACA en RNase P / RNase 
MRP snoRNPs. In overeenstemming met 
hun nucleolaire localisatie zijn snoRNPs 
voornamelijk betrokken bij de synthese en 
rijping van ribosomaal RNA (rRNA). RNase 
MRP is van oorsprong beschreven als 
een endoribonuclease dat noodzakelijk is 
voor de productie van RNA primers voor 
mitochondriële DNA replicatie. Later zijn er 
nog aanvullende functies ontdekt (klieving 
van pre-rRNA en mRNA’s die coderen voor 
cel cyclus regulerende eiwitten). RNase 
MRP is sterk gerelateerd aan RNase P, een 
endoribonuclease dat essentieel is voor 
de rijping van pre-tRNA. De secundaire en 
tertiaire structuren van de RNA moleculen 
van RNase MRP en RNase P lijken in hoge 
mate op elkaar en beide complexen delen 
verschillende eiwitten.
In Hoofdstuk 1 wordt een overzicht gegeven 
over de huidige kennis van de functies, de 
opbouw en de samenstelling van de RNase 
MRP en RNase P complexen van verschillende 
organismen. Verder is de associatie van 
RNase MRP met menselijke autoimmuun- en 
genetische ziektes beschreven.
Om meer inzicht te krijgen in de structuur en de 
intermoleculaire interacties tussen de eiwitten 
en het RNA molecuul van het menselijke 
RNase MRP complex is er een serie in vitro
interactiestudies uitgevoerd. Door middel van 
GST pull-down zijn eiwit-eiwit en eiwit-RNA 
interacties bestudeerd. De resultaten hiervan 
staan beschreven in Hoofdstuk 2. Er zijn 
in totaal 19 eiwit-eiwit interacties gevonden, 
waarbij de eiwitten hPop1, hPop4 en Rpp25 
een bijzonder hoog aantal interacties 
vertoonden. Van alle eiwit-eiwit interacties 
bleek de interactie tussen Rpp20 en Rpp25 de 
meest effi ciënte te zijn. Wat betreft eiwit-RNA 
interacties werd aangetoond dat specifi eke 
domeinen van het RNA molecuul (zoals het 
P3 domein) betrokken zijn bij de interactie 
met RNase MRP eiwitten. Gebaseerd op 
de informatie die beschreven staat in dit 
hoofdstuk is er een tweedimensionaal model 
van het menselijke RNase MRP complex 
ontworpen.
Aan de hand van eerder gepubliceerde 
informatie uit giststudies bestaan er sterke 
aanwijzingen dat de RNase MRP en RNase 
P complexen meerdere eiwitten delen. 
Voor de menselijke RNase MRP en RNase 
P complexen was hierover nog niet veel 
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informatie beschikbaar. Daarom is hier nadere 
analyse aan verricht. Om pre-ribosoom 
geassocieerd RNase MRP te scheiden van 
vrije RNase MRP / RNase P complexen 
werd er dichtheidsgradient sedimentatie 
verricht. Verder werden er immunoprecipitatie 
experimenten uitgevoerd op celextracten 
welke getagde eiwitten bevatten. In Hoofdstuk 
3 wordt getoond dat RNase P, in tegenstelling 
tot RNase MRP, niet detecteerbaar was 
geassocieerd met pre-ribosomen. Er werd 
gevonden dat de Rpp20 en Rpp25 eiwitten 
differentieel associëren met RNase MRP 
en van enkele eiwitten, waarvan tot heden 
gesuggereerd werd dat deze met zowel 
RNase P als RNase MRP associeerden, werd 
gevonden dat deze preferentieel met RNase 
P associëren. De resultaten doen vermoeden 
dat de eiwitsamenstelling van RNase MRP 
dynamisch is en samenhangt met de functie of 
de katalytische activiteit.
In navolging van het hierboven beschrevene 
is de relatie tussen Rpp20 en Rpp25 verder 
onderzocht en de resultaten van deze studie 
staan beschreven in Hoofdstuk 4. Het bleek 
dat de subcellulaire lokalisatie van Rpp20 
en Rpp25, hun associatie met RNase MRP 
en hun expressieniveau’s afhankelijk zijn 
van heterodimerisatie. De in hoofdstuk 4 
beschreven data verschaffen belangrijk inzicht 
in de gesuggereerde regulerende functie van 
de Rpp25-Rpp20 dimeer in de biologie van 
RNase MRP. In Hoofdstuk 5 staat onderzoek 
beschreven naar mutaties in het RNase MRP 
RNA die geassocieerd zijn met de ziekte 
cartilage-hair hypoplasia (CHH). De analyses 
richtten zich op het P3 domein waaraan 
Rpp20 en Rpp25 binden. Er werd gevonden 
dat de CHH-geassocieerde 40G>A mutatie de 
binding van Rpp25 volledig verbrak, zo ook 
de associatie van de Rpp25-Rpp20 dimeer. 
Andere nucleotiden van het P3 domein bleken 
ook een rol te spelen in de interactie met 
Rpp20 en Rpp25. Aanvullende structurele 
analyse van het RNase MRP RNA P3 domein 
heeft uitgewezen dat de tertiaire structuur 
van dit domein belangrijk is voor de binding 
van Rpp25. Een structurele verandering, 
veroorzaakt door de CHH-geassocieerde 
40G>A mutatie of andere CHH-geassocieerde 
P3 mutaties interfereren zeer waarschijnlijk 
met Rpp25 binding, wat vervolgens kan leiden 
tot een functioneel defect.
In Hoofdstuk 6 worden de in dit proefschrift 
beschreven resultaten bediscussieerd en 
worden aanvullende experimentele data 
getoond. Verder worden er mogelijkheden 
genoemd om de structuur en functie van 
het menselijke RNase MRP complex in de 
toekomst verder te onderzoeken.
   170                Dankwoord - Acknowledgments
Dankwoord - Acknowledgments
Voilà, het is klaar!
Voor jullie ligt mijn proefschrift en daarmee 
komt er helaas een einde aan een tijdperk in 
mijn leven. Zoals Walther van Venrooij aan 
het begin van mijn promotietijd geheel terecht 
opmerkte: “de mooiste tijd van je leven”. 
Tijdens mijn promotieonderzoek heb ik hulp 
en raad ontvangen van veel mensen en ik heb 
me verheugd op het moment dat ik deze kon 
gaan bedanken!
Ger Pruijn, mijn promotor. Jij bent de eerste 
die ik ontzettend bedank voor ontzettend veel. 
Samen met Walther was jij degene die mij als 
promovendus zag zitten. Ik dank je voor je 
vertrouwen, je geduld en het nakijken van mijn 
manuscripten. Je hebt een grote rol gespeeld 
tijdens mijn promotie en mij wetenschappelijk 
gevormd. Ons bezoek aan de “RNA meeting” 
in Madison, U.S.A. was super (een stekker 
werkt echt beter dan schoenveters en balpen 
onderdelen…). Professor Ger, ik wens je 
succes met je nieuwe BMC-groep en heel veel 
geluk!
Walther van Venrooij, tweede promotor. Mede 
door uw vertrouwen is mijn promotietijd “de 
mooiste tijd van mijn leven” geworden (al weet 
ik natuurlijk niet wat er nog gaat komen…). Uw 
raad en commentaar zijn van grote waarde 
geweest en ik waardeer uw pragmatische 
manier van denken. Het is toch een “Jochem” 
geworden he?!...
Els, waar zou de VRT/BMC zijn zonder jou?! 
Bij jou kwam ik ventileren, relativeren en 
gewoon gezellig effe zitten.  Bedankt voor 
alle regeldingen en voor de uitbreiding van je 
snoepwinkel met witte KitKat-chuncky en Mars 
Delight!
Er hebben heel wat luitjes in het “MRP U-tje” 
proefjes gedaan. Mijn studenten-“harem”, 
bestaande uit Nienke, Floor, Lianne, Sanne en 
Sylvie heeft heel veel werk verzet. Respect! 
Dankzij jullie konden gedachtenspinsels en 
hypothesen getest worden: veel GST pull-
downs (Nienke), veel kloneer geklooi en op 
en neer geloop naar het NMR lab (Floor), 
veel zout en reconstituties (Lianne), veel 
gradientfracties (Sanne) en Rpp20-Rpp25 
mutanten (Sylvie). Jullie hebben niet alleen 
van mij geleerd, ik heb ook van jullie geleerd! 
Heel erg bedankt voor een fantastische tijd 
samen. Nienke, ik hoop dat je er op mijn 
promotie bij kan zijn: heel veel succes in 
Engeland! En Floor, ik wens je alle succes en 
wijsheid tijdens je promotietijd Utrecht. Maak 
er “de mooiste tijd van je leven” van…
Bastiaan, je snapt waarom je niet bij het Harem 
staat... Ook jij hebt mooie bijdragen geleverd 
aan het MRP onderzoek. Ik heb genoten van 
de wijntjes die we samen gedronken hebben 
en nog gaan drinken en je kookkunsten. Ik 
vind het super dat jij mijn paranimf wilt zijn!
Onder het motto: “buiten het MRP U-tje is er 
ook leven” kom ik bij m’n labgenoten. Judith: 
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ook jij neemt als mijn paranimf een bijzondere 
plaats in vandaag! Bedankt voor het verzorgen 
van de wandelende takken en de cactus. 
Vooral voor al je gezelligheid en zorgen, ik 
wens je heel veel geluk met jullie kindje!!
Geurt, als Aio-Buurman bespraken we onze 
experimenten en ideeën veel samen en 
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eens goed voor te gaan zitten/hangen en de 
brainstorm begon te stormen. Bedankt voor 
je inbreng als Aio-Buurman en ik wens je veel 
succes met de voltooiing van je exosoom-
proefschrift. En “Es-Wee” know….jij bent de 
volgende!
...”I feel happy”…Met het toekennen van een 
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RNA to a small man”, werd mijn opvolgster 
bekend. Sandy, we hebben een hele tijd nog 
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Hoofdstuk 5. Het was vreemd om mijn project, 
mijn kindje, over te dragen aan een ander, 
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geweldig hoe je het project hebt opgepakt! 
Heel veel succes met je project en let goed op 
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periode geworden. Bedankt voor jullie hulp, 
enthousiasme, luisterende oren, brainstorms, 
BBQ’s, fi lmavonden, kerstdinchen, 
paaslunchen, Sinterklaasmiddagen, dagjes 
uit, cake’s van de week, geweldige act op onze 
bruiloft en alle andere FeCo-activiteiten.
Danielle, jij nog in het bijzonder heel veel 
succes in Zwitserland. Ik hoop dat jullie droom 
werkelijkheid wordt. Het is ons inderdaad 
gelukt!
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Dear Sidney, Cecilia and Yong. During my 
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and plasmids which were essential for the 
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all very much for our nice collaboration and 
confi dence during the years!
Nayef and Robert, you are also greatly 
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everything!  
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